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ABSTRACT 
Background/Aims: Obesity has increased rapidly in South African children and adolescents with 
significant variability observed among racial groups. Genes that regulate appetite have been studied in 
different populations worldwide, but their role in obesity among South African adolescents is unknown. 
The present study aimed at investigating the role of these genes, and their combined effect with 
physical activity in the development of obesity among South African adolescents. 
 
Methods: A total of 1564 South African school learners of Caucasian (n= 146), Mixed Ancestry (n= 
872) and Black African (n= 537) ethnic groups were recruited for a research project that aimed to 
elucidate diabetes and the metabolic syndrome in children and adolescents attending schools in peri-
urban areas of the Western Cape. The present case-control study included 227 obese-overweight 
(115 Black Africans and 112 Mixed Ancestry), and 204 normal weight (94 Black Africans and 110 
Mixed Ancestry) adolescents learners. The learners were genotyped for nine polymorphisms (LEP: 
19G>A, Lys36Arg, Val94Met; LEPR: Lys109Arg; Gln223Arg, Lys656Asn; CART: c.160-33G>A, 
c.499delA, and c.517A>G; GHRL: Leu72Met; and MC3R: Thr6Lys, Val81Ile) using allele-specific 
restriction enzyme analysis and automated sequencing. Genotype and haplotype associations with 
anthropometric variables such as body mass index (BMI), waist, hip, and mid-upper-arm 
circumferences (WC, HC, MUAC), and metabolic traits (fasting blood glucose, high density lipoprotein-
cholesterol, total cholesterol), and blood pressure were further conducted. Furthermore, the type and 
frequency of physical activity was assessed by means of structured questionnaires; and its effect on 
obesity-related variables investigated in learners that were genotyped for the MC3R Thr6Lys and 
Val81Ile polymorphisms. 
 
Results: In a stepwise backward logistic regression analysis (containing age, gender, and LEP, 
LEPR, CART and GHRL polymorphisms), CART c.517A>G was independently significantly associated 
with obesity (OR= 5.98; 95%CI= 2.02, 21.27). CART c.517G carriers had higher MUAC (β coefficient= 
1.88; 95%CI= 0.31, 3.44) while the LEPR 109Arg allele was significantly associated with decreased 
BMI (β coefficient = -2.36; 95%CI= -4.24, -0.47), WC (β coefficient = -5.66; 95%CI= -9.89, -1.44) and 
MUAC (β coefficient = -1.61; 95%CI= -3.00, -0.22); after adjusting for age, gender, and ethnicity. The 
haplotype containing the three LEP polymorphisms (A-A-A compared to the reference G-A-G 
haplotype) increased BMI (p= 0.0155), MUAC (p= 0.0146), and HC (p= 0.0128). The minor alleles of 
the MC3R polymorphisms decreased BMI, HC, WC, MUAC and TC; whilst only the Thr6Lys was 
associated with systolic and diastolic blood pressure (p= 0.0047 and 0.0027, respectively) in Mixed 
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Ancestry learners.  Doing house chores was associated with lower total cholesterol, independently 
and in the presence of the 81Ile allele (β coefficient = -0.355; 95%CI= 0.148, 0.561).  
 
Conclusion: To our knowledge, this is the first study that reports CART c.517A>G polymorphism as a 
risk factor for obesity in adolescents. Furthermore, the present study demonstrated that the MC3R 
polymorphisms had a positive effect on total cholesterol, which was further enhanced in physically 
active individuals. Similar to other studies, LEPR Lys109Arg and LEP polymorphisms were associated 
with variations in obesity-related variables among Black African and Mixed Ancestry South African 
learners.  
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OPSOMMING 
Agtergrond/Doelwitte: Vetsug het drasties toegeneem in Suid-Afrikaanse kinders en adelossente 
met ‘n beduidende variasie opgemerk tussen verskillende rassegroepe. Gene verantwoordelik vir 
regulering van eetlus is reeds wêreldwyd in verskillende bevolkingsgroepe bestudeer, maar hul rol in 
oorgewig Suid-Afrikaanse adolessente is  onbekend. Die huidige studie was daarop gerig om 
ondersoek in te stel na die rol van hierdie gene en hul gekombineerde effek met fisiese aktiwiteit in die 
ontwikkeling van vetsug onder Suid-Afrikaanse adolessente.  
 
Metodes:  ‘n Totaal van 1564 Suid-Afrikaanse leerders van Kaukasiese Afkoms (n=146), Gemengde 
Afkoms (n=872) en Swart Afkoms (n= 537) was gewerf in die navorsingsprojek wat ten doel gehad het 
om kinders en adolosente met diabetes en die metaboliese sindroom te identifiseer wat skole 
bygewoon het in  semi-voorstedelike gebiede van die Wes-Kaap. Die huidige gevalle studie het 227 
vetsugtige-oorgewig (115 Swart Afkoms en 110 Gemengde Afkoms) en 204 normale gewig (94 Swart 
Afkoms en 110 Gemengde Afkoms) leerders ingesluit. Die leerders was gegenotipeer vir nege 
polimorfismes (LEP: 19G>A, Lys36Arg, Val94Met; LEPR: Lys109Arg; Gln223Arg, Lys656Asn; CART: 
c.160-33G>A, c.499delA, and c.517A>G; GHRL: Leu72Met; and MC3R: Thr6Lys, Val81Ile) met die 
gebruik van alleel-spesifieke restriksie ensiem analises en geoutomatiseerde DNA volgorde bepalings 
tegnieke. Genotipiese en haplotipiese assosiasies met antropometriese veranderlikes soos 
liggaamsmassa indeks (BMI), middel-, heup- en mid-boarm omtrek (WC, HC, MUAC), metaboliese 
tendense (vastende bloed glukose, hoë-digtheid lipoproteïen-cholesterol, totale cholesterol) en 
bloeddruk was ook uitgevoer. Die tipe en frekwensie fisiese aktiwiteit was geassesseer deur middel 
van gestruktureerde vraelyste; en die uitwerking daarvan op vetsugverwante veranderlikes ondersoek 
in leerders wat vir die  MC3R Thr6Lys en Val81Ile polimorfismes gegenotipeer was. 
 
Resultate: Statistiese ontleding (‘‘stepwise backward logistic regression analysis”), wat ouderdom, 
geslag en polimorfismes (LEP, LEPR, CART GHRL) ingesluit het, het getoon dat CART c.517A>G 
betekenisvol onafhanklik geassosiasieer was met vetsug (OR= 5.98; 95% CI= 2.02, 21.27). CART 
c.517G draers het ‘n hoër MUAC waarde gehad (β koeffisient = 1.88; 95%CI= 0.31, 3.44), terwyl die 
LEPR 109Arg alleel betekenisvol geassosieer was met verlaagde BMI ((β koeffisient = -2.36; 95%CI= 
-4.24, -0.47), WC (β koeffisient = -5.66; 95%CI= -9.89, -1.44) en MUAC (β koeffisient = -1.61; 95%CI= 
-3.00, -0.22) na die aanpassing van ouderdom, geslag en etnisiteit. Die haplotipe met die drie LEP 
polimorfismes (A-A-A teenoor die G-A-G verwysingshaplotipe) het die BMI (p= 0.0155), MUAC (p= 
0.0146) en HC (p= 0.0128) verhoog. Die mindere allele van die MC3R polimorfismes het die BMI, HC, 
WC, MUAC en TC verlaag; terwyl slegs die Thr6Lys polymorfisme met sistolies en diastolies 
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bloeddruk (p= 0.0047 en p= 0.0027, onderskeidelik) geassosieer was in Gemengde Afkoms leerders. 
Die verrigting van algemene huistake was geassosieer met laer totale kolesterol vlakke, onafhanklik 
en in die teenwoordigheid van die 81lle alleel (β koeffisient= -0.355; 95%CI= 0.148, 0.561).  
 
Gevolgtrekking: Na ons wete is hierdie die eerste studie wat die CART c.517A>G polimorfisme as ‘n 
risikofaktor vir vetsug in adolessente aantoon. Die huidige studie toon ook dat die MC3R  polimorfisme 
‘n positiewe effek op totale kolesterol gehad het, wat ook verder versterk was in fisiese aktiewe 
individue. Soortgelyk aan ander studies, was die LEPR Lys109Arg en LEP polimorfismes geassosieer 
met variasies in vetsug-verwante veranderlikes onder Suid-Afrikaanse Swart en Gemengde Afkoms 
leerders.  
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Outline of thesis 
The present study is of cross-sectional design, investigating factors contributing to the development of 
polygenic obesity in South African adolescent learners. Six genes of the leptin-melanocortin pathway 
that are known to regulate food intake and energy expenditure, and have been reported to contribute 
to the development of obesity, were investigated. In addition, the role of physical activity in obesity and 
its possible association with the melanocortin receptor-3 gene was investigated. Chapter 1 provides a 
brief insight on obesity and its contributing factors, presenting an overview of what is currently known 
from studies conducted globally. The relative contribution of environmental factors such as socio-
economic status, sedentary lifestyle (consumption of high-calorie food and physical inactivity), 
urbanisation, and genetic predisposing variants are discussed. Due to the wide scope on genes 
contributing to the polygenic form of obesity, a brief overview of studies conducted on the subject (with 
special reference on monogenic obesity) is presented. A brief introduction of the six genes 
investigated in the present study follows in chapters 2 and 3.  Literature published until January 2011 
is included. Aims and objectives of the present study are presented as the last section of Chapter 1. 
Findings obtained from the present study are organised and described in detail in chapters 2 and 3, 
according to the manuscripts that were published. Each chapter consists of a brief introduction on the 
genes included, methods used for analyses, results and discussion. Finally, an integrated conclusion 
is presented in Chapter 4. References for all the chapters appear in the last section, followed by 
appendices. 

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1.1. Definition and diagnosis of obesity 
1.1.1. Definition for adults 
Obesity is listed as one of the ten leading risk factors for high mortality in both developed and 
developing countries as it is associated with potentially debilitating illnesses such as cardiovascular, 
pulmonary (such as sleep apnoea), metabolic (diabetes and dyslipidaemia) and osteoarticular 
diseases, common forms of cancer (cervical, uterus, breast, ovarian), and serious psychological 
illness (Berenson et al., 1993). Obesity together with insulin resistance, hypertension, type 2 diabetes, 
atherogenic dyslipidemia and hypertension are a group of metabolic components that constitute the 
metabolic syndrome. Physiologically, obesity is defined as an imbalance between energy intake and 
expenditure to such an extent that surplus energy is stored in fat cells (adipocytes), which expand and 
increase in number. Due to the difficulty of directly measuring body fat, obesity is often expressed as 
excess body weight rather than excess fat. As a quantitative entity, obesity is therefore defined on the 
basis of body mass index (BMI), which is calculated as weight in kilograms (kg) divided by height in 
metres squared (m2). Although BMI is not a direct measure of body fat, it is a more accurate indicator 
of overweight excess weight and obesity compared to weight alone (NIH report, 1998). An expert 
panel convened by the National Heart, Lung and Blood Institute and the National Institute of Diabetes 
and Digestive and Kidney Diseases defined overweight as a BMI of 25 to 29.9 kg/m2 and obesity as a 
BMI of 30.0 kg/m2 (Table 1.1). Similar to the World Health Organisation (WHO) recommendations, the 
National Institute of Health (NIH) defined normal weight as a BMI of 18.50–24.9 kg/m2.  
Table 1.1. International Classification of adult underweight, overweight and obesity according to the 
body mass index as recommended by the National Institute of Health and World Health Organisation 
(WHO). Adapted from www.who.int/bmi/index.jsp?introPage=intro_3.html 
Body weight category Body mass index Obesity class  
Underweight <18.5  
Normal 18.5–24.9 (NIH); 18.50 - 24.99 (WHO)  
Overweight 25.0–29.9 (NIH); 25.00 - 29.99 (WHO)  
Obesity 30.0–34.9 (NIH); 30.00 - 34.99 (WHO) 
35.0–39.9 (NIH); 35.00 - 39.99 (WHO) 
 
I 
II 
Extreme obesity >40.0 (NIH); 40.00 (WHO) III 
NIH, National Institute of Health; WHO, World Health Organisation 
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BMI is commonly used as a measure of obesity in clinical and research settings, however, alternative 
anthropometric measures such as waist circumference (WC), and waist-hip-ratio (WHR) that reflect 
abdominal adiposity have been suggested to be the most accurate determinants and predictors of 
cardiovascular diseases (CVD) and type 2 diabetes (Wei et al., 1997; Stevens et al., 2001; Janssen et 
al., 2004). This is based on the premise that increased visceral adipose tissue is associated with 
metabolic abnormalities such as decreased glucose tolerance, reduced insulin sensitivity and adverse 
lipid profiles, which are risk factors for type 2 diabetes and CVD. Several studies also suggest that 
coupling BMI with WC provides a stronger health risk indicator than using BMI alone (Chan et al., 
1994; Rexrode et al., 1998; Janssen et al., 2002 ; Ardern et al., 2003; Bigaard et al., 2003; Huxley et 
al., 2010). In support of this, the NIH guidelines indicate that the risk of acquiring CVD and type 2 
diabetes increases in a graded fashion when moving from normal-weight through obese BMI 
categories, and that within each BMI category men and women with high WC values are at a greater 
health risk than are those with normal WC values (Table 1.2[a]) (NIH, NHLBI, 1998). Vazquez and co-
workers (2007), however, conducted a meta-analysis that was based on published studies on diabetes 
from 1966 to 2004, and concluded that there is a high statistically significant correlation between BMI 
and WC, suggestive of a similar ability of these tools to predict diabetes. Similarly, Højgaard and co-
workers (2008) demonstrated that individuals with high BMI and/or high WC are more at risk of dying 
from CVD than those with lower cut-off points of these anthropometric measurements.  
 
Table 1.2(a). Combined recommendations of body mass index and waist circumference cut-off points 
made for overweight or obesity classifications, and association with disease risk. Taken from the WHO 
report, Geneva 2008. 
 
Body weight 
category 
Body mass index Obesity class  Disease risk (relative to normal weight and 
waist circumference) 
   
Men < 102 cm 
Women < 88 cm 
Men >102 cm 
Women >88 cm 
Underweight <18.5    
Normal 18.5–24.9    
Overweight 25.0–29.9  Increased  High 
Obesity 30.0–34.9 
35.0–39.9 
 
I 
II 
High  
Very high 
Very high 
Very high 
Extreme obesity >40.0 III Extremely high  Extremely high 
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The cut-off points of abdominal anthropometric measures that define the risk of CVD and type 2 
diabetes varies among different populations (Table 1.2[b]) (Huxley et al., 2010). Studies conducted in 
Asian populations, for example, have demonstrated that these population groups have an increased 
metabolic risk at lower WC (85-90 cm and 80 cm for men and women, respectively) and WHR (0.90 
and 0.80 for men and women, respectively) than Europeans (Diaz et al., 2007; Huxley et al., 2007; 
2008). It has also been demonstrated that abdominal adiposity is a more consistent predictor of 
diabetes and CVD among Asians (Cassano et al., 1992; Boyko et al., 2000; Suka et al., 2011), while 
BMI was shown to be a more reliable tool for determining the risk of diabetes among American 
Caucasians (Spiegelman et al., 1992; Chan et al., 1994). The evidence is insufficient for WC and 
WHR specific cut-offs for African-American, Hispanic and Middle Eastern populations, although some 
studies suggest the use of current cut-offs for Europeans. The values for other ethnic groups are 
between those for Caucasians (WC and WHR= respectively, 97-99 cm and 0.90 for American and UK 
Caucasian men; and 85 cm and 0.83-0.85 for American and UK Caucasian women) and Asians, as 
reviewed by Qiao et al (2010). There is also very limited data for populations of African origin, and 
hence no cut-off points are recommended for sub-Saharan populations. The available data 
recommends WC cut-off points of 75.6 cm and 80.5 cm for men, and 71.5 cm and 81.5 cm for women 
of Nigerian and Cameroon origin, respectively, for the identification of hypertension (Okosun et al., 
2000). It is, therefore, apparent that universal cut-off points of BMI and WC cannot be used globally.  
Other methods available to measure body composition in adults include dual energy X-ray 
absorptiometry, whole body plethysmography, and devices that measure body conductivity. 
Table 1.2(b). World Health Organization cut-off points for waist circumference and waist-hip-ratio 
(WHR) and risk of metabolic complications. Taken from the WHO report, Geneva 2008. 
 
Indicator  Cut-off points Risk of metabolic 
complications 
Waist circumference 94-102 cm (male); 80-88 cm (women) 
>88 cm (male); > 102 cm (women) 
Increased 
Substantially increased 
Waist-hip ratio 0.90 cm (male); 0.85 cm (women) Substantially increased 
 
1.1.2. Definition for children and adolescents 
Measuring obesity in children and adolescents is complex due to changes in body weight during 
developmental stages. The levels of growth hormone and insulin-like growth factor increase during 
puberty. Along with sex hormones, these peptides are responsible for the pubertal growth spurt 
(MacGillivray et al., 1998; Abbassi, 1998; Plant, 2001). As a result of variation in growth and sex 
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hormone during developmental stages, BMI in childhood changes substantially with age (Rolland-
Cachera et al., 1982; Cole et al., 1995). At birth the BMI median is as low as 13 kg/m2, increases to 17 
kg/m2 at age 1, decreases to 15.5 kg/m2 at age 6, then increases to 21 kg/m2 at age 20. It is for this 
reason that standardised cut-off points adjusted according to age and gender were developed. 
Definition of overweight and obesity in children and adolescents is based respectively, on the 85th and 
95th percentiles of sex-specific BMI-for-age. These reference values were developed from reference 
populations specified for a given country. For example, the 1990 British growth reference was 
developed from a survey representative of English, Scotland and Wales (Cole et al., 1998). The 
United States of America developed its own reference values, the Centres for Disease Control and 
Prevention (CDC) 2000 growth charts, from five nationally representative surveys (the National Health 
Examination Surveys II and III in the 1960s, the National Health and Nutrition Examination Surveys 
[NHANES] I and II in the 1970s, and NHANES 1988-1994) (Kuczmarski et al., 2002). The 2000 CDC 
growth charts, which were adapted from the 1977 National Center for Health Statistics growth charts, 
included a sex-specific BMI-for-age growth chart for children 2 years and older. Overweight is defined 
as a BMI at or above the 95th percentile, and at risk for overweight as that between the 85th and 95th 
percentile. In these growth charts, the ‘at risk’ of overweight corresponds to the adult overweight and 
the child overweight to adult obesity. It is recommended that WHO growth charts be used to monitor 
growth for infants and children aged 0-2 years. The WHO also developed BMI-for-age growth charts 
for preschoolers from birth to 5 years of age (WHO Multicenter Growth Reference Study Group, 2006) 
that were based on height, weight, and age. These charts, as well as the 1990 UK reference, are 
intended primarily for clinical use in monitoring children’s growth, other purposes such as definition 
and diagnosis of overweight and obesity are secondary.  
 
Due to the non-representative nature of the CDC growth charts, the International Obesity Task Force 
(IOTF) developed BMI reference values that defined childhood obesity and overweight based on the 
data pooled from different countries such as Brazil, Britain, Hong Kong, Netherlands, Singapore, and 
the United States. The IOFT reference values were not developed to replace national reference 
values, rather to provide a common set of definitions that can be used in epidemiological and other 
related research studies, and by policy makers in different countries. These reference values were 
developed based on adult cut-off points that were linked to BMI centiles (85th and 95th percentiles) of 
children and adolescents (Cole et al., 2000). Comparing the prevalence of childhood obesity between 
and within countries using the IOTF reference values is still challenging due to the complexity of body 
composition among individuals of various racial groups.  
Other anthropometric indicators have also been investigated as tools of determining weight status in 
children and adolescents. For example, a study by Chomtho et al (2006) found a strong correlation  
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between mid-upper-arm circumference (MAUC), triceps skinfold thickness, arm fat area; and total fat 
mass. In this study the authors observed that arm fat area, MAUC, and triceps skinfold thickness 
explained 67, 63, and 61% of variability in total fat mass in healthy children. Mazıcıolu and coworkers 
(2010) supported the use of more than one anthropometric measure by suggesting that the WC and 
MUAC be substituted for one another as an additional evaluation tool next to BMI in detecting 
overweight and obese children and adolescents. Regardless of these findings, it is recommended that 
reference values be developed for each population in order to properly identify children and 
adolescents at risk of developing cardiovascular diseases. 
 
1.2. Prevalence of Childhood Obesity 
Obesity, initially thought to affect affluent countries, is now a global health problem estimated to affect 
more than 1 billion adults (http://www.who.int/mediacentre/factsheets/fs311/en/index.html). Obesity 
prevalence is distributed unevenly across countries ranging from below 5% in Japan, Republic of 
Korea, China (though in some cities rates are almost 20%) and Indonesia to 75% in urban Samoa. A 
similar uneven trend in overweight prevalence has been observed across countries worldwide, with 
Japan having a lower rate of 23.2% while in USA it was as high as 66.3% (Low et al., 2009). In 
developing countries, the prevalence of overweight ranges from 2.4% in Indonesia to 35.6% in Saudi 
Arabia.  
 
South Africa is among the countries undergoing economic transition and as a result obesity and 
overweight prevalence are approaching those reported in developed countries (Puoane et al., 2002; 
Dept of Health & MRC 2008). In comparison to other African countries, South Africa is among 
(including Egypt, Libya, Cameroon, and Tunisia) those with the highest prevalence of 
obesity/overweight (WHO comparable estimates, 2005) (Fig. 1.1). Similar to other countries, gender 
differences are observed in African population groups with females more affected than males 
(Cameron and Getz, 1997; Wisniewski and Chernausek SD, 2009; Baalwa et al., 2010). In South 
Africa particularly, approximately 8.8% of men and 27.4% of women older than 15 yearswere found to 
be obese according to the second South African Demographic and Health Survey (SADHS) conducted 
in 2003 (Department of Health, 2007). Urban dwellers, particularly Black women, were more obese 
than their Mixed Ancestry and Caucasian counterparts, highlighting race and demography as other 
important contributing factors to the variable prevalence observed among the country’s population 
(Steyn et al., 1998; Walker et al., 2001; Puoane et al., 2002). However, among males, the highest 
prevalence of overweight and obesity was found in Caucasians and lowest in Mixed Ancestry and 
Blacks. 
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Similar to adults, obesity is a health concern in children and adolescents as it persists into adulthood 
with 80% of obese children likely to become obese adults (Schonfeld-Warden and Warden, 1997). In 
some cases, many complications associated with obesity are already evident in childhood, 
necessitating implementation of health management strategies at an earlier age. According to the 
WHO report (http://www.who.int/mediacentre/factsheets/fs311/en/index.html), approximately 43 million 
children under the age of 5 years globally were overweight of which 35 million were in developing 
countries. Since the1960s, childhood obesity has increased rapidly in both industrialized countries and 
those undergoing economic transition. Between 2002 and 2005, up to 32% of the population in 
developed countries was overweight or obese (Wang and Lobstein, 2006). Similar rates were 
observed in developing countries such as India, Mexico, Nigeria, and Tunisia.  
 
The prevalence of overweight (6.9% for boys and 24.5% for girls) and obesity (2.2% for boys and 
5.3% for girls) in South African adolescents appear to be the highest among all African countries 
(Wang and Lobstein, 2006). The South African Youth Risk Behaviour Survey (SA YRBS) 2002 (Reddy 
et al., 2008) found 21% of adolescents aged 13-19 years to be obese/overweight, with gender 
differences ranging from 7% in boys to 25% in girls. However, a study conducted in a rural area of 
Mpumalanga province documented a lower prevalence of overweight/obesity of 10% in adolescents of 
the same age; 16% in girls and 7% in boys (Kimani-Murage et al., 2010). Regardless of the lower 
prevalence observed in this study, gender differences were noted similar to findings of the SA YRB 
survey. Gender differences may be due to higher energy requirement in physically active boys 
compared to girls, hormone variation, and body image preference in girls (particularly in Black Africans 
and African Americans) (Kruger et al., 2006). Obesity in Black African girls increases with age while an 
opposite pattern was observed in their Caucasian counterparts (Armstrong et al., 2006). The effect of 
age in the prevalence of overweight and obesity in youth was also noted in the study by Kimani-
Murage et al. (2010). In this study, the prevalence of overweight and obesity in girls was moderate in 
early childhood and low in late childhood. However, the prevalence increased progressively from age 
10 years. This paradigm shift of obesity as the population ages may be due to cultural pressures of 
appreciating full-figured females as opposed to thin females, particularly in Black Africans.  
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a) 
 
b) 
 
Figure 1.1. Global estimates of overweight and obesity (BMI  25 kg/m2) prevalence, in a) males and 
b) females aged 15 years and above.  Accessed in World Health Organisation website in April 2011. 
Stellenbosch University http://scholar.sun.ac.za 
 
 
 
10
As observed in other countries, obesity and overweight rates in South Africa also vary according to 
ethnicity and demographics. In all South African studies conducted thus far, urban children and 
adolescents are more overweight and obese than their rural counterparts, with the prevalence ranging 
from 4-13% (overweight) and 1-6% (obesity) (Table 1.3). These regional differences may be due to 
variations in physical activity levels and the type of food consumed. For example, rural dwellers are 
more physically active as they are likely to perform household and outdoor duties, and walk more 
frequently than their urban counterparts. They also consume less processed food with less fat content 
than urban dwellers (Vorster et al., 2005). Among obese/overweight children living in urban areas, 
Caucasians were mostly affected (Reddy et al., 2008). The higher prevalence observed in this 
population group may be due to cultural and socio-economic factors, which will be discussed in the 
following sub-section.  
Table 1.3. Comparison of overweight and obesity in rural and urban dwellers in South African national 
studies. Taken from Kimani-Murage et al. (2010). 
Study Population (n) Reference Overweight Obesity 
   
Rural Urban Rural Urban 
NFCS (1999) 1-9 years (2894) Labadarios et al., 2005 12 13 4 6 
NFCS (2005) 1-9 years (2469) Department of Health, Stellenbosch 
2007 
10 10 4 4 
Agincourt 
(2007) 1-20 years (3489) Kimani-Murage et al. (2010) 6  2 - 
 1-4 years (671)  7 - 1 - 
 5-9 years (970)  4 - 1 - 
 10-14 years (944)  6 - 2 - 
 15-20 years (904)  8 - 4 - 
Abbreviations: DHS, Department of Health Survey; NFCS, National Food Consumption Survey; SAVACG, South African 
Vitamin A Consultative Group; UYRBS, National Youth Risk Behaviour Survey  
 
1.3. Aetiology 
The next section discusses the underlying causes of obesity. Although the causes apply in both 
children and adults, there are those that specifically affect the former group, and these will also be 
discussed.  
 
1.3.1. Environmental factors 
The aetiology of obesity is multifactorial in nature being a consequence of the interrelationship 
between increased food intake, physical inactivity, and an individual’s genetic composition 
(Rosenbaum et al., 1997; Schwartz et al., 1999; Weber, 2003). However, bad dietary habits and 
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reduced physical activity or sedentary lifestyle are influenced or promoted by an obesogenic 
environment such as neighbourhoods with easily accessible transportation (Nestle and Jacobson, 
2000; James, 2008) and high crime, social and cultural beliefs about the preferred body size, 
availability and marketing of energy-dense food (Drewnowski and Specter, 2004), and increased 
television viewing and TV or computer games. In children and adolescents, there are other 
contributing factors such as exposure to the intrauterine environment, infant feeding, and puberty that 
is marked by dynamic physiological and psychological transitions in both boys and girls. This sub-
section describes environmental factors involved in the development of childhood obesity.   
 
1.3.1.1. Socioeconomic and cultural factors 
Cultural factors: Culture is defined as an integration of shared attitudes, values, and practices that 
characterise a group of people (or ethnicity), community, institution or organisation. It is learned and 
distributed within a group that does not necessarily possess the same knowledge or attitudes. Public 
knowledge about obesity is influenced by cultural beliefs and practices. For example, some socio-
cultural environments among certain ethnic groups tend to favour the development of obesity as, to 
them, it is a sign of wealth rather than a risk factor of cardiovascular diseases, cancer and type 2 
diabetes. These ethnic groups are usually characterized by low socio-economic status and 
accelerated weight gain during adulthood (Sobal and Stunkard, 1989; O’Dea, 2003). In USA the 
greatest increase in obesity prevalence is currently observed among African Americans, Hispanic, and 
Native American children (Crawford et al., 2001). There is evidence to suggest that African-American 
and Hispanic children are at greater risk for being overweight or obese, with 24% reported to be above 
the 95th percentile for body mass index (BMI) measurement. Data from African-American studies 
suggest that this population group has a preference for sweet and high-fat food, and as a result this 
type of food is highly consumed by this racial group (Bacon et al., 1994; Rocchini, 2002; Strauss, 
2002; Centers for Disease Control and Prevention, 2003; Institute of Medicine, 2004; Larsen et al., 
2006). Furthermore, a preference for a body image that favours obesity development has been 
documented, although in some communities this attitude co-exists with a negative perception about 
excess weight (Kumanyika et al., 1993; Flynn et al., 1998; Liburd et al., 1999; Jain et al., 2001). A 
‘heavy’ body size particularly in females is considered attractive by African-Americans and does not 
necessarily have a negative effect on self-esteem, even among adolescent girls (Kimm et al., 1997). 
Being too thin on the other hand is linked to certain diseases such as cancer, tuberculosis or acquired 
immune deficiency syndrome, and drug abuse (Grosvenor et al., 1989; Ockenga J and Valentini L, 
2005; Hira et al., 1998). Although these cultural beliefs are popular among adults, adolescents (from 
13 to 18 years) are also affected as they are easily influenced by their environment.   
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Cultural differences were also observed in South African racial groups, and are believed to contribute 
to the variation in prevalence of overweight and obesity observed in Blacks, Mixed Ancestry and 
Caucasians. One of the cultural differences is in the perception of an acceptable ‘body figure’ among 
adolescent girls. As observed in African-Americans, it is desirable within the African culture for girls to 
be overweight as it is an indication of good health and happiness (Mvo et al., 1999; Mokhtar et al., 
2001; Senekal et al., 2001; Puoane et al., 2005). In contrast, South African, American and Australian 
Caucasians negatively stigmatise obesity (Mvo et al., 1999; Crandall et al., 2001). These cultural 
groups are more discriminatory against obese people and perceive fitness and thinness as important 
determinants of interpersonal and economic success than Indian and African cultures. Men and 
adolescent boys, on the other hand, idealise large body size and muscularity; and would not view 
adiposity to be a problem.  
 
Similarly, preferences for certain foods cooking methods may be culture specific with some cultures 
being traditionally inclined to have a higher fat intake, and other ethnic groups preferring healthy food. 
For example, Asian and Latino were known to consume higher fruit and vegetable and lower soda 
than Caucasians (Allen et al., 2007). However, recently the opposite is observed among Latinos while 
the intake of this type of food by Asians remained the same. Rural migration of other cultural groups, 
particularly in South Africa, has shifted the preference of food from traditional diets high in complex 
carbohydrates and fiber to highly processed and energy-dense diets (Bourne et al., 1994; Faber et al., 
2005). 
 
Socioeconomic status: Socioeconomic variables such as occupation, education, and household 
income are known to increase the risk of obesity in adulthood (Oh et al., 2011). The status of adults, 
however, directly affects that of children and adolescents as they are economically dependent on their 
parents. In a review done by Shrewsbury and Wardle (2008), the majority of studies conducted in 
developed countries found an inverse association between childhood obesity and socio-economic 
status (SES), similar to studies reviewed by Sobal and Stunkard (1989). Of the SES indicators 
investigated (such as age, gender, parental adiposity and marital status, maternal employment status, 
etc), parental education was more consistently inversely associated with adiposity in children 
(Shrewsbury and Wardle, 2008). It is suggested that the reason for this strong association may be that 
parent education is a more stable SES indicator than occupation and income. Additionally, education 
is suggested to influence knowledge and beliefs, which may be a key to healthy lifestyle more than 
access to resources is. Sex-specific differences in the relationship between SES and obesity were 
noted in adolescents, with the positive association identified in females but not in males (McLaren, 
2007; Singh et al., 2008; Kautiainen et al., 2009; Oh et al., 2011). One of the suggested causes for 
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gender differences is attitude towards body image, with negative attitude towards obesity observed in 
girls (Yoon et al., 2006). Social and cultural perspective toward obesity is stricter in females than in 
males. Depending on cultural preferences, females quickly adjust their lifestyle to maintain a slimmer 
body shape. However, changes in lifestyle increase expenses and only individuals with high SES are 
able to maintain a healthy diet and engage in physical activities; hence the prevalence of obesity is 
higher in females with lower SES (Wardle et al., 2002; McLaren et al., 2007; Yoon et al., 2006; Wang 
and Beydoun, 2007).    
 
In developing countries, on the other hand, a strong direct relationship between SES and childhood 
obesity was observed (Sobal and Stunkard, 1989). Developing countries are predominantly 
characterised by low SES with an abundance of affordable fast foods, snacks, and soft drinks, in 
addition to lack of facilities for physical activity (Darmon and Drewnowsk, 2008). Unhealthy food and 
lack of physical activity have been linked to rising obesity prevalence among children and youth. High-
fat food and sweets cost only 30% more than 20 years ago while the cost of fresh produce has 
increased more than 100% (Monsivais and Drewnowski, 2007). Foods with the lowest energy density 
(mostly fresh vegetables and fruit) increased in price by almost 20% over 2 years, whereas the price 
of energy-dense foods high in sugar and fat remained constant. Thus, low-income household are 
restricted to buying unhealthy food, which in addition to the lack of physical activity facilities, results to 
uncontrolled weight gain. On the other hand, adequate calories may be available at low cost but 
requires an unrealistic investment in time. In most households in developing countries women are 
forced to work long hours in order to provide for their families, and as a result, there is a trade-off 
between money and time to prepare healthy food (Caprio et al., 2008). For example, it is reported that 
working women on average spend 6 hours per week preparing food while unemployed women spend 
11 hours per week (Rose, 2003). In one South African study conducted in economically active 
individuals representing four different ethnic groups, factors such as Black ethnicity, low education and 
physical activity were associated with low SES.  In addition to having one overweight parent, these 
factors were associated with higher BMI in children (Senekal et al., 2003).  
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1.3.1.2. Physical activity, sedentary lifestyle, and diet 
Physical activity  
Methods of measuring physical activity: Physical activity is an important aspect of life that must be 
practised to ensure good health as it prevents obesity and its associated co-morbidities (Scrutinio et 
al., 2005). The obesity epidemic is believed to be mainly due to a high dietary intake, particularly fat, 
and reduced physical activity. Participation in moderate physical activity for 45-60 minutes each day is 
required to prevent obesity (Gelaye et al., 2009; Department of Health, London 2004). The body 
achieves this by utilising and breaking down energy stored as fat through exercise. Physical activity 
can therefore be used as a tool to modulate the effect of fat intake in the body. It is for these reasons 
that many policies that are developed to combat obesity involve physical activity. 
 
Several studies have been conducted to assess the magnitude of the effect of physical activity in 
obesity. It is however, a challenging endeavor as there are several methods used to define and 
measure physical activity. Physical activity can be defined as energy expenditure per body mass, 
physical activity level (daily energy expenditure as a multiple of resting energy expenditure), time 
spent in activities, etc. The validity of physical activity measurements depends on the methods used 
and the population under study. The doubly-labeled water test is the gold standard for measuring total 
daily energy expenditure under free-living conditions. This technique measures the average metabolic 
rate over a long period of time in subjects for whom other types of direct or indirect calorimetric 
measurements of metabolic rate would be difficult or impossible (Schoeller and van Santen, 1982). A 
minimum number of two samples (saliva, urine, or blood) are required to perform the method, an initial 
sample that is taken after the isotope has reached equilibrium, and a second sample taken some time 
later (24 hrs for small animals and 14 days for human adults). Although the method is considered a 
golden standard, it is expensive and therefore not suitable for large epidemiological studies (Goris and 
Westerterp, 2008). Physical activity questionnaires and diaries are more applicable in large 
epidemiological studies but, they provide less accurate estimates of physical activity level compared to 
more objective measures as the tool relies on self-reported (parental or child/adolescent) information 
(Bull et al., 2009). The questionnaires are a measure of physical activity variables such as games, 
sport, work, transportation, recreation, physical education, and planned exercise performed at home, 
school and communities. These variables are expressed in terms of duration (e.g., minutes), or 
frequency (e.g., times per week), or intensity, or a combination of these.  
 
Pedometer is also one of the commonly used and inexpensive tools of monitoring and promoting 
physical activity in both adults and children. Given their low cost, pedometers are practical for use in 
large-scale epidemiological studies. It is an easy-to-use small device worn around the hip or waist that 
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is used to count the number of steps walked per day (Pedometers, 2004). A pedometer measures 
steps by using a spring-suspended mechanical lever that moves up and down in response to vertical 
displacement. Each of these movements is recorded and usually displayed digitally. Pedometers can 
also provide a number of derived output readings. These vary depending on the brand, and include 
distance traveled, calories expended and time spent at specific activity intensities (Tudor-Locke et al., 
2009). However, these additional features are estimates and have not been validated among children.  
Although pedometers may be a good option to monitor walking in children, several studies have 
demonstrated that their accuracy and precision increases with speed, and tend to underestimate 
physical activity at a slower pace; and thus require discretion in their use (Schneider et al., 2003; 
Melanson et al., 2004; Beets et al., 2005; Crouter et al., 2005; Mitre et al., 2009). The use of 
pedometer to assess other movements such as cycling and swimming is another limitation that is not 
covered in the current literature, and this requires further investigation. Generally, the accuracy of a 
pedometer to assess physical activity was found to strongly correlate with accelerometer (r= 0.88) and 
lesser with doubly labeled water method (r= 0.67) (Ramirez-Marrero et al., 2005). The latter may be 
explained by the suitability of the doubly-labeled water method to measure energy expenditure than 
monitoring step counts, unlike the pedometer that only counts walking steps.  
 
Built environment: Urbanisation has changed community structures, creating environments that 
promote obesity. An individual’s external environment can be changed depending on the needs 
enforced by the changing lifestyle or modernisation. Such an environment is termed built environment 
and is defined as the range of structural elements in a residential setting: housing, roads, walkways, 
density, transportation networks, shops, parks, and public spaces (Weich et al., 2001; Handy et al., 
2002). The built environment can either promote or hinder physical activity and healthy eating. This 
effect may vary according to gender, family structures, age groups and socio-economic status groups; 
depending on how individuals perceive and interact with the environment (Papas et al. 2007). For 
example, areas with few or lack of recreational facilities are characterised by high crime levels, uneven 
or hilly landscape, insufficient lightning and the presence of easily accessible public transport, and can 
therefore hinder physical activity (Booth et al., 2005). A significant association was observed between 
poor neighbourhoods with low-educated dwellers, the lack of physical activity facilities and subsequent 
disparities in health-related behaviour, and obesity measured at the individual level (Gordon-Larsen et 
al., 2006; Blomquist and Bergstrom, 2007; Vieweg et al., 2007). Children who spent more time outside 
the home were found to be more active, with farmland and grassland use in rural areas, and gardens 
and street environments in urban areas accounting for 40% of moderate to vigorous physical activity 
bouts (Jones et al., 2009). Furthermore, the presence of physical activity facilities in a particular area 
has been shown to be associated with an increased likelihood of engaging in 5 bouts of moderate-
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vigorous physical activity per week and a decreased relative risk of overweight. However South 
African studies have reported the contrary: a higher prevalence of obesity was found among 
Caucasian children (14.2%) who lived near the central business district where physical activity 
facilities are expected to be found, compared to Blacks and Mixed Ancestry scholars who resided in 
areas characterized by low SES (Mvo et al., 1999). This may be explained, in part, by the presence of 
fast-food outlets and other highly available energy-dense food products in the central business district, 
near residential areas of Caucasian children. This picture however is beginning to change as 
obesity/overweight prevalence among Black African and Mixed Ancestry youth is approaching that of 
Caucasians due to the transitions in political environment and migration of the former population 
groups to urban areas (Bourne, 1994; Steyn et al., 1994; Steyn et al., 1996; Puoane et al., 2002).  
 
Gender differences have also been observed in several studies. Boys have been found to be 
influenced to exercise when seeing their peers engaged in physical activity, if they reside in an area 
with roads and traffic calming measures (Carver et al., 2008). On the other hand, automobile 
transportation to school, length of annual school sports meetings, availability of game shops near the 
home and time spent playing video games were associated with boys’ physical inactivity (Trang et al., 
2009). 
Sedentary lifestyle 
There is evidence indicating that children and adolescents have become less physically active due to 
the decreased amount of time they spend outdoors (Andersen and van Mechelen, 2005; Dollman et 
al., 2005). It is reported that these age groups spend approximately 80% of their time engaged in 
minimum physical activities or sedentary activities such as television (TV) viewing, playing digital 
games and computer usage (Dietz Jr and Gortmaker 1985; Reilly et al., 2004; Rennie et al., 2005; 
Rivera et al., 2010). According to the WHO’s Health Behaviour in School-aged children (HBSC) 
survey, the prevalence of TV viewing ranged from 26.5 to 49% (Currie et al., 2004). Dietz Jr and 
Gortmaker (1985) were the first to link high TV viewing with a higher risk of overweight and obesity 
among children. From this study it was also observed that among adolescents, for each additional 
hour of TV viewing per day, the prevalence of obesity increased by 2%. Since then, several studies 
have provided evidence supporting the relationship between TV viewing and obesity. A meta-analysis 
by Marshall and co-workers (2004), demonstrated a significant negative effect between TV viewing, 
video/computer game use and physical activity. Furthermore, a statistically significant association 
between TV viewing and body fatness was reported by Marshall and coworkers (2004), however, the 
effect size was small (0.066) implying that 99% of the variance in body fatness may be due to other 
factors. Other studies, however, reported a strong and conclusive relationship between TV viewing 
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and body fatness or obesity (Gortmaker et al., 1996; Beyerlein et al., 2011). For example, Gortmaker 
et at (1996) reported that 10-15 years old American adolescents that watched TV for more than 5 
hours a day were 4.6 times more likely to be overweight than those watching TV for 2 hours or less 
per day. Similarly, a positive association between weekly hours spent sitting down and prevalence of 
obesity, and a negative correlation between obesity and leisure time physical activity was observed in 
a study conducted in males and females older than 15 years (Martinez-González et al., 1999). 
Potential determinants related to TV viewing, particularly in the home environment have been 
reported. It has been reported that children and adolescents having TV sets in their bedrooms spend 
more hours watching TV (van Zutphen et al., 2007; Delmas et al., 2007). However in few cases, 
children’s desire to watch TV is counteracted by playing with their parents and the rules imposed on 
them about TV viewing, thereby minimising the time they spend watching TV (Salmon et al., 2006). 
 
While the exact mechanism underlying the association of television viewing and obesity is unclear, it is 
evident that it occurs at the expense of physical activity. It has also been reported that television 
viewing is always accompanied by consumption of higher caloric food, and the lack of having healthy 
family meals (Epstein et al., 2005; Blass et al., 2006; Zutphen et al., 2007). Recently, in the California 
Health Interview Survey, Shi and Mao (2010) reported that adolescents who viewed more than three 
hours of television per weekday were 38% likely to consume fast food than those who did not view 
television as much. Additionally, the study reported an association between excessive weekday 
recreational computer use and consumption of sugary drinks more than once. Media advertising is 
believed to be promoting high caloric intake during TV viewing.  According to Kunkel (2001), children 
spend an average of 5.5 hours per day using various media and are exposed to at least one food 
advertisement every 5 minutes (40 000 TV commercials annually). The majority of the adverts are for 
high-calorie food. Additionally, advertising campaigns of these types of food are linked to movies, 
cartoon characters, toys, video games, branded kids clubs, internet, and educational materials, 
features of which are enticing to children. Television viewing forms part of the family environment that 
promotes consumption of high caloric food, snacks and soft drinks, and therefore, influences eating 
behaviour of children.  
 
Diet 
In addition to TV viewing, Campbell and co-workers (2006) reported a high parental perception of a 
child’s dietary adequacy to be associated with children’s reduced consumption of vegetables and 
increased consumption of energy-dense savory and sweet snack foods. This association may stem 
from the fact that adults tend to perceive the aspects of their diet to be better than they actually are 
(Variyam et al., 2001; Lechner et al., 1997). Furthermore, parents perceive the cost of fruit and 
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vegetables to be high, hence the low preference and purchase of these products. Gillman and co-
workers (2000) also showed evidence that eating a family dinner was linked cross-sectionally with 
health promoting dietary intake patterns, including the consumption of more fruit and vegetables. The 
reports presented here suggest that parents provide direct role models to children for the type of food 
they consume.  
 
Fast-food, soft drink and candy (sweet) vendors are rapidly increasing in schools, further promoting 
consumption of such products by children and adolescents. On average, adolescents consume 11% 
of calories from soft drinks and twice as much from milk, putting them at a higher risk of becoming 
obese or overweight (Ludwig et al., 2001; Lim et al., 2009). Dietary intake behaviour or food intake is 
also affected by portion size, taste, and method of food preparation. There are also strong cultural 
influences on the type of food consumed with some racial groups having a preference for their 
traditional food. Often these types of food are enriched with carbohydrates, and are dominantly 
consumed in poorer countries, whilst a high fat diet enriched with saturated fatty acids is common in 
developed countries (Faber et al., 2001; Willett, 2002; Cordain et al., 2005). African countries, 
particularly, are characterised by the existence of nutrition transition and cultural-based nutritional 
differences, resulting in coexistence of under- and over-nutrition between and within populations and 
across all ages (Bourne et al., 1994; Steyn et al., 1994; Mvo, M Phil Thesis 1999; Savy et al., 2005; 
Bourne et al., 2007). Although overweight/obesity is generally associated with increased fat intake, 
Bray and Popkin (1998) reported a high prevalence of overweight on individuals consuming low-
percentage energy from fat. Likewise, Kruger and co-workers (2002) found a weak correlation 
between dietary fat intake and BMI in the THUSA study. These studies suggest that a general 
assessment of diet is not an effective tool for investigating the association of nutrient intake and 
obesity. It is for this reason that several studies began to specifically investigate diet composition, 
instead of conducting a generalised assessment of diet and its effect on body weight changes.   
 
Diet composition: There is substantial evidence showing that energy balance is achieved by 
separate regulation of carbohydrates, fats, and proteins.  Insulin is an important regulator of glucose 
homeostasis, modulator of energy partitioning (Schenck et al., 2008), polyunsaturated fatty acid 
(PUFA) synthesis (Brenner, 2003; Wang et al., 2006), fatty acid transport (Ghebremeskel et al., 2004; 
Thomas et al., 2005), and hypothalamic action on the control of food intake (Bruning et al., 2000). In 
the postprandial state, insulin enhances fuel storage, inhibits lipolysis (Unger, 2003), and is involved in 
leptin release by adipocytes (Cheng et al., 2000). Any abnormalities related to dysregulation of 
carbohydrates, fats and protein can lead to cardio-metabolic disorders. For example, nutritional factors 
including energy excess, high energy density, increased consumption of carbohydrates and fat have 
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been reported to lead to obesity (Rolls et al., 2002; Astrup et al., 2004; Webber et al., 2005; Canete et 
al., 2007).  
 
With specific reference to fat, it has also been proposed that dietary fat composition and the amount of 
energy intake may contribute to the development of obesity (Jones and Scholler, 1988; Khor, 2004). 
Fat composition refers to the structure of fatty acids, chain length, degree of unsaturation, position and 
configuration of the double bonds; which have been suggested to affect the metabolic fate of dietary 
fatty acids (DeLany et al., 2000; Madsen et al., 2005). Studies in animal models have demonstrated 
that body weight change may be responsive to different types of dietary fats (Lynn and Brown, 1959; 
Marette et al., 1990; Moussavi et al., 2008). However, as noted by Moussavi and coworkers (2008), 
the conditions and type of diet used in animal studies are not similar to those of human even though 
investigators tried to emulate them. Human diet contains diverse fatty acid profiles. The effect of 
different types of fats in human body weight seems to be complex as observed in both metabolic and 
epidemiological studies. Some studies have shown that consumption of a diet rich in medium-chain 
fatty acid could lead to a decrease in body weight (Kauntiz et al., 1958; Hainer et al., 1994; Dulloo et 
al., 1996; Tsuji et al., 2001; St-Onge et al., 2003).  
 
The effect of a diet rich in monounsaturated fatty acids has also been investigated with the majority of 
studies reporting a positive association between this type of fatty acids and BMI (Williams et al., 2000; 
Brunner et al., 2001; Sanchez-Villegas et al., 2006). Several reasons for the conflicting outcomes of 
studies conducted were proposed (Moussavi et al., 2008). For example, in both clinical trials and 
epidemiological studies, physical activity which is the major component of the energy equation was not 
accounted for; the total energy intake in populations was either not adjusted for or it was estimated, 
impairing the power of detecting any effect present; different statistical methods were used.      
 
As observed on fat diet, the composition of dietary carbohydrates as opposed to the total amount may 
potentially influence body weight and insulin sensitivity. Depending on chemical structure, 
carbohydrates are traditionally classified as simple or complex (polysaccharide) (Jenkins et al., 1981). 
The latter are considered to be a healthy alternative to dietary fats. However, many complex 
carbohydrates (eg, baked potatoes and white bread) produce even higher glycemic responses than do 
simple sugars (Ludwig, 2002). The quality of carbohydrates is determined by the amount and type of 
fiber, the extent of processing, and glycemic index and load (GI and GL). The GI of food is an area 
under the two hour blood glucose response curve measured two hours after ingesting 50 grams of a 
carbohydrate portion (Jenkins et al., 1981). GI values of individual food largely depend on the rate at 
which they are digested and the speed of carbohydrate absorption, making their physical forms an 
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important factor (Brouns et al., 2005). Typically, foods with more compact granules and high amounts 
of viscose soluble fiber (eg, barley, oats, and rye) are digested at a slower rate and have lower GI 
values than do highly processed carbohydrates (for example, white bread). These refined 
carbohydrates are more rapidly attacked by digestive enzymes due to grinding that reduces particle 
size and removes most of the bran and the germ. It has been shown that consumption of high-GI 
carbohydrates has less of an effect to suppress appetite and a diminished ability to induce satiation 
than foods with lower GI (Ludwig, 2000; Roberts, 2000). The long-term effect of consuming high-GI 
diets may lead to energy overconsumption and promote weight gain, creating a platform for the 
development of cardio-metabolic disorders. Refined carbohydrates are likely to cause even greater 
metabolic damage through increased GI and high insulin secretory responses than saturated fat in a 
predominantly sedentary and overweight population (Hu, 2010). This is despite any rigorous 
supportive evidence and convincing data to the contrary that central administration of insulin acts to 
suppress appetite and reduce energy intake in primates and rodents (Schwartz et al., 1992). The 2003 
evidence-based report from the WHO found that the only convincing dietary factor protecting against 
weight gain and obesity was a high dietary fiber intake.  
 
1.3.1.3. Intrauterine environment, and factors acting on early life and during puberty 
Pre and post natal factors: The prenatal period, infancy, and early childhood may be stages of 
particular vulnerability to obesity development because they are unique periods for cellular 
differentiation and development. Maternal environment during fetal and infant development determines 
the future course of an individual from child- to adulthood (Lederman et al., 2004). For example, 
maternal malnutrition during fetal and infant development have been associated with permanent 
structural and functional changes of the body and later development of diseases of lifestyle such as 
type 2 diabetes, obesity, glucose intolerance, hyperlipidemia, insulin resistance, and hypertension 
(Gray et al., 2002). Both maternal malnutrition and postnatal overnutrition influence programming of 
obesity during fetal development through hormonal dysregulation of appetite (Remacle et al., 2004; 
Grattan et al., 2008). According to animal models the key player in this mechanism is leptin (LEP) 
(Bouret et al., 2004; McMillen et al., 2005; Chen et al., 2008). These studies have demonstrated that 
both maternal malnutrition and overnutrition may cause fetal programming through a common 
pathway that involves neuropeptide Y (NPY) and proopiomelanocortin (POMC), targets of leptin in the 
arcuate nucleus of the hypothalamus. Upon activation, neurons expressing NPY and POMC mature 
continuously for up to three weeks after birth in rodents, allowing permanent programming of appetite 
regulatory centers by maternal and fetal hormones (Grove et al., 2005; Melnick et al., 2007). 
Hyperphagia and leptin resistance are common phenotypes during pregnancy, leading to increased fat 
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accumulation in adipose tissue. In obese individuals, this may have a long-term effect on developing 
offspring while in lean females it is an adaptive response to hormonal changes associated with 
pregnancy so that the mothers can store energy in preparation for the high metabolic demands of the 
forthcoming lactation (Naef and Woodside, 2007; Augustine et al., 2008). One in five women in their 
reproductive age is obese with direct effects on maternal and fetal complications (Chu et al., 2008). 
Infant complications associated with maternal obesity include increased body fat mass and greater 
subcutaneous adipose tissue (Sewell et al., 2006; Forsum et al., 2006). It is also suggested that a 
higher maternal BMI during the first trimester of pregnancy is related to obesity in 3-6 months old 
infants (Rising and Lifshitz, 2008) and 2-4 year old children (Whitaker, 2004). 
 
Insulin has also been implicated in mediating fetal programming that results in childhood and later 
adult metabolic complications. The insulin effect is a result of maternal diabetes during pregnancy. 
During pregnancy maternal glucose is transferred to the fetus, and the developing fetal pancreas 
respond to a glucose load by producing insulin, which acts as a fetal growth hormone in addition to 
glucose regulation (Freinkel, 1980). Increased insulin levels were observed in amniotic fluid reflecting 
fetal pancreatic insulin production, and this was correlated with obesity during adolescence (at ages 
14 to 17 years) (Silverman et al., 1998). According to Silverman and co-workers (1991), obesity in 
children of diabetic mothers is apparent at birth, and only progresses after the age of 4 years. Not all 
studies, however, have found an association between gestational diabetes and risk of offspring 
obesity. Whitaker and co-workers (1998) found no increase in BMI among young adults of mothers 
with mild, diet-treated gestational diabetes. Another study found a moderate increase in risk of 
adolescent overweight among offspring of diabetic mothers, but the risk disappeared after adjustment 
for maternal BMI (Gillman et al., 2003). These studies suggest that severe fetal hyperinsulinemia may 
be required for the fetus to manifest programming for later obesity. 
 
Intrauterine growth restriction possible due to maternal undernutrition affects approximately 30 million 
births per year, most of these occurring in developing countries: 75% in Asia, 20% in sub-Saharan 
Africa and 5% in Latin America and the Caribbean (de Onis et al., 1998). A meta-analysis that was 
based on cohorts in Brazilian, Guatemala, Indian, Philippines, and South African populations on long-
term effects of maternal and child undernutrition observed the following outcomes related to 
cardiovascular diseases: undernutrition was associated with short adult height, and in women, with 
lower offspring birth-weight; increased size at birth and in childhood were positively associated with 
adult BMI (Victora et al., 2008).  A baby of low birth-weight, who is stunted and underweight in infancy 
and rapidly gains weight in childhood and adult life upon exposure to obesigenic environment, can 
ultimately develop cardiovascular and metabolic disease, according to several studies (Bhargava et 
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al., 2004; Prentice and Moore, 2005; Barker et al., 2005; Lawlor et al., 2007). Rapid weight gain is 
relevant in low-income and middle-income countries that are undergoing rapid economic transition, 
and where there is co-existence of poverty and wealth. Indeed, a South African study conducted in 
rural villages of the Limpopo Province reported a high prevalence of stunting (48%) in 3-year old 
children of which 31% were overweight (Mamabolo et al., 2005). In Africa as a whole, 35% of children 
under 5 years of age are believed to be stunted (de Onis et al., 2000; Hautvast et al., 2000). 
 
Birth-weight: The relationship between birth weight and obesity has also received great attention. As 
with maternal obesity, birth weight has been linked to various measures of abdominal adiposity in 
childhood and adulthood (Kuh et al., 2002). One of the studies that examined fetal origin of adult 
diseases reported evidence of association between obesity, accelerated growth velocity and low birth 
weight (Barker et al., 2002). Another study, however, suggests that being small for the gestational age 
and not a low birth weight alone is most likely to increase the risk for obesity in adulthood (Ong and 
Dunger, 2004). Other studies however, have reported an association between high birth weight and 
overweight and obesity in both children (Stettler et al., 2002; Dubois and Girard, 2006) and adults 
(Law, 2001; Freedman et al., 2005). Apart from maternal obesity, the role of small for gestational age 
(SGA) and birth weight in obesity is confounded by other factors such as preterm and term infancy, 
growth velocity, and maternal substance abuse (Gaskins et al., 2010). For example, preterm birth, low 
birth weight, and SGA have been associated with increased risk for adolescent overweight (Abe et al., 
2007) but not associated with BMI among 8-year-old children (Casey et al., 2006). On the other hand, 
high birth weight was associated with overweight and obesity at 3 to 7 years in term children, (Hui  et 
al., 1997; Mei et al., 2003; Zhang et al., 2009) and 11 years among children born preterm (Gaskins et 
al., 2010) but not in adolescents. However in one study, a 1 kg-increase in birth weight was associated 
with 30% increase in the risk of overweight during the ages of 11-14 years after adjusting for maternal 
BMI and other covariates (Gillman et al., 2003).  
 
Growth velocity: There is substantial evidence supporting an association between rapid weight gain 
during early life and risk of obesity in adulthood (Monteiro and Victora, 2005). Rate of fetal growth is 
also determined by genetic factors. Increased weight gain velocity in childhood from 1 year and 9 
months to 5 years was shown to be an independent predictor of adults BMI and waist circumference 
(McCarthy et al., 2007). Similarly, increased weight gain velocity between 0 and 6 months and 
between 2 and 5 years was found to be strongly associated with adult BMI among individuals of 
different ethnicities (Sachdev et al., 2005). This association was further supported in a South African 
study, which demonstrated that 20% of children sampled in the study with rapid weight gain were 
significantly lighter at birth and developed obesity throughout childhood (Cameron et al., 2003). 
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Crowther and co-workers (2008) also demonstrated that in South African children, increased growth 
velocity in early childhood at all ages lead to higher body weight at age 7 years. Increased growth 
velocity is often seen in children who are thought to have experienced intrauterine growth retardation, 
a phenomenon called catch-up growth. This process is called catch-up growth because growth rate 
increases as an effort to bring a child's height-for-age or weight-for-age status back toward the normal 
centile. Acceleration of growth velocity during the first 2 weeks of life has also been reported to 
increase insulin-related risk processes (McCarthy et al., 2007; Crowther et al., 2008).  
 
Infant feeding: Infant feeding has been reported to play a major role in child’s development. Several 
studies in developed countries suggest that breast-feeding reduces the risk of obesity during 
childhood and adolescence, with corresponding benefits on adult health (Hediger et al., 2001; Gillman 
et al., 2001; Owen et al., 2005). Some studies reviewed by Owen and co-workers (2005) suggested 
that the duration of breastfeeding is an important factor as it was shown to have a slightly stronger 
protective effect. How breastfeeding reduces the risk of obesity is unclear. It is suggested that the 
presence of leptin in breast milk protects breastfed babies against obesity later in life compared to 
those fed milk formula (Stocker and Cawthorne, 2008). Not all studies were able to demonstrate the 
reducing effect of breast milk on the risk of obesity (Butte et al., 2000; Hediger et al., 2001). The 
inconsistency observed in different studies may be due to the presence of confounding factors such as 
socioeconomic status, maternal obesity and smoking, and variation in the statistical power of 
difference studies.  Formula feeding, on the other hand, has been associated with the development of 
atopy, diabetes mellitus, and childhood obesity (Gaynor, 2003; Wolf, 2003). Food and Drug 
Administration recommended that the following nutrients be present in all infant formulas: protein, fat, 
vitamins C, A, D, E, K, B1, B2, B6, and B12, niacin, folic acid, pantothenic acid, calcium, phosphorous, 
magnesium, iron, zinc, manganese, copper, iodine, sodium, potassium, and chloride (Stehlin, 1993). 
The amount of each formula nutrient varies significantly compared to breast milk, and their 
composition does not change as the infant ages. Formula is, thus, reported to be unresponsive to the 
growing infant’s needs, making the digestive process more difficult (Lawrence, 1994). Differences in 
digestive and absorption of breast and formula milk have been implicated in the mechanism 
underlying poor child health outcomes. It is suggested that the mechanism involves increased insulin 
concentration in response to the presence of high protein and/or nitrogen in formula milk, which in turn 
stimulates fat deposition and early development of adipocytes (Lucas et al., 1980; 1981). Breast milk 
on the other hand, contains bioactive factors which may modulate epidermal growth factor and tumour 
necrosis factor , both of which are known to inhibit adipocyte differentiation in vitro (Petruschke et al., 
1994; Hauner et al., 1995).  
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 Adiposity rebound: The adipose tissues undergoes several changes during human development 
(Häger, 1977; Knittle et al., 1979): during the first year adiposity increases due to increasing size of 
adipocytes, it decreases in the following year or two, and remains stable for several years. While 
adipose tissue growth is decreasing, body height continues to increase. During this first phase, the 
number of adipocytes remains stable. Adiposity rebound commences at about 6 years, and this is 
when both the number and size of adipocytes increases (Häger, 1977; Knittle et al., 1979). It has been 
demonstrated on several studies that there is an association between timing of adiposity rebound and 
later risk of obesity. Initial estimates of adiposity rebound were obtained using BMI, and it was 
uncertain whether early rebound reflects greater relative weight gain or reduced height velocity (Dietz, 
2000). Only longitudinal studies could demonstrate that indeed early rebound is the result of higher 
rates of weight gain rather than slower average accrual of height, with the weight gain being 
predominantly due to a rapid increase in body fat (Taylor et al., 2004; Williams, 2005).  
 
On investigating the relationship between timing of adiposity rebound, Cameron and Demerath (2002) 
observed that earlier adiposity rebound (that occurring before the age of 5–5.5 years) is associated 
with later obesity and adverse health outcomes including elevated blood pressure and diabetes. A 
study conducted in the US showed that each year decrease in age at adiposity rebound was 
associated with a 2.5 kg/m2 increase in the predicted BMI level at age 19–23 years (Freedman et al., 
2001). The clinical utility of adiposity rebound in identifying children at risk of developing obesity has 
been questioned by some authors (Williams et al., 1999; Cole, 2004), stating that BMI at age 7 has the 
same predictive value for later fatness as age at adiposity rebound, and measuring adiposity rebound 
requires a minimum of three serial BMI measurements. Taylor and co-workers (2005) further argued 
that if the timing of adiposity rebound can only be detected beyond the age of 7 years, those children 
showing a very early rebound would miss an opportunity to initiate interventions at an early stage. 
Other authors, however, have suggested that, compared to a high BMI that may only appear after a 
progressive increase over many years, an early adiposity rebound is a better indicator of the timing of 
the origin of obesity (Rolland-Cachera and Bellisle, 1990; Rolland-Cachera, 1993). These authors 
further suggest that very early adiposity rebound recorded in most obese subjects may imply that 
factors promoting obesity have operated very early in life and probably several years before the 
adiposity rebound. A reduced energy balance owing to high-protein, low-fat intake in early life is 
reported to be one of the possible factors (Rolland-Cachera et al., 2006). It is hypothesised that a 
relative energy deficit early in life may programme mechanisms of adaptative thermogenesis (Dulloo 
et al., 2002). According to Rolland-Cachera and co-workers (2006), adaptation to low fat intake in 
early life may have adverse effects later in life, when children are exposed to and eat a more abundant 
high-fat diet.  
Stellenbosch University http://scholar.sun.ac.za 
 
 
 
25
 
Physical activity has also been proposed to be one of the factors influencing early adiposity rebound. 
A retrospective analysis demonstrated that 10-year-old children who were more physically active 
underwent adiposity rebound at a later age than those who were less active (Deheeger et al., 1996). 
Watching television for more than 8 hours per week at the age of 3 years increased the risk of obesity 
at 7 years of age by 55%. In their study Janz and co-workers (2002) observed that inactive boys 
(measured using accelerometry) who watched a lot of television (as assessed by questionnaire) had 
6.8% greater fatness than active boys who watched television the least. These authors also observed 
a similar trend in girls, although the differences were less (1.4 kg fat mass and 4.4% greater fatness). 
 
Pubertal stage: This is a stage characterised by gender differences in adiposity, with females having 
a higher BMI than males (Del Parigi et al., 2002). Gender variation is more dramatic during 
adolescence, a transition period that begins with puberty and marked by profound physiological and 
psychological changes in boys and girls. The physiological and psychological changes, which are 
governed by hormonal levels, have been shown to influence the risk of obesity in females. Overeating 
among adolescents is associated with a variety of adverse behaviours and negative psychological 
experiences including low self-esteem and suicidal tendencies (Ackard et al., 2003). Some longitudinal 
studies identified depression as the major predisposing factor for late weight gain in adolescents 
(Tanofsky-Kraff et al., 2006). Depressed individuals tend to overeat leading to obesity, and affected 
individuals experience appearance-related teasing, which is associated with higher weight concerns, 
more loneliness, poor self-perception of physical appearance, higher preference for sedentary or 
isolated activities and lower preference for social activities (Hayden-Wade et al., 2005).  
 
Physiologically, there are differences in fat distribution and changes in total and percentage body 
weight between girls and boys (Ogle et al., 1995; Taylor et al., 1997). According to Taylor and co-
workers (1997) gender differences in percentage body fat are apparent even before puberty with boys 
having a lower fat content than girls, despite similarities in overall body weight, height and BMI. As a 
result, female adults have approximately 22% body fat while their male counterparts have an average 
of 15%. Furthermore, fat in females is usually deposited peripherally in breasts, hips, and buttocks 
while in males it is centralised in the abdomen (Deurenberg et al., 1990; Goodman-Gruen and Barrett-
Connor, 1996). It is noteworthy that up to 80% of overweight adolescents are likely to become obese 
adults (Must and Strauss, 1999; Freedman et al., 2001).  
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1.3.2. Genetics of obesity 
The complex nature of human obesity stems from the multiple interaction of several genes that control 
the physiology of food intake, energy expenditure, development of the body, and behavioral patterns 
towards food intake, and the environment (Tambs et al., 1992; Maes et al., 1997). According to twin, 
adoptees and family studies, genetic factors account for 40-70% of the variability observed in human 
adiposity (Stunkard et al., 1986; Bouchard et al., 1988; Tambs et al., 1992; Allison et al., 1996; Vogler 
et al., 1995; Maes et al., 1997). Twin studies have also demonstrated that the heritability of adiposity is 
higher than other quantitative traits. The heritability of obesity traits (Table 1.4) has been further 
supported by identification of quantitative trait loci (QTL) and genes through methods such as 
genome-wide scans (studies conducted on unrelated obese individuals), linkage analyses (conducted 
in families), and association studies (investigating the correlation between obesity and 
polymorphisms). The number of contributing genes, however, is still unknown.  
 
Table 1.4. Heritability of obesity-related phenotypes as reported by several studies. 
Obesity-related 
phenotypes 
Heritability 
measure 
Reference 
Body mass index 0.50-0.70 Allison et al., 1996; Fabsitz et al., 1994 
Total and regional fat  0.71-0.86  Malis et al., 2005 
Skinfold thickness and 
waist circumference 
0.72-0.82 Rose et al., 1998 
Waist-hip-ratio 0.36-0.61 Rose et al., 1998 
Cognitive to restraint 
to eating 
0.59 Tholin et al., 2005 
Uncontrolled eating 0.45 Tholin et al., 2005 
Emotional eating 0.60 Tholin et al., 2005 
 
Although research on the genetic basis of obesity has advanced, the mechanisms underlying the 
condition are still complex due to its heterogeneity even within families. Genetically, obesity can be 
classified into three forms: monogenic obesity caused by single gene defects, a syndromic obesity 
(Mendelian disorders for which obesity is a clinical manifestation but not a dominant feature), and 
common polygenic obesity that result from gene-gene and gene-environmental interaction. Genes of 
the leptin-melanocortin pathway that cause monogenic obesity only explains a small portion (1-5%) of 
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the condition. The polygenic form of obesity, on the other hand, is due to combined modest effects of 
many polymorphisms in several genes that interact with modifiable environmental factors (collectively 
termed obesogenic environment).  
 
Animal models of obesity have been studied extensively in an effort to elucidate the mechanisms 
underlying human obesity, and currently there are several hundred genes that have demonstrated the 
heritability of body weight (Rankinen et al., 2006). Some of the popular genes implicated include leptin 
(LEP), leptin receptor (LEPR), agouti-related peptide (AgRP) and carboxypeptidase E genes. In 
addition to these genes, 408 QTL for obesity and body weight have been mapped in mice (Brockmann 
and Bevova, 2002; Rankinen et al., 2006). Identification of obesity genes in mice has paved a way of 
unraveling the complex nature of human obesity. This part of the literature review describes these 
genetic forms of obesity. 
 
1.3.2.1. The Leptin-melanocortin system  
Physiologically, obesity is characterised by excessive accumulation of fat in adipose tissue as a result 
of weight dysregulation (Campfield and Smith, 1999). Weight dysregulation involves an imbalance 
between energy intake and expenditure. The pathophysiology of obesity therefore requires an 
understanding of energy homeostasis, which is a complex system controlled through bidirectional 
communication between the periphery and brain (Stricker, 1990; Le Magnen, 1992). The periphery 
communicates with the brain relaying messages about the body’s energy state through neural 
connections that are provided by the autonomic nervous system, hormones or metabolites. Of note is 
a number of circulating peptides and steroids that regulate food intake, which act mainly on the 
hypothalamus, brain stem, or afferent autonomic nerves (Table 1.5). These molecules are produced 
from at least three sits: gastrointestinal tract, adipocytes, and pancreas (beta cells).  
 
Adipose tissue produces LEP (Zhang et al., 1994; Murakami and Shima, 1995; Maffei et al., 1995), 
while the pancreas secretes insulin (Steiner et al., 1967), and the gastrointestinal tract produces short-
term meal-related signals such as peptide YY (Leiter et al., 1987), glucagon-like peptide-1 (Mojsov et 
al., 1986; Orskov et al., 1986), cholecystokinin (Friedman et al., 1985; Eysselein et al., 1986) and 
ghrelin (Kojima et al., 1999). In the brain, energy homeostasis is controlled by neural circuits that 
regulate feeding, mood, pleasure, pain, memories about the reward and punishment of behaviour, and 
cognitive functions such as liking, wanting, and decision-making for appetitive behaviours (Royall et 
al., 2002; Salamone and Correa, 2002; Berridge, 2003). There are three major centres in the brain 
that perform the above mentioned functions: the caudal brainstem, hypothalamus, and parts of the 
cortex and limbic system. 
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Table 1.5. Description of peptides and hormones involved in regulation of appetite. Adapted from 
Macia et al., 2006 
Peptide Main site of synthesis Receptor Site of action Effect on 
food intake 
BDNF Hypothalamus and caudal 
brianstem 
TrkB Hypothalamus  
MCH Hypothalamus MCH1R Hypothalamus  
OR Hypothalamus, gut OXR  Various brain 
regions and adrenal 
gland 
 
Drosophila Single-
minded 1 
Hypothalamus Hypothalamus -  
Serotonin (5-
hydroxytrypamine) 
Midbrain and hindbrain 5HT2C serotonin-
receptor 
Hypothalamus  
ADIPOQ Adipocytes AdipoR1 Hypothalamus  
Interleukin-1 Macrophages, keratinocytes, B 
lymphocytes, fibroblasts, and 
hypothalamus 
Interleukin-1 type 
1 receptor   
Hypothalamus  
Interleukin-6 Macrophages, T lymphocytes, 
adipocytes 
Interleukin-6-
receptor 
Hypothalamus  
Cholecystokinin Gastro-intestinal tract CCKA Hindbrain  
Peptide YY3-36 Gastro-intestinal tract neuropeptide Y 
receptor.  
Hypothalamus  
Obestatin Gastro-intestinal tract GPR39 Hypothalamus  
GLP-1 Gastro-intestinal tract GLP-1 receptor Brainstem and hypothalamus  
Oxyntomodulin Gastro-intestinal tract GLP-1 receptor Brainstem and hypothalamus  
Insulin Pancreatic islets INSR Hypothalamus  
Pancreatic polypeptide Pancreatic islets Y4 and Y5 
receptors 
Medulla oblongata 
(area postrema)  
Glucocorticoids Adrenal glands Glucocorticoids 
receptors 
Hypothalamus and 
brainstem  
Tri-iodothyronine Thyroid gland THRB*   
Estradiol Gonads ER, and ER  Hypothalamus  
* thyroid hormone receptor α and  are alternately spliced to generate three major highly homologous nuclear receptor 
isoforms: TR1, TR1, and TR2.  The specific thyroid hormone receptor that mediates the effects of thyroid hormones on 
appetite is unknown. Abbreviations: ADIPOQ, Adiponectin; BDNF, Brain-derived neurotrophic factor; CCKA, Cholecystokinin 
receptor subtype A; ER, and ER, estradiol receptor alpha and beta; GLP-1, Glucagon-like peptide-1; GPR39, G protein-
coupled receptor 39; 5-HT, 5-hydroxytrypamine; INSR, insulin receptor; MCH,  melanin-concentrating hormone; OR, orexin; 
OXR, orexin receptor; PYY3-36, Peptide YY3-36; THRB, thyroid hormone receptor ; TrkB, Tyrosine kinase receptor; Sim1, 
Drosophila Single-minded 1; Y2R, neuropeptide Y receptor.  
 
 
The hypothalamus in the central nervous system is the major centre that integrates signals about the 
nutritional status from the periphery. Within the hypothalamus, the arcuate nucleus (Fig. 1.2) in 
particular, is part of the network that controls appetite and energy expenditure by processing leptin 
and ghrelin signals, forming the leptin-melanocortin pathway. The arcuate nucleus contains two types 
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of cells that are responsive to leptin and ghrelin signals, namely, the appetite-stimulating (orexigens) 
and food-suppressing (anorexigens) neurons (Cone, 2005). The orexigens express two peptides, 
Agouti-related peptide (AgRP) and Neuropeptide Y (NPY), while the anorexigens produces peptides 
such as cocaine and amphetamine-related transcript (CART), and pro-opiomelanocortin (POMC). The 
action of leptin and ghrelin is reciprocal, resulting in opposite effects of energy regulation. 
 
 
Figure 1.2. The leptin-melanocortin system. Leptin is secreted by the adipocytes and binds to 
hypothalamic leptin receptors, stimulating the expression of POMC-derived peptides and CART but 
inhibits the expression of NPY and AgRP. Neurons that express POMC-derived peptides and CART 
project to other sites of the hypothalamus that express MC4R and Y1R. Leptin also regulates BDNF–
TrkB through an unknown pathway. Abbreviations: AgRP, Agouti-related peptide; BDNF, brain-derived 
neurotrophic factor; CB1, CART, cocaine and amphetamine related transcript; MCH, melanin-concentrating 
hormone; MC3R, melanocortin 3 receptor; MC4R, melanocortin 4receptor; α-MSH, alpha melanocortin-
stimulating hormone; NPY, neuropeptide Y; Ob-Rb, leptin receptor, b isoform; POMC, pro-opiomelanocortin 
gene. Adapted from Flier, 2004. 
 
The level of leptin released by the adipocytes into the circulation is in proportion to body fat content. 
Upon release in response to fat storage, leptin crosses the blood-brain barrier to the hypothalamus 
where it binds to leptin receptors, thereby activating POMC/CART neurons and inhibiting NPY/AgRP 
neurons (Flier, 2004; Cone RD, 2005). Leptin acts via its receptors to also inhibit NPY/AgRP neurons 
thereby suppressing the expression and secretion of NPY and AgRP. Conversely, a decrease or 
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deficiency in leptin action stimulates appetite by the suppression of the synthesis of anorectic 
neuropeptides, and increased expression of orexigenic peptides. However, an absolute deficit of leptin 
does not underlie most cases of obesity. Instead, most obese individuals exhibit elevated circulating 
leptin levels (leptin resistance), which increase proportionally with their adipose mass (Considine et 
al., 1996; Maffei et al., 1996; Farooqi and O'Rahilly, 2005). Experiments revealed that naturally 
occurring obese (ob/ob) mice were deficient in leptin as a result of a loss-of-function mutation in the 
leptin gene, while diabetic (db/db) mice produced the circulating satiety factor in excess but lacked the 
ability to respond to it due to mutation in the leptin receptor gene (Zhang et al., 1994; Friedman and 
Halaas, 1998). These mutations, however, were not detected in obese humans, suggesting that 
different genetic defects may be responsible for this phenotype in humans. Leptin resistance was also 
observed in mice with diet-induced obesity, which were not responsive in peripheral leptin 
administration to reduce food intake and body fat (Van Heek et al., 1997).  
 
A number of mechanisms have been proposed to explain leptin resistance, and these include the 
failure of circulating leptin to reach its target receptor within the brain, decreased expression of the 
leptin receptor within hypothalamic neurons, perturbations in developmental programming, etc 
(Bjørbaek and Kahn, 2004; Flier, 2004; Remacle et al., 2004). Another mechanism that has received 
attention is the attenuation of the intracellular leptin signaling cascade (Bjørbaek et al., 1998). The 
action of various cytokine receptors is negatively regulated by an intracellular protein, the suppressor 
of cytokine signaling-3 (Socs-3) (Starr et al., 1997). Leptin is structurally related to cytokines and acts 
via a receptor that belongs to the cytokine receptor family. It is, therefore believed that Socs-3 limits 
leptin signalling, and mediates leptin resistance (Kievit et al.; 2006). It has been demonstrated in 
mouse models that complete loss of Socs-3 is embryonic lethal, and mice with only one functional 
copy of Socs-3 or those with neuronal deletion of Socs-3 are lean and leptin sensitive (Howard et al., 
2004; Kievit et al., 2006; Mori et al., 2004). Regardless of the proposed mechanism, the question that 
still remains is whether leptin resistance reflects the underlying initiating mechanism of obesity, a 
consequence of obesity, or a combination of both.  
 
Activation of NPY/AgRP neurons occurs via the release of ghrelin from the stomach, and its binding 
respective receptors in the arcuate nucleus when fasting ensues. Ghrelin has been shown to peak 
before meal initiation (Cummings et al., 2001) and to decrease postprandially in proportion to the 
caloric content of the meal (Tschöp et al., 2001; Callahan et al., 2004). This has also been observed in 
animal models, which demonstrated that ghrelin mRNA expression and secretion are increased by 
fasting, weight loss, and insulin-induced hypoglycaemia; and reduced by re-feeding and oral glucose 
administration (Tschöp et al., 2000). Ghrelin administration in rodents increased respiratory quotient 
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by stimulating glycolysis instead of fat oxidation, favouring fat deposition and explaining the increased 
weight gain and adiposity observed in these animals (Tschöp et al., 2000). In rats and humans ghrelin 
administration stimulated appetite and increased food intake, further supporting its role in energy 
regulation (Wren et al., 2000; 2001; Druce et al., 2004). In contrast, one study reported that the fasting 
plasma ghrelin concentration, independent of body weight, is a significant negative predictor of ad 
libitum energy intake (Salbe et al., 2004). Votruba and co-workers (2009), on the other hand, found no 
correlation between fasting ghrelin concentrations and food intake in a larger group. According to 
these authors, the possible explanation could be that ghrelin concentrations in obese individuals 
respond differently to meal challenges than in lean individuals. These conflicting findings may be due 
to the difference in the selection criteria of study groups: other studies have focused on such 
extremes, for example, many subjects with BMI <18.5 due to anorexia nervosa in one (Shiiya et al., 
2002) and severely obese subjects with BMI 33–65 kg/m2 in another (Holdstock et al., 2003).  
 
Lack of NPY and AgRP had a modest effect on the pathophysiology of obesity in mice models, 
becoming modestly lean late in life (Wortley et al., 2005). In humans the effect varies according to 
age, with loss of NPY and AgRP leading to a severe life threatening hypophagia in adults while in 
newborn babies it results in mild food suppression and body weight loss (Flier, 2006). This suggests 
that neonates have a network-based compensation mechanism not present in adults. It is however, 
not known whether the suppressed food intake is due to the loss of NPY and AgRP or the absence of 
other neurotransmitters is involved.  
 
The POMC is a polypeptide that is post-translationally cleaved in specific tissues by prohormone 
convertases 1 and 2 to produce molecules such as melanocortins α, β, and γ-melanocortin-stimulating 
hormones (MSH). One or more of the melanocortin peptides are involved in controlling food intake 
and energy expenditure by binding to and stimulating melanocortin-4-receptor (MC4R), and 
melanocortin-3-receptor (MC3R) (Fig 1.2). In addition, the melanocortins play significant roles in the 
cardiovascular system (Gruber and Callahan, 1989; Versteeg et al., 1998). They exert different effects 
by binding to 5 melanocortin receptors designated 1-5. These receptors are members of the G-
protein-coupled family that are positively linked to adenylase cyclase, with cAMP as the intracellular 
second messenger (Chhajlani and Wikberg, 1992; Mountjoy et al., 1992; Tatro, 1996; Adan and 
Gispen, 1997). The γ-MSH has a high binding affinity for MC3R while α-MSH is the ligand for all the 
MCRs except MC2R, which mediates corticotrophin stimulation of steroidogenesis. Only the MC3R 
and MC4R play a role in body weight and blood pressure regulation as demonstrated in several 
studies (Coll et al., 2004; Greenfield et al., 2009; Ni et al., 2003).  
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Distal to the leptin-melanocortin pathway, there are other proteins that appear to contribute to the 
regulation of food intake and energy expenditure (Table 1.5). Of note is the brain-derived neurotrophic 
factor (BDNF), a neural growth factor that exerts its effect by binding to the kinase B receptor (TrkB).  
BDNF was known to play critical roles in the synaptic activity and plasticity in mature neurons 
(McAllister et al., 1999; Poo, 2001; Lu, 2003) until in 1992 when Lapchak and Hefti described that 
central infusion of BDNF attenuated weight gain in rats, suggesting another role in regulation of body 
weight. Subsequently, Pelleymounter and co-workers (1995) showed that infusion of BDNF in the 
lateral ventricule of adult rats induced severe, dose-dependent appetite suppression and weight. In 
humans, several genetic defects in BDNF gene or its receptor (TrkB) have also been linked with 
eating disorders accompanied by developmental delay, impaired short-term memory and unusually 
hyperactive behaviour (Yeo et al., 2004; Gray et al., 2006).  Furthermore, individuals with Wilms' 
tumor, aniridia, genitor–urinary anomalies and mental retardation (WAGR) are characterized by gene 
defects and display obesity when deletions are extend into the BDNF locus (Kernie et al., 2000; Marlin 
et al., 1994;  McGaughran et al., 1995). Four variants of the BDNF-encoding gene have been 
described in human patients with anorexia nervosa (AN) or bulimia nervosa (BN) (Ribases et al., 
2003; Ribases et al., 2004). The most common polymorphism, BDNF Val66Met, has been shown to 
affect the sorting of BDNF into the nerve terminals and markedly reduces its activity-dependent 
secretion (Egan et al., 2003; Chen et al., 2004). Mutations in the gene encoding TrkB have also been 
linked to eating disorders. A de novo Y722C mutation was described in a young boy displaying severe 
obesity. This mutation was shown to considerably alter the signalling capabilities of the receptor TrkB 
(Yeo et al., 2004). Other mutations on the gene encoding TrkB have been linked to AN and BN, 
although the consequences of these mutations on the function of TrkB are currently unknown 
(Ribases et al., 2005).  
 
BDNF has been proven to participate in the regulation of energy homeostasis downstream of leptin, 
with the ventromedial hypothalamus (VMH) identified as a key site for BDNF expression that is 
modulated by nutritional state (Xu et al., 2003). In this study, Xu and co-workers (2003) demonstrated 
that central infusion of BDNF in mice with abnormal MC4R suppressed hyperphagia and obesity. In 
addition, mice with a loss-of-function trkb mutation closely resembled those lacking Mc4r as they also 
developed hyperphagia and obesity, and increased linear growth when fed a high fat diet. To further 
support the role of BDNF in energy regulation, Wang and co-workers (2007) demonstrated that 
intraparenchymal injection of BDNF in the ventromedial hypothalamus reduced food intake and body 
weight gain, an effect that was abolished by preadministration of TrkB-Fc fusion protein, blocking 
binding between BDNF and its receptor TrkB. It has also been demonstrated that BDNF plays a role 
as a downstream effector of melanocortinergic signaling within the dorsal vagal complex (DVC), and 
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that its protein content within the DVC is under the control of brainstem melanocortin system (Bariohay 
et al., 2009). The DVC is located in the caudal brainstem and comprises three interconnected 
structures, the nucleus tractus solitarii (NTS), area postrema, and dorsal motor nucleus of the vagus 
nerve.  
 
In the lateral hypothalamus, another orexigenic neuropeptide, melanin-concentrating hormone, is 
expressed and compelling evidence exists that demonstrates its role in energy balance (Flier, 2004). 
MCH knockout mice were hypophagic while those over-expressing the gene developed obesity and 
insulin resistance. In ob/ob mice, MCH was over-expressed while those lacking the gene had reduced 
body fat. In addition, Alon and Friedman (2006) showed that targeted ablation of MCH neurons 
caused hypophagia, increased energy expenditure and late-onset leanness. 
 
1.3.2.2. Monogenic Obesity 
Eleven genes have been implicated thus far in non-syndromic monogenic forms of obesity: 
corticotropin-releasing hormone receptor 1 (CRHR1); corticotropin-releasing hormone receptor 2 
(CRHR2); G protein-coupled receptor 24 or melanin-concentrating hormone receptor 1 (GPR24 or 
MCH1R); leptin (LEP); leptin receptor (LEPR); melanocortin-3-receptor (MC3R); melanocortin-4-
receptor (MC4R); neurotrophic tyrosine kinase, receptor, type 2 (NTRK2); proopiomelanocortin 
(POMC); prohormone convertases 1 (PC1 or PSCK1); and single-minded homolog 1 (SIM1). This 
section will briefly describe a few genes due to their relevance to the present study.  
 
LEP mutations: Zang and coworkers (1994) identified the first obesity-causing null mutation in ob/ob 
mice. Subsequently, inactivating homozygous mutations were reported in humans, which resulted in 
severe early-onset obesity accompanied by hyperphagia but with very low serum leptin levels 
(Montague et al., 1997; Strobel A et al., 1998).  
 
LEPR mutations: A short variant of lepr was identified in db/db mice (Chen et al., 1996; Lee et al., 
1996) and Zucker fa/fa rats (Takaya et al. 1996), which, in both animal models resulted in severe 
obesity. Similarly, LEPR homozygous mutation that resulted in a truncated protein was reported in 
humans. This mutation was characterised by early-onset severe obesity, lack of pubertal 
development, and a reduced secretion level of both growth hormone and thyrotropin (Clément et al., 
1998; Farooqi et al., 2007). Leptin receptor heterozygotes, similar to that of leptin, appeared to have a 
normal phenotype. 
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POMC mutations: Homozygous and compound heterozygous mutations have been reported in 
POMC (Krude et al., 1998; Krude et al., 2003; Farooqi et al., 2006), which caused early-onset obesity 
accompanied by adrenal insufficiency and red hair pigmentation (Ichihara and Yamada, 2008). The 
reported mutations resulted in the loss of either one or two POMC products, or all of its derived 
peptides.  
 
Prohormone convertase 1 gene (PC1) mutations: PC-1 defects are one of the rare causes of 
human monogenic obesity with currently two cases of compound heterozygous mutations reported. In 
one case, the two mutations resulted in a truncated immature and inactive PC1 that could not be 
transported outside the endoplasmic reticulum (Jackson et al., 1997). The affected adult female had 
early-onset morbid obesity that was associated with hypogonadotropic hypogonadism, abnormal 
glucose homeostasis, small bowel malabsorption, and elevated plasma concentration of proinsulin 
and POMC. The second case involved an individual with a missense and nonsense mutation 
characterised with severe refractory neonatal diarrhea due to absorptive dysfunction in the small 
intestine (Jackson et al., 2003). 
 
MC4R mutations: There is currently no known MC4R obesity-causing mutation in animal models 
reported, however, gene targeting in mice resulted in Mc4r activation and subsequently maturity-onset 
obesity syndrome associated with hyperphagia, hyperinsulinemia, and hyperglycemia (Huszar et al., 
1997). In humans, MC4R defects are the most common causes of monogenic obesity with more than 
100 mutations described in different ethnic groups, the majority of which are transmitted in an 
autosomal dominant manner (Yeo et al., 1998; Vaisse et al., 1998; Mergen et al., 2001; Kobayashi et 
al., 2002). These mutations are characterised by clinical heterogeneity, and sometimes incomplete 
disease penetrance.  
 
MC3R mutations: Unlike MC4R, MC3R is more a predisposing factor of polygenic obesity than a 
cause of monogenic obesity. It is only recently that 9 possible obesity-causing mutations were 
reported. Three mutations (Ile183Asn, Ala70Thr, and Met134Ile) were identified in 3 unrelated 
subjects but not in control subjects (Lee et al., 2007). Although functional studies revealed impaired 
MC3R signaling activity as a result of these mutations, in some cases the variants did not co-
segregate with obesity in adults but interestingly did with childhood obesity. Individuals harbouring 
heterozygous mutations exhibited higher leptin levels and adiposity, and less hunger compared to 
obese controls, reminiscent of the Mc3r knockout mice. Three additional mutations (Ala293Thr, 
Ile335Ser and X361Ser), which co-segregated with obesity were identified in Italian obese subjects 
(Mencarelli et al., 2008). However, only one mutation caused a functional defect in in vitro expression 
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studies.  Recently, three other heterozygous mutations (Asn128Ser, Val211Ile, Leu299Val) were 
identified in three unrelated children. Although no conclusive evidence for functional impairment of the 
Asn128Ser and Val211Ile mutated receptors could be established, the Leu299Val mutation negatively 
affected the function of the MC3R (Zegers et al., 2010). 
 
Mutations in peptides that function downstream the melanocortin receptors: single-minded 
drosophila homolog 1 (SIM1) and neurotropic tyrosine kinase receptor type 2 (NTRK2) genes 
Further downstream of the melanocortin receptors only two genes, single-minded drosophila homolog 
1 (SIM1) and neurotropic tyrosine kinase receptor type 2 (NTRK2), are reported to be defective in 
children with severe obesity among other abnormalities. A de novo balanced translocation involving 
chromosome 1p22.1 and 6q16.2 was identified in a girl with early-onset obesity (Holder Jr et al., 
2000). When these authors cloned and sequenced both translocation breakpoints, they observed that 
SIM1 was disrupted on 6q, separating the 5-prime promoter region and the basic helix-loop-helix from 
the 3-prime PER-ARNT-SIM and putative transcriptional regulation domains. Holder and co-workers 
(2000) hypothesized that haploinsufficiency of SIM1, possibly acting upstream or downstream of 
MC4R in the PVN, was responsible for severe obesity in their patient. A deletion was also identified in 
chromosome 6q16.1-q21 in a patient with Prader Willi syndrome, resulting in the absence of SIM1 
(Faivre et al., 2002). Although the transcriptional targets of Sim1 are unknown, it is expressed in the 
developing kidney and central nervous system, and is essential for formation of the supraoptic and 
paraventricular (PVN) nuclei of the hypothalamus (Holder et al., 2000). There is strong evidence 
suggesting that in the PVN neurons SIM1 is coexpressed with MC4R (Balthasar et al., 2005; Kublaoui 
et al., 2006). Animal studies have also demonstrated that SIM1 plays a role in regulation of appetite. 
As observed in a study by Holder and co-workers (2004), the absence of one copy of SIM1 in mice 
resulted in reduced food intake when these animals were switched from normal chow to a high-fat 
diet, suggesting that the gene is involved in regulation of appetite. Similar defects were observed in 
Mc4r knockout mice with defective melanocortin signaling (Huszar et al., 1997). Another de novo 
missense mutation, Tyr722Cys, was detected in NTRK2 that caused a severe early-onset obesity and 
impaired memory, learning, and nociception. The NTRK2 is a receptor of the BDNF, a peptide that 
regulates the development, survival, and differentiation of neurons (Xu et al., 2003).  
 
1.3.2.3. Syndromic Obesity 
Currently there are more than 25 human genetic syndromes associated with obesity and these include 
among others, Prader Willi, Alstrom, Bardet-Biedl, Cohen, Albright hereditary osteodystrophy, and 
Borjeson Forssman Lehmann, (Chung and Leibel, 2005). In these cases obesity occurs in association 
with other clinical phenotypes such as mental retardation, dysmorphic features, and organ-specific 
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developmental abnormalities. These syndromes are caused by genetic defects or chromosomal 
rearrangements, and can be transmitted either autosomal dominantly or X-linked. 
 
Prader-Willi syndrome (PWS): The PWS is caused by defects in the inheritance of imprinted genes 
on chromosome 15q11.2-q12 (Horsthemke et al., 2003). The majority of cases (75%) arise from 
paternal deletions of this locus, 22% result from maternal uniparental disomy, less than 3% from 
imprinting errors caused by microdeletions of the imprinting center at the small nuclear 
ribonucleoprotein polypeptide N upstream reading frame locus or an abnormal imprint without a 
detectable microdeletion, and less than 1% from paternal translocations (Nicholls and Knepper, 2001). 
Other candidate genes in the affected interval include NDN (necdin-encoding gene, a growth 
suppressor present in all postmitotic neurons in the brain) (Jay et al., 1997), and three families of C/D-
box small nucleolar RNA genes (HBII-13, HBII-52, HBII-85) (Runte et al., 2001). Individuals with PWS 
exhibit central obesity, neonatal hypotonia, hyperphagia, hypothalamic hypogonadism, and mild 
mental retardation with somatic abnormalities such as short stature, peculiar facial features and small 
hands (Gunay-Aygun et al., 2001). There may be other unknown genetic defects causing PWS 
because several patients with clinical features of the disease have normal chromosome 15 but with 
cytogenetic alterations of chromosome 6q (Gilhuis et al., 2000). 
 
Bardet-Biedl syndrome (BBS): Unlike the PWS, BBS is genetically heterogeneous with more than 
two chromosomal loci reported, and these include chromosome 11q13, 16q21, 3p12-q13, 15q22.3-
q23, 2q31, 20p12, 4q27, 14q32.1, 7p14, 12q21.2, 9q31-q34.1, and 4q27 (Beales et al., 1997; Stoetzel 
et al., 2006; Chiang et al., 2006; Stoetzel et al., 2007). As a result of these reported genetic loci, BBS 
cases were named BBS1-BBS12 in order of the identified chromosomal regions. Although several 
genetic loci have been reported, in approximately 50% of the cases of BBS the cause is unknown. The 
BBS was initially thought to be transmitted recessively and caused by homozygous mutations, but 
later an additional mutation was discovered in a second locus making the transmission triallelic 
(Katsanis et al., 2001). For example, a heterozygous mutation on chromosome 3p12-q13, which was 
found to modify the expression of the Met390Arg mutation on chromosome 11q13 (Fan et al., 2004). 
The Met390Arg mutation accounts for about 80% of all cases caused by defects found in chromosome 
11q13 (Mykytyn et al., 2003). Clinically, BBS is characterised by early-onset obesity associated with 
progressive rod-cone dystrophy, morphological finger abnormalities, dyslexia, learning disabilities, and 
progressive renal disease (Beales et al., 1999). 
 
Alstrom syndrome (ALMS): The ALMS is an autosomal recessive disorder but unlike BBS, it is 
genetically homogeneous caused by defect in the ALMS1 that is located in chromosome 2p13 
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(Marshall et al., 1997). Defects of the ALMS1 that cause ALMS include balanced translocations that 
disrupt the gene, and a few number of nonsense and frameshift mutations. ALMS is characterised by 
obesity associated with small stature, dilated cardiomyopathy, and type 2 diabetes. It is also 
associated with other clinical features of heterogeneous severity such as hyperthyroidism, retinal cone 
dystrophy, progressive sensorineural hearing loss, chronic nephropathy, and hepatic dysfunction.   
 
Borjeson-Forssman-Lehmann syndrome (BFLS): The BFLS is an X-linked disorder caused by a 
zinc-finger plant homoedomain-like finger gene (PHF6), which plays a role in transcription. Eight 
different missense and truncation mutations have been detected in seven familial and sporadic cases 
of BFLS (Lower et al., 2002). Affected males exhibit clinical symptoms such as hypotonia, failure to 
thrive, big ears, small external genitalia as infants, moderate short stature with emerging truncal 
obesity, gynecomastia, macrocephaly, tapering fingers, and shortened toes (Dereymaeker et al., 
1986).  Females with heterozygous PHF6 mutations have milder clinical features as a result of skewed 
X inactivation (Turner et al., 2004). 
 
Cohen syndrome (COH1): This is an autosomal recessive disorder mostly found in Finnish 
populations (Kolehmainen et al., 2003). It is caused by mutations in the vascular protein sorting 13 
yeast homolog of the B (VPS13B) gene. Several gene defects have been reported and include 
frameshift, nonsense and missense mutations. The VPS13B is thought to function in vesicle-mediated 
sorting and transportation of proteins within the cell. The COH1 syndrome is characterised by mild 
truncal obesity, thin extremities, and short stature. Other clinical features identified in affected Finnish 
individuals include non-progressive mild severe psychomotor retardation, motor clumsiness, 
microcephaly, characteristic facial features, hypotonia and joint laxity, progressive retinochoroidal 
dystrophy, myopia, intermittent isolated neutropenia and a cheerful disposition (Chandler et al., 2003). 
 
1.3.2.4. Polygenic Obesity 
Unlike monogenic obesity, the polygenic form is quite complex resulting from the effect of several 
polymorphisms in many genes, which only precipitate in obesogenic environments (Strauss and 
Knight 1999; Hebebrand et al., 2003; Hebebrand and Hinney, 2009). Completion of the Human 
Genome and HapMap projects have not only generated data but also provided tools to investigate the 
genetic basis of many diseases. As reviewed by Rankinen et al (2006), several genes implicated in 
common obesity have been detected through three approaches: linkage analysis, candidate gene and 
genome-wide association (GWA) studies. Employing these strategies however has its challenges as 
they are less effective in identifying polymorphisms with modest effect, and not replicable due to 
differences in study design or populations and insufficient power to detect significant association. 
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Responsible genes are identified through linkage analysis by either mapping genes or positional 
cloning, which is based on inheritance or segregation of genetic markers with the disease in affected 
multigeneration families or extensive groups of sib-pairs (McCarthy et al., 2008). Upon identification of 
chromosomal regions with positive linkage, candidate genes within that region are investigated further 
by association studies to identify polymorphisms and compare the frequencies of variant alleles 
between affected individuals and normal controls (Baron, 2001). Some of the genes identified through 
positional cloning based on linkage analysis include glutamate decarboxylase 2 (GAD2) (Boutin et al., 
2003), ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) (Meyre et al., 2005) and solute 
carrier family 6 (amino acid transporter), member 14 (SLC6A14) (Suviolahti et al., 2003; Durand et al., 
2004). These genes are functionally related to obesity: GAD2 catalyses the formation of the 
neurotransmitter -aminobutyric acid, which increases food intake; ENPP1 inhibits insulin receptor 
activity, and SlC6A14 is a tryptophan transporter. Apart from requiring families and the difficulty to 
replicate, the majority of linkage association studies of common complex disease can only identify 
polymorphisms with strong effects (Walley et al., 2009).  
 
Candidate gene association studies have an advantage over linkage analysis in that their analysis 
involves fewer steps, are limited to functionally-related genes, and can be conducted in unrelated 
individuals who can be easily recruited. Several genes studied (Table 1.6) including MC4R, BDNF, 
LEP and LEPR were plausible candidates due to their role in monogenic and syndromic obesity. 
These genes are now known to predispose to polygenic obesity in both adults and children (Jiang et 
al., 2004; Li et al., 1999; Chagnon et al., 2000; Roth et al., 1998).  Candidate gene association studies 
have provided strong evidence for modest effects of genes on obesity, but replication of the results is 
also challenging.   
 
Candidate gene and linkage association studies have been superseded by GWA studies, which 
enable identification of a wide range of genes including those with poorly understood functions (Walley 
et al., 2009). The GWA studies of complex diseases utilise gene variants data generated from the 
HapMap project, testing the correlation between polymorphisms across the entire human genome and 
traits variation in study populations. Large numbers of subjects can be analysed to increase the 
statistical power of identifying variants with smaller effects.  From reported studies, GWA give higher 
significant effects (p < 10-6) compared to linkage and candidate gene associations studies (Walley et 
al., 2009). Although the GWA approach has identified polymorphisms associated with complex 
diseases such as obesity, it is limited to common polymorphisms, and rare variants are often missed 
(Iyengar and Elston, 2007). To date, 253 QTL for human obesity have been detected from 61 
genome-wide scans in different racial groups (Rankinen et al., 2006) of which only approximately 21% 
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of these associations have been replicated in two or more studies. Novel genes such as insulin-
induced gene 2 (INSIG2) (Herbert et al., 2006), Niemann-Pick disease type C1 (NPC1), the proto-
oncogene (MAF) and phosphotriesterase related (PTER) (Meyre et al., 2008), catenin beta-like 1 
(CTNNBL1) (Liu et al., 2008) have been identified through GWA studies. Table 1.7 summarises 
published findings on polymorphisms that have been found to be associated with obesity and BMI 
through GWA studies. Fat mass and obesity-associated (FTO) is the first gene with replicated 
association with BMI, followed by MC4R. However, both genes only explain approximately 0.84% of 
the total variance in BMI (Frayling et al., 2007; Loos et al., 2008; Willer et al., 2009; Beckers et al., 
2011). The Genetic Investigation of ANthropometric Traits (GIANT) consortium study identified four 
known obesity-associated genes (FTO, MC4R, BDNF and SH2B1) in addition to seven new 
chromosomal regions (TMEM18, KCTD15, NEGR1, SEC16B, ETV5, BCDIN3D) that influence BMI 
(Thorleifsson et al., 2009). Furthermore, Naukkarinen and co-workers (2010) recently conducted a 
genome-wide transcript profiling of adipose tissue samples and GWA in Finnish and European 
Caucasian populations, respectively, identifying thirteen genes harboring twenty three SNPs that were 
slightly significantly associated with BMI. Seven SNPs identified in the coagulation factor XIII A1 
subunit gene (F13A1) showed association with BMI. The GWA identified the intronic rs714408 
polymorphism in F13A1 as showing the strongest association with BMI.  
 
Apart from SNPs, other sequence aberrations such as copy number variations (CNVs) and DNA 
methylation have been implicated as risk factors for obesity. Studies have demonstrated association of 
common CNVs, a deletion near the neuronal growth regulator 1 gene and a duplication of a region 
encompassing the neuropeptide Y receptor, with BMI (Willer et al., 2009; Sha et al., 2009; Jarick et al., 
2011). The NPY receptor is directly involved in food intake and a key regulator of energy homeostasis 
with potential role in body weight variation (Kamiji and Inui, 2007), while the neuronal growth regulator 
1 is thought to affect neuronal outgrowth (Schäfer et al., 2005).  Other studies reported rare, large 
CNVs, which were initially implicated to cause complex disorders (autism and mental retardation) with 
obesity but were later associated with severe obesity (Bochukova et al., 2010; Walters et al., 2010; 
Wang et al., 2010). Recently, Jarick and coworkers (2011) reported a CNV region on chromosome 
11q11, which covers sequences of three olfactory receptor genes (OR4P4, OR4S2 and OR4C6). A 
possible link between obesity and the olfactory receptor genes is suggested to be based on altered 
olfactory acuity in morbidly obese individuals.  
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Table 1.6. Candidate genes for polygenic obesity studied from 2005 to 2009. Adapted from Walley et 
al (2009). 
 
Gene Number of subjects Phenotype P value Odds ratio 
ENPP1 6147 Obesity 6 × 10–3 (adults)  
6 × 10–4 (children)  
1.50 (adults) 
1.69 (children) 
PCSK1 13659 Obesity 7 x 10-8 (adults) 
2 x 10-12 (children) 
1.34 (adults) 
1.22 (children) 
NAMPT 4559 Severe obesity 8 x 10-15 (adults) 
6 x 10-9 (children) 
Not applicable 
Not applicable 
LMNA 4559 Obesity 1 x 10-2 1.25 
 5693 Waist circumference 3 x 10-13 1.14 
GHSR 2513 Obesity 7 x 10-4 2.74 
SOCS1 8108 Obesity 4.7 x 10-2 Not applicable 
SOCS3 1425 Body mass index 
Waist-hip ratio 
3 x 10-3 
2 x 10-4 
Not applicable 
KLF7 14818 Obesity 1 x 10-3 0.90 
MTMR9 3220 Body mass index 5 x 10-4 1.40 
DLK1 1025 trios Obesity 2 x 10-3 1.34 
CNR1 5750 
  
Obesity 1.1 x 10-6 (adults) 
3 x 10-5 (children) 
1.85 (adults) 
1.52 (children) 
TBC1D1 9 multiplex pedigree, 423 
population controls 
Obesity 7 x 10-6 Not applicable 
NPY2R 3096 Obesity 2 x 10-3 (adults) 
2 x 10-2 
1.40 (adults) 
1.20 (children) 
Abbreviations: ENPP1, Ectonucleotide pyrophosphatase/phosphodiesterase 1; PCSK1, Proprotein convertase 
subtilisin/kexin type 1; NAMPT, Nicotinamide phosphoribosyltransferase; LMNA, Lamin A/C; GHSR, Growth hormone 
secretagogue receptor; SOCS1, Suppressor of cytokine signalling 1; SOCS3, Suppressor of cytokine signalling 3; KLF7, 
Krüppel-like factor 7; MTMR9, Myotubularin related protein 9; DLK1, Delta-like homologue 1; CNR1, Cannabinoid type 1 
receptor; TBC1D1, TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1; NPY2R, Neuropeptide Y receptor Y2. 
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Table 1.7. Polymorphisms associated with obesity and body mass index (BMI) in genome-wide 
association studies. Adapted from Walley et al (2009). 
 
Abbreviations: BMI, body mass index; TMEM18, transmembrane protein 18; BCDIN3D, BCDIN3 domain-containing protein; 
BDNF, brain-derived neurotrophic factor; CTNNBL1, catenin beta like 1; ETV5, ets variant 5; FTO; GNPDA2, glucosamine-6-
phosphate deaminase 2; KCTD15, potassium channel tetramerisation domain containing 15; MAF, v-maf 
musculoaponeurotic fibrosarcoma oncogene homolog; MC4R, melanocortin 4 receptor; MTCH2, mitochondrial carrier 
homolog 2; NEGR1, neuronal growth regulator 1; NPC1, Niemann-Pick disease, type C1; PTER, phosphotriesterase-related 
protein; SEC16B, SEC16 homolog B (S. cerevisiae); SH2B1, SH2B adaptor protein 1. 
 
SNP rs number Gene Number of subjects Phenotype P value Odds ratio 
rs9939609 FTO 28,587 adults BMI 3 x 10-15 1.67 
  10,172 children  7 x 10-9 1.27 
rs9930506 FTO 6148 subjects BMI 8.6 x 10-7 Not applicable 
rs17782313 MC4R 77,228 adults BMI 2.8 x 10-15 1.12 
  10,583 children BMI 1.5 x 10-8 1.30 
rs10508503 PTER 8,128 adults BMI 8.7 x 10-5 0.68 
  8,855 children BMI 1.9 x 10-4 0.64 
rs1805081 NPC1 8,128 adults BMI 7.7 x 10-8 0.75 
  8,855 children BMI 2.1 x 10-2 0.75 
rs1424233 MAF 8,128 adults BMI 1.9 x 10-8 1.39 
  8,855 children BMI 1.6 x 10-6 1.12 
rs6548238 TMEM18 84,823 adults BMI 1.4 x 10-18 1.19 
  9,320 children BMI 3.4 x 10-5 1.41 
rs7561317 TMEM18 69,593 adults BMI 4.2 x 10-17 1.20 
rs11084753 KCTD15 71,706 adults BMI 2.3 x 10-8 1.04 
  9,156 children BMI 9.7 x 10-4 0.96 
rs29941 KCTD15 69,593 adults BMI 7.3 x 10-12 1.10 
rs7498665 SH2B1 86,677 adults BMI 5.1 x 10-11 1.11 
  69,593 adults BMI 3.2 x 10-10 1.08 
rs10838738 MTCH2 80,917 adults BMI 4.6 x 10-9 1.03 
rs10938397 GNPDA2 81,758 adults BMI 3.4 x 10-16 1.12 
  9,309 children BMI 2.0 x 10-2 1.20 
rs2815752 NEGR1 83,499 adults BMI 6.0 x 10-8 1.05 
rs2568958 NEGR1 69,593 adults BMI 1.2 x 10-11 1.07 
rs6013029 CTNNBL1 1,000 adults BMI 2.69 x 10-7 1.42 
  3,812 adults Obesity 7.8 x 10-4 1.42 
rs10913469 SEC16B 69,593 adults BMI 6.2 x 10-8 1.11 
rs7647305 ETV5  75,043 adults BMI 7.2 x 10-11 1.11 
rs925946 BDNF 69,593 adults BMI 8.5 x 10-10 1.11 
rs7138803 BCDIN3D 69,593 adults BMI 1.2 x 10-7 1.14 
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1.3.2.4.1. Gene-environmental interaction 
As noted earlier in the current review, both the individual’s genetic background and obesogenic 
environment play a significant role in polygenic obesity. The concept of gene-environment interaction 
refers to a situation where the precipitation of a disease (in this case, obesity) depends on the 
exposure of a certain genotype to a specific environment. In obesity, these genotypes must be 
susceptible to alterations in energy balance. Both human (Bouchard et al., 1990; Bouchard C et al., 
1990; Bouchard et al., 1994) and animal models (West et al., 1992; West et al., 1995; Prpic et al., 
2002) have provided strong evidence demonstrating that genes influence a substantial percentage of 
responses to nutrition and exercise. The existing literature on animal studies focuses on finding 
specific genes that respond to weight gain rather than investigating the allele contribution in response 
to diet changes. Although extensive research has been conducted, the knowledge of which specific 
genes, diets and exercise, and their interaction contribute to the majority of human obesity risk is 
largely unknown. The reported findings from these studies are generally in an exploratory phase and 
require further investigation. Below are some of the findings obtained on such studies. 
 
In the context of gene-diet interactions, PPARG2 Pro12Ala is the most widely studied polymorphisms, 
particularly in Caucasians of different countries such as Spain, USA, Britain, Canada and Germany.   
The majority of the studies have focused on the interaction between fat intake and PPARG2 Pro12Ala 
(Kadowaki et al., 2002; Memisoglu et al., 2003; Robitaille et al., 2003), probable due to the role of 
PPARG in adipocyte differentiation, lipid storage, and insulin sensitivity (Spiegelman, 1998). The 
relationship between the variant and carbohydrate intake or alcohol consumption has also been 
investigated in different studies (Marti et al., 2002). In relation to fat intake, a Quebec Family study 
reported an interaction between the Ala12 variant and total fat intake and its association with higher 
BMI and waist circumference (Robitaille et al., 2003). In a study by Memisoglu and co-workers (2003), 
a significant interaction between total fat intake and BMI was found: a highest quintile of total dietary 
fat was associated with increased risk of obesity among Pro12Pro subjects. A PREDIMED intervention 
trial found that a Mediterranean diet rich in virgin olive oil or nuts was able to reverse the negative 
effect that the 12Ala allele had on waist circumference (Razquin et al., 2009). Interestingly, 12Ala 
carriers that followed a conventional low fat diet had a significantly higher waist circumference 
compared to individuals carrying the Pro12 allele. The interaction of the PPARG2 Pro12Ala 
polymorphisms with diet was further supported by a trial conducted on animal models, in which the 
beneficial effect of the 12 Ala allele was diminished when carriers were introduced into high-fat diet 
instead of a chow diet (Heikkinen et al., 2009). 
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The FTO rs9939609 polymorphism has also been widely studied in relation to its interaction with fat 
intake and the effect on obesity. In a cross-sectional study, Sonestedt and co-workers (2009) identified 
a significant interaction between fat intake and FTO genotype and also between carbohydrate intake 
and FTO genotype on BMI. An increase in BMI across all genotypes of the rs9939609 polymrphisms 
(TT and AA homozygotes and TA heterozygotes) was restricted to those who reported intake of high-
fat diet, whereas in those consuming lower fat diet the polymorphism was not associated with BMI. 
Similarly, individuals who reported lower intake of carbohydrates had lower BMI compared to those 
who consumed a carbohydrate-rich diet. Intervention studies based on the presence of the FTO 
rs9939609 (T>A) polymorphism were also conducted, however, most of them were related to both 
dietary changes and physical activity. In one longitudinal study conducted in children (who were 
followed from the age of 7 months until 15 years old), the polymorphism was associated with 
increased BMI in children older than 7 years even after being assigned to lifestyle intervention 
(parents told to reduce the exposure of children to environmental risk factors of coronary heart 
diseases) (Hakanen et al., 2009). According to these authors, these results suggested that the 
intervention was not effective enough to cancel the effect of the FTO polymorphism. Similarly, other 
studies did not find any modulating effect of the FTO polymorphism on BMI after lifestyle modification 
(Lappalainen et al., 2009; Reinehr et al., 2009). However, in one study carriers of the FTO rs9939609 
A allele had lower body weight gain after 3 years of nutritional intervention with a Mediterranean-style-
diet but no weight loss was observed in all individuals included in the study (Razquin et al., 2010).  
The findings of this study suggest that the magnitude of the effect of the FTO polymorphism on BMI 
may be dependent on the type of diet consumed by individuals, particularly the A allele carriers.  
 
Most studies investigating the interaction of genetic polymorphisms with physical activity examined the 
effectiveness of exercise regimes on individuals with certain genotypes, many of which have not been 
replicated (Rankinen et al., 2006). Some of these studies were selected to understand the energy 
intake pathways that influence energy balance (LEPR, AGRP, MC4R, and GHRL) (Rankinen et al., 
2006; Loos et al., 2005). One example is the Finnish Diabetes Prevention study which demonstrated 
that the GHRL Leu72Met and -501A/C polymorphisms modified the effect of moderate-to-vigorous 
physical activity on changes in weight and waist circumference, and high-density lipoprotein 
cholesterol (Kilpeläinen et al., 2008). The authors further showed that the LEPR Lys109Arg 
polymorphism in combination with physical activity was associated with changes in blood pressure. 
Elsewhere, an interaction between the FTO-rs9939609 genotype and physical activity was observed, 
where physically inactive homozygous risk A-allele carriers had a 1.95 +/- 0.3 kg/m2 higher BMI 
compared with homozygous T-allele carriers (Andreasen et al., 2008). 
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1.3.2.4.2. Epigenetics 
Apart from the interaction of SNPs and environmental stimuli, modified gene expression levels in 
response to external stimuli and epigenetic factors such as DNA methylation and histone modification 
have been proposed as other mechanisms underlying the complexity of common obesity (Franks and 
Ling, 2010). Epigenetics is a phenomenon of reversible genetic modifications that occur irrespective of 
nucleotide sequence changes but affect regulation of genomic function. These changes can either be 
inherited or can be a response to nutrient availability, physical exercise and aging, among other 
factors. Early-life nutrition is one good example of a stimulus that can trigger epigenetics, affecting an 
individual's response to metabolic load and disease susceptibility in adulthood.  Several animal 
studies have supported this hypothesis. In a study conducted in rodents, unbalanced prenatal nutrition 
(through protein restriction) induced hypomethylation that increased the expression levels of 
glucocorticoid receptor (GR) and peroxisomal proliferator-activated receptor alpha (PPAR) genes in 
offspring (Lillycrop et al., 2005). These authors further demonstrated that induced methylation 
changes of individual CpG dinucleotides in the PPAR promoter in juvenile rats persisted into 
adulthood, and that such changes may consequently affect the capacity of the tissue to respond to a 
metabolic challenge (Lillycrop et al., 2008).  
 
The effect of caloric restriction in DNA methylation was also demonstrated in human studies (wang et 
al., 2010; Bouchard et al., 2010). One example of modified gene expression level is explained by the 
effect of aerobic exercise on a subset of genes, particularly those involved in oxidative energy 
metabolism, which are upregulated upon exposure to the stimulus (Franks and Loos, 2006). Recently, 
in a weight-loss intervention study, Bouchard et al. (2010) identified 644 genes that showed differential 
transcript levels between low and high responders to calorie restriction after intervention. Two of the 
genes that were differentially methylated encode a potassium channel (KCNA3) and the nuclear factor 
I/X (NFIX), and were implicated in weight control as demonstrated by knockout mouse models (Driller 
et al., 2007). The third gene, ectodermal-neural cortex 1 (ENC1), is required for adipocyte 
differentiation making it a plausible candidate obesity predisposition (Zhao et al., 2000). DNA 
methylation of the peroxisome proliferator-activated receptor- coactivator 1- gene in response to a 
high-fat diet was also reported in human studies (Brøns et al., 2010). Furthermore, an association 
between methylation in the POMC promoter and early life overnutrition and obesity was observed in a 
study by Plagemann and coworkers (2009). A direct link between DNA methylation and obesity 
phenotype was reported by Wang and co-workers (2010). In this study, two genes that were 
differentially methylated between obese and normal-weight individuals were identified: the ubiquitin-
associated and SH3 domain-containing A gene was highly methylated than the tripartite motif-
containing 3 gene in obese compared to the normal-weight group. Both these genes are involved in 
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obesity-induced immune responses. A possible role of DNA methylation in the development of obesity 
was also reported in a study by Bell and co-workers (2010). This study identified a genotype-
epigenotype interaction in the FTO gene: the FTO rs8050136 risk allele A homozygotes were shown 
to have a higher average level of methylation, followed by heterozygotes at intermediate level, and 
carriers of the homozygous C allele with the lowest level of methylation. The SNP is within a linkage 
disequilibrium block that contains polymorphisms shown to be associated with BMI in several studies. 
The association identified in this study, however, was with the individual’s genotype not their body 
weight status. While these studies have demonstrated a relationship between DNA methylation and 
obesity, they did not establish whether changes in methylation are a cause or consequence of the 
weight gain. Epigenetic studies are limited by high costs of methylation chips, hypothesis tests 
performed in multiplex experiments and corresponding procedures to correct for type 1 errors, and the 
source of genetic material used.  
 
1.4 Complications of obesity  
Obesity is considered to be a risk factor for several diseases with significant morbidity and mortality. 
Obesity as measured by BMI should be treated with caution as BMI measures both muscle and fat 
mass. Accumulation of fat to the abdomen, particularly, is the cornerstone of the metabolic disorders 
as it is associated with increased risk of insulin resistance, diabetes, hypertension, dyslipidemia and 
atherosclerosis. Together with dyslipidemia, hypertension, and insulin resistance, visceral fat 
accumulation (referred to as central obesity) constitute the Metabolic Syndrome (MetS) (Reaven, 
1988). Combined, these metabolic disorders pose a risk of developing diabetes, cardiovascular 
diseases, polycystic ovary syndrome, some forms of cancer, and liver diseases. MetS can also occur 
in non-obese individuals as previously observed in the National Health and Nutrition Examination 
Survey (NHANES) III in 5% to 10% of the population with BMIs ranging from 20 to 25 kg/m2 (Cook et 
al., 2003). In this study, people with MetS were not obese but had substantial visceral fat.  
 
Although MetS is well recognized, its definition and diagnosis across population is problematic as 
there are currently more than two definitions used with revised cut-off points for several components. 
Although it was initially thought to affect adults, MetS presents early in life and progresses with age 
and puberty (Chen et al., 1999; Maffeis, 2002; Goedecke et al., 2006; Zachurzok-Buczyska et al., 
2011; Kassi et al., 2011). This necessitated early diagnosis of MetS with possible identification of 
adolescents at increased and premature cardiovascular risk. Adult definitions could not be applied due 
to age- and sex- dependent changes in normal body proportion and other components during pubertal 
development, which may vary among individuals of different ethnic groups. Thus, adult MetS 
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definitions were modified for children, by the National Cholesterol Education Program Expert Panel on 
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III 
(NCEP ATP III) (Cook et al., 2003), WHO (Goodman et al., 2004), and International Diabetes 
Federation (IDF) (Zimmet et al., 2007). Table 1.8 summarises two of the commonly used criteria to 
identify the MetS in children. The IDF and the American Heart Association/National Heart, Lung and 
Blood Institute (AHA/NHLBI) released a consensus definition for Mets, the Joint Interim Statement 
(JIS), whereby abdominal obesity was removed as a prerequisite for the diagnosis of metabolic 
syndrome (Alberti et al., 2009). Consequently, the JIS definition classifies an individual as having 
MetS if an individual has three of either, raised blood pressure, elevated triglycerides, low high-density 
lipoprotein cholesterol levels, central obesity or hyperglycaemia. A variety of studies using three or 
four criteria reported diverse prevalence of MetS in children and adolescents (Kassi et al., 2011). It is 
however, evident that the condition is prevalent in obese children, and if they stay obese in adulthood, 
this will further increase the risk of subsequent related disorders (Kiess et al., 2006). The existence of 
MetS, regardless of the definition used, was also evident in a South African study, which reported 
MetS in two thirds of obese or overweight learners aged 10-16 years (Matsha et al., 2009). According 
to the recent review by Kass and co-workers (2011), the main concern of clinicians is the extrapolation 
of adult MetS definitions to children and adolescents. The hypothesis that MetS in childhood is related 
to MetS in adulthood has not been fully tested, and there is a limited number of large longitudinal 
studies linking pediatric MetS with adult cardiovascular disease. 
 
 
Table 1.8. Examples of Metabolic Syndrome definitions used in children 
 
The IDF ages 10 – 16, (Zimmet et al., 2007)  The NCEP ATP III, (Cook et al., 2003)  
 
  Any 3 or more of the following: 
Central obesity 
(WC)  > 90th percentile     > 90th percentile, age gender specific  
 
And any 2 or more of the following: 
  
FBG   5.6 mmol/L (100mg/dL) or     5.6 mmol/L (100mg/dL) 
known type 2 diabetes  
  
Hypertension SBP 130 or DBP  85 mmHg    90th percentile for age, sex & height 
 
TG   1.7 mmol/L (150mg/dL)     1.24 mmol/L (110mg/dL) 
 
HDL-C  < 1.03 mmol/L (40mg/dL)   	 1.04 mmol/L (40mg/dL) 
 
 
Stellenbosch University http://scholar.sun.ac.za 
 
 
 
47
1.5. Aims and objectives of the present study 
Childhood obesity is one of the most serious public health problems facing the developed, and 
increasingly the developing world. South Africa, in particular, is faced with a rapid increase in 
childhood obesity of 10% among children under the age of 2 and 5-20% among those less than 6 
years of age. The prevalence of obesity is increasing in children of all ages and represents the 
complex integration of genetic, behavioural and environmental influences. Genetic factors are 
currently estimated to account for approximately 40-70% of the variance in human adiposity. Although 
intensive investigation has been conducted in other countries including Nigeria and Ghana (Kramer et 
al., 2005; Bonilla et al., 2006), to our knowledge, there is limited data reported on the molecular 
aetiology of obesity (both monogenic and polygenic forms) in South African populations. It is only 
recently (in 2011) that Dr Zane Lombard of the National Health Laboratory services reported a 
significant finding on LEP risk alleles, which increased the risk of obesity in adolescents residing in 
Soweto (Johannesburg). 
 
The present investigation is a case-control study aimed at assessing the contribution of 
genetic factors, together with environmental factors, to childhood obesity/overweight in South 
African adolescents as observed in other populations. A better understanding of the factors that 
contribute to the increasing incidence of childhood obesity/overweight could offer holistic opportunities 
for prevention and intervention programmes. The hypothesis of the present study is that genetic 
variations, particularly those of the leptin-melanocortin pathway in association with 
environmental factors may promote early onset obesity. The hypothesis is based on the following 
observations: Firstly, the leptin-melanocortin system regulates food intake and energy homeostasis in 
humans. Secondly, since the discovery of the rare monogenic forms of obesity, several genes that 
are part of the leptin-melanocortin axis have been reported as causing this condition. To date, five 
monogenic obesity disorders have been reported where obesity in early childhood predominates 
without children developing behavioural abnormalities and dysmorphisms. However, recently, genetic 
variations in this pathway have also been linked with polygenic forms of obesity. Thirdly, 
environmental factors, particularly physical inactivity due to a sedentary lifestyle has been shown to 
play a major role in the development of obesity.  
Thus the aims of this project are as follows: 
1. Identify sequence variants in six genes involved in the leptin-melanocortin pathway that may 
play a role in childhood obesity in adolescents residing in the semi-urban/rural and urban 
areas of the Western Cape Province, South Africa. There is currently no data showing the 
contribution of genetic factors to obesity in South African children and adolescents. This will be a 
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case-control study involving obese/overweight adolescents of Black and Mixed Ancestry ethnic groups 
(both males and females) who consent to genetic analysis.  
2. To assess the role of identified mutations/sequence variations in obesity/overweight and its 
related traits such as blood pressure, blood glucose and lipid levels, and anthropometric 
parameters, and their relationship with physical activity.  
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2.1. BACKGROUND 
The melanocortin receptors belong to a family of rhodopsin 7-transmembrane, G-protein coupled 
receptors that signal through intracellular cyclic adenosine monophosphate (Gantz and Fong, 2003; 
Cone et al., 2005). Their structure is composed of a single polypeptide of seven α-helical 
transmembrane domains, an extracellular amino (N)-terminus, and an intracellular carboxyl (C)-
terminus. Although melanocortin receptors share many structural features conserved in other G 
protein-coupled receptors, they are the smallest receptors in this group, with short N- and C-terminal 
ends, and small second extracellular loops (Fig 2.1). All human melanocortin receptors contain 
conserved amino acids such as the aspartic acid-arginine-tyrosine motif at the junction of the 
transmembrane 3 domain, and cysteine residues at the C-terminus and extracellular loop. Functional 
studies indicate that the cysteine residues in the extracellular loop form a disulfide bond that is 
essential for the receptor function while those in the C-terminus may have different roles in receptor 
expression, ligand binding and receptor activation (Yang et al., 2007).   
 
 
Figure 2.1. Model of human MC4R, comparison to the rat Mc3r. Gray circles indicate residues 
identical in the rat Mc3r and the human MC4R. Black circles indicate regions with complete 
homology. Abbreviations: MC3R, melanocortin 3 receptor; MC4R, melanocortin 4 receptors. Adapted from 
Oosterom et al., 1999. 
 
MC3R and MC4R are single-exon genes encoding 360- and 333-amino acid proteins, respectively 
(Gantz et al., 2003). They have been mapped, respectively, on chromosomes 20q13.2 and 18q22 
(Gantz et al., 1993; Gantz et al., 1993). The two receptors are widely distributed in the brain and 
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central nervous system, mainly in the paraventricular, dorsomedial and lateral nuclei of the 
hypothalamus (Mountjoy et al., 1994; Cone, 1999; Gantz et al., 2003). Melanocortin receptors, 
particularly the MC4R, have been reported to play a major role in the development of both monogenic 
and polygenic obesity (Farooqi et al., 2003; Carroll et al., 2005). Mutations in MC4R are the most 
common cause of early onset obesity, accounting for up to 6% of the condition, particularly in 
European populations (Farooqi et al., 2003). Furthermore, more than 50 additional MC4R single 
nucleotide polymorphisms (SNPs) have been reported in obese and control individuals with different 
effects depending on the population and family studied (Carroll et al., 2005). On the other hand, it is 
only recently that obesity-associated SNPs were identified in the MC3R (Tao et al., 2007; Lee et al., 
2007; Mencarelli et al., 2008; Mencarelli et al., 2011; Zegers et al., 2011). Similar to MC4R 
polymorphisms, common variants in MC3R show significant frequency variation, with nonreplicable 
association tests with obesity-related variables among different populations (Table 2.1). Although 
MC3R have been associated with morbid (Ala293Thr, Ile335Ser, Ter361Ser, Ile183Asn, Ala70Thr, 
and Met134Ile) (Lee et al., 2007; Mencarelli et al., 2008) and mild obesity, the effect of reported 
polymorphisms has not been linked to physical activity.  
 
Physical activity plays an important role in maintaining the balance between energy intake and 
expenditure. It is therefore acknowledged that physical inactivity and predisposing genetic factors are 
major determinants of obesity in both adults and children despite the small number of South African 
studies demonstrating their association with obesity (Kruger et al., 2002; 2003; Senekal et al., 2003; 
McVeigh et al., 2004; Mamabolo et al., 2007). A combination of poor environment with lack of exercise 
facilities, high crime rate, and attitudes towards slim body figures seem to contribute to low levels of 
physical activity among South Africans (Reddy et al., 2002; Kruger et al., 2003). Urbanisation in South 
African children has introduced sedentary lifestyle, replacing physical activity with watching television, 
playing computer games, and use of transport.  
 
It is widely accepted that weight gain can be reversed by increasing energy expenditure and reducing 
energy intake. Physical activity, therefore, has been identified as one of the interventions for obesity 
management in both adults and children, and several studies have reported the effectiveness of 
physical activity in reducing weight and associated cardiovascular risk factor (Klem et al., 1997; 
Skerrett and Manson, 2002; Wing, 1999; Paterson and Warburton, 2010; Janssen and LeBlanc, 
2010). However, there is interindividual variation on the effect of both inactivity and activity on weight 
and associated cardiovascular risk factor that may be caused, in part, by the presence of susceptibility 
polymorphisms. Among the genes that mediate the effect of physical activities on metabolic diseases 
are MC4R, leptin receptor and ghrelin genes (Lakka et al., 2004; Loos et al., 2005; Kilpeläinen et al., 
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2005; Rankinen et al., 2006). For example, The Finnish Diabetes Prevention study demonstrated that 
the Leu72Met and -501A/C polymorphisms in the ghrelin gene modified the effect of moderate-to-
vigorous physical activity on weight and waist circumference, and high-density lipoprotein cholesterol; 
while the leptin receptor Lys109Arg polymorphism mediated the effect of physical activity in blood 
pressure (Kilpeläinen et al., 2005). Recent studies have consistently reported significant associations 
between body mass index (BMI) and fat mass and obesity-associated (FTO) gene polymorphisms and 
the modified effects of the gene when food intake and physical activity or inactivity are accounted for 
(Lee et al., 2010; Sonestedt et al., 2010; Ahmad et al., 2011). For example, Ahmad et al. (2011) 
reported an additive effect of the FTO rs8050136 risk allele among women who were both inactive and 
consuming large amounts of food. Although the FTO is predicted to have slight DNA demethylase 
(Gerken et al., 2007) and non-heme dioxygenase activities (Sanchez-Pulido et al., 2007), the reported 
association studies are suggestive of its role in energy intake and expenditure. Energy intake and 
expenditure are mainly regulated by the leptin-melanocortin pathway. The pathway also plays a role in 
glucose homeostasis, and insulin secretion. Neuropeptides in the melanocortin system regulate food 
intake and energy balance by binding to melanocortin receptors, particularly MC4R, and to a lesser 
extent MC3R.  
 
Although both MC3R and MC4R have been extensively studied and shown to presdispose to obesity 
in various population groups globally, to our knowledge, no studies have been published on the 
contribution of the two genes in obesity among South African ethnic groups. The present chapter 
therefore, was aimed at analysing MC3R and MC4R for identifying polymorphisms that may 
predispose to obesity in South African Black and Mixed Ancestry adolescents.  Furthermore, this 
chapter focused at establishing whether or not the association of MC3R polymorphisms with obesity-
related traits could be influenced by physical activity.  
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Table 2.1. Association studies for melanocortin 3 receptor gene polymorphisms and metabolic parameters in different population groups, 
worldwide. 
Polymorphism Population group Phenotype Association Reference 
-201C>G, -239 A>G, -762A>T, -
769T>C; Val81Ile 
209, adults Obesity No Li WD et al., 2000 
Thr6Lys and Val81Ile French (n=526) Type 2 diabetes, body mass index No Hani et al., 2001 
+2138InsCAGACC Québec, adults (n=812) Fat mass, percent body fat, and total 
abdominal fat 
Yes Boucher et al., 2002 
Ile183Asn Asian (n= 162) Percent body fat Yes Lee et al., 2002 
Thr6Lys and Val81Ile Finnish (n= 300) Increased insulin-glucose ratio; 
hyperleptinemia; body mass index 
Yes Schalin-Jantti et al., 
2003 
Val81Ile Greek, adults (n=228) Hyperinsulinemia; hyperleptinemia; body 
mass index and fat mass 
Yes Yiannakouris et al., 
2004 
Thr6Lys and Val81Ile African and Caucasian American 
children (n=350) 
Fat mass and leptin Yes Feng et al., 2005 
Thr6Lys and Val81Ile Finnish, adults (n= 216) Lipid and glucose oxidation Yes Rutanen et al., 2006 
Thr6Lys and Val81Ile Asian children (n= 389) Hyperleptinemia, percentage body fat, 
insulin sensitivity 
Yes Lee et al., 2007 
Thr6Lys and Val81Ile Italian children (n= 368) Weight loss Yes Santoro et al., 2007 
Ala293Thr, Ile335Ser and 
Stop361Ser 
Italian, adults (n= 505) Obesity Yes Mencarelli et al., 2008 
Thr6Lys and Val81Ile African and Caucasian American 
children and adolescents (n= 416) 
body mass index and fat mass Yes Savastano et al., 2009;  
Arg257Ser, Thr6Lys/Val81Ile Canadian Caucasians, adults 
(n=1821) 
Obesity No Calton et al., 2009 
Leu299Val Caucasian 448 children and 236 
adults 
Obesity Yes Zegers et al., 2011 
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rs3746619 Caucasians, adults (n=1321) Body mass index Yes Zegers et al., 2010 
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2.2. MATERIALS AND METHODS  
 
2.2.1 Ethical approval, Consent and Confidentiality 
The present study was accepted and registered by the Research Ethics Committee of the University of 
Stellenbosch (Project number: N07/07/160, Appendix A). Permission to conduct the ‘parent’ research 
project (Reference number: CPUT/HAS-REC 0016, Appendix A) was granted by the Faculty of Health 
and Wellness Science Ethics Committee, Cape Peninsula University of Technology, while the study 
was conducted according to the Code of Ethics of the World Medical Association (Declaration of 
Helsinki).  Permission to perform the study was also obtained from the Western Cape Department of 
Education, school governing bodies and principals. Written informed consent from parents or 
guardians and oral assent from learners was obtained after all the procedures had been fully 
explained. All recruited participants had a right to decide voluntarily whether to participate in the study 
or to withdraw without the risk of incurring penalties or prejudicial treatment. They also had a right to 
refuse to give information and ask clarity about the objectives of the study or specific procedures.    
 
2.2.2 Study design 
The study was a cross-sectional study in which the dependent and independent variables were 
measured simultaneously. The school setting provided an ideal social context and almost ready-made 
sampling frame (gender, age, education level, geographical area, etc.) to obtain information, making it 
the most appropriate sampling frame for this study (Retzlaff et al., 1997).  
 
2.2.3 Study population 
The present study was part of an investigation that aimed to elucidate obesity, diabetes, hypertension 
and the metabolic syndrome in 8-18 year old learners residing in the peri-urban communities of the 
Western Cape. The study population of the ‘parent’ research project consisted of a total of 1564 
(males = 621; females = 943) learners between the ages 8-18 years that were recruited as previously 
described (Matsha et al., 2009). Briefly, participants were recruited through a proportionally stratified 
multistage random sampling technique from government funded primary and secondary schools using 
a list of 107 schools obtained from the Western Cape Education Department. As private schools 
represented less than 2% of the total number of schools they were excluded from the sampling frame. 
Fourteen schools participated in the study and randomisation took place at the learner and class 
levels. The response rate was 65% and learners that declined to participate were approached twice 
personally. 
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Study group 
• Learners were classified according to their weight status as obese, overweight and normal 
using the International Obesity Task Force criteria as reported by Cole et al (2000). The 
parent study population comprised of learners of Black African, Caucasian and Mixed 
Ancestry racial groups of South Africa. However, for this project only the Black African and 
Mixed Ancestry subjects were included due to the limited number of Caucasians from the 
parent study.  A total of 431 (227 obese-overweight, and 204 normal) individuals between 
11-16 years of age were selected for this study. The case group (227 obese-overweight 
learners) was made up of 115 Black Africans and 112 Mixed Ancestry learners whilst the 
age-, gender-, and ethnic-matched normal weight learners consisted of 94 Black Africans 
and 110 Mixed Ancestry learners. Participants who chose not to give blood for DNA 
analysis because of various personal reasons such as low blood pressure, anxiety 
problems related to the sight of blood and fear of surgical needles, and those not 
consented by parents were excluded from the study. 
Inclusion Criteria 
• The study groups were selected from learners who consented to participate and gave blood 
for genetic analysis. 
•  Black African and Mixed Ancestry learners aged 11-16 years were selected from the parent 
group as these racial groups were well represented in the parent study (Matsha et al., 
2009). 
• Case group: This consisted of 227 (115 Black Africans and 112 Mixed Ancestry) obese and 
overweight learners, males and females.   
• Control group: Age-, gender-, and ethnic-matched normal weight learners (94 Black 
Africans and 110 Mixed Ancestry) formed a control group.  
 
2.2.4 Sample size 
The main research project consisted of 1564 learners from which the study population of the present 
project was selected. The study reported an overweight and obesity prevalence of 15.5% and 7.2%, 
respectively (Matsha et al., 2009). To obtain statistically significant observations on allelic distributions 
and adequate power for association tests between obesity-related traits and genotypes given the 
reported prevalence, the number of a control group was chosen based on a 1:1 case-control ratio. In 
order to successfully analyse association studies, the sample size must be sufficiently large to create 
enough statistical power to reduce the probability of generating false-positive associations (Berry et 
al., 1998). The following guided our genotype sample size calculation: If the “risk” allele frequency in 
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the general population (controls) is 40%, then a study with 227 cases and 204 controls have 80% 
power to detect, at a 5% significance level, a “risk” allele frequency of 57% in cases. 
 
2.2.5. Data collection 
A detailed protocol describing data collection procedures (questionnaires and physical examination) 
was developed. Team members consisting of professional nurses and community health care workers 
were trained, and a pilot study consisting of 22 learners was performed to validate the questionnaires 
and synergise the workflow. A supervisor was allocated for each team who monitored the performance 
of the personnel and was responsible for calibrating equipment according to a standard protocol. In 
addition, weekly meetings were held to assess progress and solve encountered problems. The school 
premises were used as points of data collection and temporary screens were constructed to serve as 
examination rooms in order to maintain the privacy of participants. The questionnaires were completed 
confidentially under the supervision of a professional nurse or learner educator. One school was 
visited per week to collect research materials such as personal details of learners, anthropometric 
measurements, biochemical analyses and lifestyle indicators by professional nurses and trained field-
workers. This information was recorded in the form of questionnaires (Appendix B). Learners were 
requested to fast for at least 8 hours prior to sampling. On the day of sampling, venous blood was 
collected from learners who consented for genetic analysis. 
 
2.2.6. Physical activity measurement  
The Physical Activity and Energy expenditure was assessed in the form of questionnaires that were 
developed based on the validated questionnaires designed by Arvidsson and coworkers (2005). This 
set of questionnaire contained indicators of sporting as well as leisure activities, and assessed the 
frequency and type of activities learners participated in. All questionnaires were developed in English, 
and then translated into Afrikaans and Xhosa. A pilot study was conducted among 22 school learners 
that were randomly selected from a school with similar characteristics as the present study population.  
The questionnaire was further used in a research study that aimed at investigating the prevalence of 
obesity amongst learners attending schools in Belhar, Delf, and Mfuleni in the Western Cape Province 
(Somers, MTech Thesis, 2004). On the sampling day, each learner was asked about the frequency at 
which they performed activities during the week such as walking, sport, cycling, household chores, 
and time spent on watching television. Furthermore, learners were asked if their schools offered 
physical education, and if yes, the number of days per week they attended the session. Each activity 
was then categorized according to the frequency of performing each activity as follows: not at all or 
physically inactive (0 days per week), occasional (1-2 days per week), and often (3-5 days per week). 
  58
The frequency of performing these activities was used as an indirect measure of learner’s physical 
fitness. 
 
2.2.7. Obesity-related anthropometric and metabolic variables 
Anthropometric and biochemical parameters of interest that were measured are as follows: body 
weight and height; waist and hip circumference & waist-hip ratio and skinfold measurements, blood 
pressure, blood glucose and lipid levels. Body weight and height measurements were used to 
calculate the BMI. Professional nurses and field workers who were trained in the use of prescribed 
standardised techniques conducted anthropometric measurements and biochemical analyses. These 
standardised techniques and associated data-collection methods were piloted, and used in a research 
project that aimed at investigating the prevalence of obesity amongst learners attending schools in 
Belhar, Delf, and Mfuleni in the Western Cape Province (Somers, MTech Thesis, 2004). In a pilot 
study, careful selection of instruments with adequate detection limits and sensitivity was done to 
enhance the accuracy and validity of results. Statistical measures in the form of repeated measures 
were used to ensure inter- and intra-validity. Measurements and analyses were performed as follows: 
A. Anthropometric measurements 
Weight and height measurements 
• Weight 
Weight measurements were done using a digital bathroom electronic scale (Fuzhou Sunny Electronic 
Co., Ltd., China). All heavy clothing and shoes were removed. The scale was calibrated and 
standardised using a weight of known mass. The subject was asked to stand in the middle of the scale 
platform after the scale had been zeroed. It was then ensured that the subject’s weight was evenly 
distributed with the arms hanging relaxed along the sides. Readings were taken to the nearest 0.1 kg. 
 
• Height 
The height of each participant was measured using a Stadiometer (Anand Medical Exports, India). 
The subject was asked to stand on a flat surface that is at 90° angle to the vertical lever/ board of the 
Stadiometer. The subject’s weight must be evenly distributed on both feet. The scapula and the 
buttock had to be in contact with the wall/ board, with the buttock and the heel in the same vertical 
line. The subject was then asked to take a deep breath in and maintain a fully upright position. The 
required accuracy was 0.1 cm (Martin et al., 1988). 
 
• Body mass index (BMI) 
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The BMI was calculated for each subject as weight (kg) ÷ [height (m)]2, and used for classifying 
learners according to their weight status using the International reference gender-and age-based cut-
off points provided by the IOTF as developed by Cole and co-workers (2000). 
 
Circumference measurements 
• Mid-upper-arm 
The measurement was done on the arm mid-way between the acromion and radial points, with the 
arm relaxed and hanging by the sides. The required accuracy was 2 mm. 
 
• Waist circumference 
The waist measurement was taken with the subject in an erect position, abdomen relaxed, arms at the 
sides and feet together. Measurements were performed facing the subject, in a horizontal plane, with 
a non-elastic tape measure placed at the level of the natural waist. The natural waist is defined as the 
narrowest part of the torso as seen from the anterior view. In obese subjects it may be difficult to see 
the waist narrowing, therefore the smallest circumference measured in the area between the ribs and 
the iliac crest was taken. The measurement was taken three times at the end of normal expiration and 
average recorded. The accuracy was 0.1 cm. 
 
• Hip circumference 
Hip circumference was measured as the maximal circumference over the buttocks using a non-elastic 
tape. The field worker had to squat beside the subject so that the maximum extension of the buttock in 
the horizontal plane at this level could be taken without compressing the skin.  The measurements 
were taken three times and the average of the measurements recorded. The required accuracy was 
0.1 cm. 
 
• Waist-hip Ratio 
This was calculated as the average of the waist circumference divided by the average of the hip 
circumference. This was recorded to four decimal places. 
 
Skinfold measurements 
The skinfold measurement is a measurement of the compressed thickness of a double layer of skin 
and the underlying subcutaneous adipose (fat) tissue. The 4-site methods used in this study were: 
triceps, biceps, sub-scapula and supra-iliac skinfold. All measurements were taken on the right side of 
the subject (Harrison et al., 1988). In some obese subjects it may be impossible to elevate a skinfold 
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with parallel sides. In these circumstances the measurement was not taken, instead the two-handed 
technique was used. In this technique, the skinfold is lifted using two hands and measured. 
 
Sites of measurements 
• Triceps 
The triceps were measured from the back on the posterior surface of the arm, mid-way between the 
top of the shoulder (acromion process) and the posterior aspect of the elbow (olecranon process). It 
was ensured that the upper limb hung loosely by the subject’s side with the subject in the standing 
position. 
 
• Biceps 
The biceps were measured on the anterior (front) surface of the arm, mid-way between the top of the 
shoulder (acromion process) and the front of the elbow (anterior surface of the cubital fossa). The 
subject remained in the same position as for the triceps measurement. 
 
• Sub-scapula 
 The measurement was taken about 20 mm just below the inferior (lower) angle of the scapula, with 
the fold in an oblique plane descending outwards and downwards at an angle of approximately 45° to 
the horizontal. 
 
• Supra-iIliac 
The measurement was taken about 20 mm above the iliac crest, in the axillary line, with the fold in the 
oblique plane, descending medially and downwards at an angle of 45˚ to the horizontal. The subject 
remained erect with the upper limbs by the side and the abdominal muscles relaxed. 
 
B. Biochemical analysis 
Blood glucose and lipid measurements 
Fasting blood samples obtained through finger pricking was used for glucose and lipid measurements. 
Prior to screening, the fasting state was determined by interview on the morning of examination. Blood 
glucose levels were measured using the Accutrend GCT glucometer (Stellenbosch Medical Supplies 
CC, South Africa). Capillary glucose measurements are as suitable as venous glucose measurements 
in the diagnosis and detection of type 2 diabetes mellitus in epidemiological studies (Solnica et al., 
2003; Kruijshoop et al., 2004). The commercial glucometer used in this study had a mean imprecision 
  61
of < 5%, with a range of 1.1– 33.3 mmol/L on capillary whole blood. Total cholesterol, HDL-
cholesterol, and triglycerides were measured using CardioCheckTM P.A analyzer (Polymer Technology 
Systems, Inc. USA) according to the manufacturer’s instructions. CardioChek PA complied with the 
National Cholesterol Education Program Expert Panel guidelines for total cholesterol (TC) and high 
density lipoprotein-cholesterol (HDL-C) as tested in a study conducted by Panz and coworkers (2005). 
According to this study, lipid levels measured by the CardioChek PA analyser agreed satisfactorily 
with the laboratory results, and instrument therefore could be used for screening purposes. For quality 
control purposes, one control sample was included everyday during sample collection. 
 
C. Blood pressure 
Qualified healthcare professionals performed all the clinical examinations. Blood pressure 
measurements were performed according the WHO guidelines (1999). Measurements were performed 
using a semi-automatic digital blood pressure monitor (Rossmax PA, USA) on the right arm in sitting 
and relaxed position with the learner not having ingested coffee or smoked for 30 minutes before 
measurement.  The cuff was placed at a point midway between the olecranon and acromion to ensure 
accurate measurement. After a 10 minute rest period, three readings were taken at 5 minutes interval 
and the lowest of the three readings was taken as the blood pressure. 
 
2.2.8. Data management 
Each participant was assigned a unique code that was used for confidentiality purposes and all data 
collection documents (questionnaires, Appendix C) and biological specimen containers reflected this 
code. Data was captured on an Excel Spreadsheet at the end of each day of sampling. For quality control 
purposes, data captured was randomly checked by an independent person. Data was extensively cleaned 
and analysed using various options available in statistical package STATA version 7. (STATA Copyright 
1984-1999 Stata Corporation. Texas, version 7.0). All consent forms (Appendix B) with the same code as 
the questionnaire were attached together. Both consent forms and questionnaires were then stored in 
confidential files and securely locked away for follow-up studies.  
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2.2.9. Genetic analyses 
2.2.9.1. DNA extraction 
A. Extraction from whole blood 
Venous blood samples were collected from consenting learners (learners 15 years old) by 
professional medical nurses into specimen tubes containing ethylenediamine tetra acetic acid (EDTA). 
Samples were transported to the laboratory at room temperature, and stored at -20°C when immediate 
extraction was not possible. Genomic DNA was extracted from venous blood samples using a 
modified salting out procedure (Miller et al., 1988). A volume ranging from 5-8 ml of whole blood was 
transferred from an EDTA tube into a 50 ml Falcon tube. Cold lysis buffer (Appendix D) was adjusted 
according to the volume of blood used (according to the procedure 30 ml of cold lysis buffer for every 
10 ml of blood) and added to a final volume of 40 ml. All reagents used in subsequent steps were 
adjusted accordingly. The mixture was then placed on ice for 15 minutes and inverted every five 
minutes. This mixture was then centrifuged at 1500 rpm (400 x g) for 10 minutes at 4°C (J-6M/E 
centrifuge, Beckman, United Kingdom). The supernatant was carefully discarded and the pellet (white 
blood cells) resuspended in 0.9% phosphate buffered saline (PBS) (Appendix D). This was followed 
by centrifugation at 1500 rpm for 10 minutes after which the supernatant was discarded and the pellet 
resuspended in nuclear lysis buffer (Appendix D), 0.3 mg/ml Proteinase K and 1% (w/v) sodium 
dodecyl sulphate (SDS) (Appendix D). The contents were mixed well and incubated at 55°C overnight. 
Thereafter, 6 M NaCl (Appendix C) was added to the solution and the tubes shaken vigorously for 1 
minute. The mixture was centrifuged at 2500 rpm (1500 x g) for 30 minutes. The supernatant 
containing the DNA was subsequently transferred to a clean Falcon tube, and the pellet discarded. 
The supernatant was vortexed for 15 seconds, followed by centrifugation at 2500 rpm (1500 x g) for 
15 minutes. The supernatant was transferred to a clean Falcon tube without the foam or the pellet. 
Two volumes of cold 99.9% (v/v) ethanol (EtOH) was added to each tube and agitated to precipitate 
the DNA. The DNA was pulled out using a sterile pipette tip, placed in a clean 1.5 ml eppendorf tube, 
and washed with cold 70% (v/v) ethanol. The tubes were centrifuged using a benchtop microcentrifuge 
(Microcentrifuge® Lite, Beckman Coulter™) at 8000 rpm (6000 x g) for 2 minutes. The ‘washing step’ 
was repeated until the pellet was clear. The ethanol was discarded, tubes left at room temperature to 
dry. Depending on the size of the pellet, 200-800 µl of 1X tris ethylenediamine tetra acetic acid (TE) 
buffer (Appendix D) was added to dissolve the DNA. To ensure a homogenous solution, the DNA was 
dissolved by shaking the tubes using a rotator at room temperature. Alternatively, a TE buffer heated 
at 56°C can be used to dissolve the DNA pellet.  
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DNA concentration and purity were determined using the Nanodrop® ND-100 Spectrophotometer 
v3.0.1 (NanoDrop Technologies Inc, DE, and USA). The NanoDrop® employed UV/VIS 
spectrophotometer to accurately determine nucleic acid concentration in a sample which is recorded in 
nanograms per microlitre (ng/µl). DNA samples, where possible, were diluted to obtain a final 
concentration of 200 ng/µl. The quality and purity of the DNA was determined by measuring the ratio 
of absorbance at 260 nm and 280 nm, whereby a ratio of approximately 1.8 was considered to be of 
good quality  
 
B. Extraction from Whatman FTA® cards 
This method was used for obtaining DNA samples from children less than 15 years old. The use of 
only a minute amount of whole peripheral blood (~80 
l) allows collection of blood by heel or finger 
prick, requiring less skill and fewer supplies. Whole blood specimens provide high quality DNA yields, 
however, venipuncture is an invasive procedure that is not always practical for infants and children; 
requires specialist collection, processing, and storage facilities; and can necessitate the added 
expense and inconvenience of travel for families, often resulting in low participation rates (Dlugos et 
al., 2005). Whatman FTA® cards are convenient and safe for collecting the required amount of blood 
and obtaining DNA samples from children. FTA Cards are impregnated with a patented chemical 
formula that lyses cell membranes and denatures proteins on contact. Nucleic acids are physically 
entrapped, immobilised and stabilised for storage at room temperature. Capillary blood obtained from 
a finger prick was collected on circles of Whatman FTA cards (Sigma Aldrich, Canada), each circle 
assigned to a particular participant. A minimum of six spots of blood were applied on each circle. 
Sample cards were allowed to dry at room temperature for at least one hour before being stored in 
Ziploc plastic bags. DNA was extracted according to the manufacturer’s instructions as follows: from 
each sample spot a disc was cut using a Uni-Core Punch (varies according to size, 1.2 or 2 mm Uni-
Core Punch can be used depending on the PCR reaction volume to be prepared) and placed in a 
labeled 0.2-ml PCR tube. The sample disc was washed 3 times by a FTA purification reagent, 
discarding the used reagent after a 5 minute incubation period at room temperature. The disc was 
then washed with a TE buffer (10 mM Tris-HCl and 0.1 mM EDTA, pH 8.0) 2 times discarding the 
used TE buffer after a 5 minute incubation period at room temperature. The disc was allowed to dry at 
room temperature for about 1 hour or at 56°C for 10 minutes. 
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2.2.9.2. Identification of sequence variants in melanocortin 3 and 4 receptor genes (MC3R and 
MC4R) 
Possible sequence variants in MC3R and MC4R were detected using a polymerase chain reaction-
based single strand conformation polymorphism (SSCP) analysis. Seventy six samples from obese-
overweight individuals were analysed using SSCP, and those with different mobility shifts were 
sequenced. The remaining individuals that were included in the study were genotyped for the two 
MC3R polymorphisms that were detected using allele-specific restriction enzyme (ASREA) analysis. 
Below is the description of the techniques used in the present study. 
 
Polymerase chain reaction (PCR): MC3R and MC4R are single-exon genes of 1084 and 1438 base-
pairs (bp) long, respectively. The coding regions of both genes are 972 and 999 bp long. Due to the 
recommended optimum detection limit of 150 to 200 bp fragment size for the SSCP technique, MC3R 
and MC4R coding regions were divided into 5 fragments, resulting in 5 sets of oligonucleotide primers. 
Five previously reported primer pairs (Vaisse et al., 2000) were used to amplify the MC4R coding 
region as follows: a total volume of 50 microliters (µl) reaction mixture contained 0.25 micrograms 
(µg)/µl DNA template, 0.24 micromolar (µM) of both forward and reverse primers, 1x buffer, 1.0 
millimolar (mM) magnesium chloride (MgCl2), 0.3 mM dNTP, 0.4 units DNA polymerase, and distilled 
water (dH2O) added to a final volume. MC4R was amplified in a Perkin Elmer 2720 thermal cycler 
(Applied Biosystems, USA) as follows: initial denaturation at 95°C for 3 minutes, 35 cycles of 
denaturation at 95°C for 30 seconds, annealing at 54°C and 55°C (depending on the primer set) for 45 
seconds, extension at 72°C for 45 seconds, and final extension at 72°C for 5 minutes. Amplicons, 
which ranged from 246-273 bp, were electrophoresed on 2% agarose gels and visualized in a GelDoc 
system (BioRad, GmbH). 
 
Five MC3R fragments were amplified using previously reported primers (Schalin-Jantti et al., 2003) 
and BIO-X-ACT short PCR kit (Bioline, USA) as follows: a total volume of 50 µl reaction mixture 
contained 0.25 µg/µl DNA template, 0.24 µM of both forward and reverse primers, 1x Opti buffer, 2.5 
mM MgCl2, 0.3 mM dNTP (Promega, USA), 2.5 units DNA polymerase, and dH2O was added to a final 
volume. Amplification was carried in a Perkin Elmer 2720 thermal cycler (Applied Biosystem) as 
follows: initial denaturation at 94°C for minutes, followed by 35 cycles of denaturation at 94°C for 30 
seconds, annealing at 55°C for 45 seconds and extension at 72°C for 5 minutes, and final extension at 
72°C for 5 minutes. All amplicons were electrophoresed on a 2% agarose gel and visualized in a 
GelDoc system (BioRad, GmbH). Amplicons generated ranged from 245-300 bp. 
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SSCP: SSCP is a molecular technique that is used to detect possible different mobility shifts due to 
nucleotide changes in amplified DNA sequences (Orita et al., 1989). This technique is based on the 
principle that single stranded DNA molecules form secondary structures under certain conditions in a 
solution. The secondary structures formed depend on the base composition of the sequence and DNA 
fragments with as small as one nucleotide difference. SSCP analysis involves denaturing double 
stranded DNA and then rapidly cooling it so that the single stranded DNA form secondary structures to 
create a unique banding pattern when subjected to electrophoresis on a polyacrylamide gel. Certain 
conditions may be altered in order to obtain optimal results. In this study, one such optimisation was 
employed by varying the percentage of polyacrylamide and urea in the gel. Under optimal conditions 
(fragment size, 150 to 200 bp), 80–98% of potential nucleotide changes are detectable by SSCP. 
 
The samples were run on both 8% and 10% mildly-denaturing polyacrylamide gels containing 5% 
glycerol and 15% urea that were prepared as illustrated in appendix D. The SSCP gel was prepared 
as follows: gel was developed between a back and front glass plates. The two plates were first 
cleaned with 70% ethanol, and the gel bond placed with its hydrophobic side on the back plate. The 
gel bond (provides support for the gel so that it does not break during staining) was attached to the 
plate using ethanol, making sure to remove air bubbles that may be formed by pushing them out of the 
glass. Spacers were put on left and right sides of the back plate to create space for the well comb. The 
spacers and the well comb must be of the same thickness. The front plate was placed over the gel 
bond and two plates sealed with a yellow tape and gasket to prevent leaking of the gel solution. The 
SSCP solution was poured and a well comb inserted immediately. The gel was allowed to polymerise 
for 2 hours. Once polymerised, the plates with a gel were mounted onto a vertical SSCP tank with a 
built-in fan heater sensor (Cleaver Scientific Ltd, UK), and its reservoirs filled with 0.5x 
Tris/Borate/EDTA (TBE) buffer. A total volume of 5 µl PCR product were mixed with equal volume of 
SSCP loading dye (Appendix), and denatured at 95°C for 5 minutes, followed immediately by snap-
chilling on ice to prevent reannealing of single-stranded DNA. Denatured amplicons were loaded into 
the gel and electrophoresed at room temperature overnight at 22 Watts overnight with the cooling 
system of the tank switched on to avoid overheating of the gel. For every gene region amplified a test 
sample was sequenced, and these were included in respective SSCP electrophoresis. Subsequently, 
DNA bands were visualised by silver staining (Appendix D). Samples with different mobility band 
patterns were sequenced to determine possible sequence variations.  
 
Purification of PCR products: For sequencing, DNA was purified using Exonuclease I and Shrimp 
Alkaline Phosphatase (Inqaba Biotechnologies, SA) according to manufacturer’s instructions. 5U of 
Shrimp Alkaline Phosphatase and 5U of Exonuclease I was added to 5
l of PCR product. The mixture 
was then incubated at 37ºC for 15 minutes followed by 80ºC for 15 minutes to deactivate the 
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enzymes. The concentration and purity of the PCR products were checked using the Nanodrop® 
according to manufacturer’s specifications. Where necessary, samples were diluted down to the 
desired concentration using nuclease-free water. 
 
Automated sequencing: Purified amplicons were sequenced using a BigDye terminator version 3.1 
Cycle sequencing kit (Applied Biosystems) according to the manufacturer’s instructions, and resolved 
on an ABI 3130X ® Genetic Analyzer (Applied Biosystems, USA) at the Central Analytical Facility, 
University of Stellenbosch. The sequencing data was analysed using the Geospiza’s FinchTV version 
1.4 software programs.  
 
Genotyping of case and control groups: Obese, overweight and normal individuals were genotyped 
for the MC3R Thr6Lys and Val81Ile polymorphisms by digesting the amplicons with Mae III and BseD 
1, respectively (Schalin-Jäntti et al., 2003). The Thr6Lys and Val81Ile polymorphisms were detected in 
fragments 1 and 2 of MC3R, and the PCR protocol for amplifying these fragments to be digested is 
described above. The restriction enzyme digest mixture used was prepared as follows: 0.35 U of 
enzyme was mixed with 2 µl of 10x buffer, 7.3 µl of nuclease-free water, and 10 µl of amplicon.  
Restriction digest mixtures for cutting fragment 1 and 2 amplicons were then incubated overnight at 
65°C and 55°C, respectively. Digested amplicons were separated along with a negative control 
(undigested amplicon) and a 100-bp ladder in 3% agarose gels and visualised with GelRed under 
ultraviolet light. 
 
2.2.10. Statistical analysis  
All statistical analyses were conducted by Prof Lize van der Merwe, a Biostatistician at the Medical 
Research Council of South Africa. Data was analysed using the freely available programming 
language R (R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0; URL: 
www.r-project.org). In order to test association between relevant clinical variables and genetic markers 
(genotype and allelic), and to determine linkage disequilibrium (LD) and Hardy-Weinberg equilibrium 
(HWE), specific packages DGC-genetics was used.  
 
A. Statistical analyses of clinical data  
Clinical variables such as anthropometric measures, fasting blood glucose, blood pressure, and lipid 
profiles were tabulated for all learners included in the study. These main variables were compared 
between obese-overweight and normal, and genders. Variables are summarised as mean±SD unless 
indicated otherwise, and p-values are for joint model, each adjusted for the other. Triglycerides, 
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Diastolic and Systolic blood pressure were summarised as median, (interquartile range) and were log-
transformed to improve normality.   
 
B. Statistical analyses of genetic data 
The aim of the study was to determine whether in the selected genetic polymorphisms, there are 
differences in allelic or genotype distribution between Mixed Ancestry and Black African learners, and 
between obese-overweight (case group) and normal weight (control group) individuals. Increased 
allele or genotype frequencies in the case group compared to controls may indicate that carriers of 
that specific allele or genotype are susceptible to obesity, or the polymorphism is in linkage 
disequilibrium with such a risk variant.  
 
Comparing allele frequencies between cases and controls is not statistically valid without prior 
assumption of independent segregation of alleles within each individual. For this to be true, the 
population under investigation should obey the Hardy-Weinberg law, which states that in a large 
randomly mating population, the allele and genotype frequencies remain constant from one generation 
to the next. Consequently, for a locus consisting of alleles A and a, with population frequencies p and 
q respectively, the genotype frequencies within a population in HWE will be equivalent to p2 (AA), 2pq 
(Aa) and q2 (aa). P-values for a HWE were calculated using the R package DGC-genetics.    
 
Pairwise LD was analysed using the LD function from R package DGC-genetics. Values of D’> 0.33 
(Moffat et al., 2000; Kruglyak, 1999), and r2> 0.1 (Ardlie et al., 2002; Tiret et al., 2002) were selected 
as useful LD. More than one polymorphism were identified per gene, and haplotypes were constructed 
and analysed using “haplo.stats” (version 1.2.0). This program assigns the probability for the 
occurrence of each haplotype in each individual, and then directly models an individual’s phenotype as 
a function of the inferred haplotype, weighted by their estimated probability to account for haplotype 
ambiguity. Global and haplotype-specific scores with associated p-values are then generated (Schaid 
et al., 2002). A global haplotype is obtained by applying a global test for association on H-1 df (where 
H is the number of haplotypes for the data available). A haplotype-specific score refer to a test for 
association for that particular haplotype. The number of simulations for the empirical global and 
specific p-values was set at 1000. We inferred haplotypes from the genotypes of the two variants and 
compared between obese and control subjects. All models were adjusted for age and gender, and 
replicated measurements were also controlled for as random effects.  
 
Logistic regression was used to assess case-control association with genotype and ethnicity in joint 
models.  Allelic distributions differed highly significantly between ethnic groups. The differences were 
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of such a nature, that adjusting trait-gene association analyses for ethnicity would not be valid. All 
analyses were therefore stratified by ethnicity. Linear models were used to test association between 
quantitative traits and genotypes, alleles (additive) and haplotypes. Triglycerides, diastolic and systolic 
blood pressure were log-transformed prior to analysis, because of skewed distributions. Genotype-
association (2 degrees of freedom) was tested by coding genotype as a categorical factor as 
described by Cordell and Clayton (2005) and additive allelic association (1 degree of freedom) with a 
numerical variable, counting the number of minor alleles.  Haplotype analysis was done using 
methods described by Schaid and co-workers (2002).  
   
Association between MC3R genotypes and physical activity: Linear models were also used to 
assess the effect of the MC3R genotypes on anthropometric and metabolic parameters while adjusting 
for frequency of participation in each activity (walking, sport, cycling, and household chores), age, 
ethnicity and gender.  Finally linear models were used to assess the interaction between the MC3R 
genotypes and frequency of participation in various physical activities (such as walking, sport, cycling, 
household chores) on anthropometric and metabolic parameters while adjusting for age, ethnicity and 
gender.  
 
Multiple comparison consideration: P-values obtained from all analyses were not corrected for 
multiple testing because it has been suggested that correction is too conservative when several 
associations are tested in the same group of individuals (Nyholt, 2004), and might not be appropriate 
in a situation such as this, where there is prior evidence that such effects exist (Perneger, 1998). Our 
tests are not of independent null hypotheses as required by Benjamini, Yoav; Hochberg, Yosef (1995), 
as the SNPs are in tight LD with each other, and we explored different (genotype and additive allelic) 
models with individual SNPs, combinations of genotypes and also combinations of alleles from the 
same SNPs. The statistical significance of each association can only be validated when their biological 
meaning have been identified, and replicated in multiple studies. In all analyses conducted, results 
with p-values below 5% are described as significant.  The effect sizes and 95% confidence intervals 
reported in the results and tables were calculated from each specific model.  
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2.3. RESULTS 
Clinical characteristics of participants according to ethnicity are summarized in Table 2.2. By selection, 
anthropometric obesity variables (weight, BMI, WC, hip and MUAC) and blood pressure were 
significantly higher in obese-overweight learners. However, there was no significant interaction 
between obesity susceptibly and ethnicity on anthropometric obesity variables. The fasting blood 
glucose (FBG) was significantly higher in Mixed Ancestry learners (p = 0.0088) irrespective of BMI 
categories (obese-overweight and normal weight status).  
 
SSCP and subsequent sequencing of samples that showed different mobility shifts failed to detect 
sequence variants in MC4R (Figure 2.2), whilst the different mobility shifts detected on MC3R SSCP 
analysis represented two common polymorphisms upon sequencing. Different mobility shifts were 
detected in fragments 1 and 2 of MC3R (Figure 2.3). Nucleotide sequences of MC3R fragment 1 
revealed a C>A nucleotide substitutions at position 618 (g.618C>A) whilst that of fragment 2 showed 
G>A nucleotide change at position 842 of the genomic sequence (g.842G>A). The sequences were 
further translated to determine the effect of the substitutions in the amino acid sequence. The C>A 
variant resulted in a threonine to lysine substitution at position 6 (Thr6Lys or T6K) (rs3746619), and 
G>A to a valine to isoleucine amino acid substitution at position 81 (Val81Ile or V81I) (rs3827103) of 
the protein sequence. The Thr6Lys and Val81Ile polymorphisms are located, respectively, in the 
amino-terminal extracellular region and the first transmembrane helix of the MC3R protein. The 
nucleotide substitutions identified in MC3R affect restriction enzyme recognition sites: the C>A 
abolishes a Mae II recognition site and the G>A abolishes a BSeD 1 site. Seventy six samples 
underwent SSCP analysis, however, the entire study population was genotyped for the two MC3R 
polymorphisms using ASREA (Figure 2.4).  
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Table 2.2. Anthropometric and metabolic variables of obese-overweight and normal Black African and Mixed Ancestry South African 
learners.  
Summary statistics are mean±SD unless indicated otherwise. P-values are for joint model, so each is adjusted for the other. *Triglycerides, Diastolic 
and Systolic blood pressure were summarised as median, (interquartile range) and were log-transformed to symmetry for tests.   
Abbreviations: BMI, body mass index; FBG, fasting blood glucose; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-cholesterol; 
MUAC, mid-upper-arm circumference; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; WC, waist circumference.
  Obese and overweight Normal weight P-value   
  Black Africans Mixed ancestry Black Africans Mixed ancestry Obesity Race Interaction 
n 115 112 94 110    
Age (years) 13.2±2.0 13.4±2.0 13.3±2.0 13.6±2.1 0.5897 0.3293 0.8795 
Gender, male (%) 21 (25) 26 (31) 16 (19) 20 (24) 0.8150 0.8280 0.6530 
Weight (kg) 62.7±12.5 65.4±13.9 46.3±8.5 45±9.6 <0.0001 0.4273 0.0730 
Height (cm) 153.3±8.1 156.3±8.7 153.5±9.3 153.3±10.8 0.8901 0.8533 0.0732 
BMI (kg/m2) 26.5±3.6 26.6±4.1 19.5±2.1 19±2.5 <0.0001 0.2278 0.3050 
FBG (mmol/L) 3.9±0.8 4.2±0.8 3.8±0.8 4.1±0.7 0.1545 0.0088 0.9134 
TC (mmol/L) 3.8±1 3.7±0.8 3.7±0.8 3.7±0.8 0.3645 0.9612 0.5332 
TG (mmol/L)* 0.73 (0.57, 0.95) 0.65 (0.57, 0.99) 0.57 (0.57, 0.79) 0.57 (0.57, 0.80) 0.2736 0.1621 0.4489 
HDL-C (mmol/L) 1.1±0.4 0.9±0.3 1.2±0.4 1.1±0.4 0.0650 0.2048 0.1473 
MUAC (cm) 27.5±3.4 27.7±3.2 22.7±2.5 22.1±2.3 <0.0001 0.1011 0.1134 
Waist (cm) 79.4±8.8 80.4±10.1 66.4±6.6 64.9±6.7 <0.0002 0.1934 0.1183 
Hip (cm) 99.1±9.5 100.9±10.1 84.7±8.3 84.6±9.1 <0.0003 0.9871 0.3119 
SBP (mm Hg) * 114 (104, 123) 111 (105, 117) 103 (97, 115) 104 (95, 116) <0.0004 0.8680 0.3440 
DBP (mm Hg)* 69 (63, 78) 69 (64, 73) 64 (59, 71) 66 (59, 72) 0.0002 0.6880 0.3889 
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Figure 2.2. Single strand conformation polymorphism analysis of MC4R.  A) 2% agarose gel showing 
5 amplified fragments (A1-4), a 100-bp ladder (DL) and a blank (B). B) 10% polyacrylamide SSCP gel 
showing 7 amplicons with similar mobility shifts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Single strand conformation polymorphism analysis of MC3R. (A, fragment 1, and B, 
fragments 2) A: Fragment 1- two different band patterns (forming heteroduplexes) were identified as 
indicated by arrows (lanes 3 and 4). From left: lanes 1-7, amplicons; lane 8, undenatured amplicon; 
lane 9, lambda Pst 1 DNA ladder. B: Fragment 2- two different band patterns were identified as 
indicated by arrows. From left: lanes 1-9, amplicons.  
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Figure 2.4. Polymerase chain reaction-based allele-specific restriction enzyme analysis of MC3R, 
fragments 1 and 2 that contained Thr6Lys and Val81Ile, respectively. The two fragments were 
amplified successfully resulting in a 245 bp amplicon (A, fragment 1) and a 292 bp amplicon (C, 
fragment 2) as indicated. Lanes from left to right:  A) DL= 100-bp ladder, A1-4= amplicons, B= blank 
(PCR solution without a DNA template). B: DL= 100-bp ladder, A1 and A2= amplicons, B= blank. 
Three genotypes were identified for each polymorphism as indicated.  
 
 
Thr6Lys and Val81Ile were in strong linkage disequilibrium in all groups, ranging from D'= 0.7437 in 
Mixed Ancestry normal weight learners to D’=0.9264 in the Black African obese learners. The 
frequency distributions, both genotype and allele, differed significantly between the racial groups, after 
adjusting for case-control status.  The differences were of such a nature that potential effects would be 
cancelled out if the genotype association test was adjusted for ethnicity. Therefore all subsequent 
analyses were stratified according to race. Only the distribution of the Val81Ile A allele was 
significantly different between Mixed Ancestry obese/overweight and normal weight learners, 
respectively 28% and 40%, p = 0.0144 (Table 2.3).  Table 2.4a shows P-values from individual 
genotype and allele (additive) association tests with anthropometric and metabolic obesity traits 
stratified by race, adjusted for gender and age for both polymorphisms. Both Thr6Lys and Val81Ile 
showed associations with obesity anthropometric traits (body weight, BMI, and hip and waist 
circumferences, and mid-upper-arm) and total cholesterol, whilst only the Thr6Lys was associated with 
blood pressure in Mixed Ancestry learners. For example, the estimated effect of the Thr6Lys A allele 
was a decrease of 0.814 cm in mid-upper-arm circumference, 2.873 cm in hip circumference, 3.225 kg 
in weight and a corresponding 0.959 kg/m2 reduction in BMI (Table 2.4b). Total cholesterol was 
significantly decreased, respectively, by 0.170 and 0.162 mmol/L in Lys6Lys and Ile81Ile carriers 
compared to the respective wild type homozygotes. Learner homozygous for the 6Lys allele had 
approximately 2.4 mm Hg less blood pressure than those carrying the wildtype allele. 
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Table 2.3. Allelic and genotype counts (n), frequencies (f) and p-values for tests of association with obesity status,  
stratified by race** and genotype association with race, adjusting for case-control status*.   
 
  
Obese (n = 227) Normal (n = 204) p-value 
 
Black Africans Mixed ancestry Black Africans Mixed ancestry 
Black 
Africans* 
Mixed 
ancestry*  Race** 
  
n f n f n f n f       
Thr6Lys 
           
typed 115  112  94  110     
            
C 104 0.45 159 0.71 99 0.53 137 0.62    
A 126 0.55 65 0.29 89 0.47 83 0.38 0.1055 0.0589 <0.0001 
         
   
C/C 21 0.18 59 0.53 22 0.23 43 0.39    
C/A 62 0.54 41 0.37 55 0.59 51 0.46    
A/A 32 0.28 12 0.11 17 0.18 16 0.15 0.2237 0.1246 <0.0001 
         
   
Val81Ile 
        
   
typed 115  112  94  110     
         
   
G 106 0.46 162 0.72 96 0.51 133 0.60    
A 124 0.54 62 0.28 92 0.49 87 0.40 0.2873 0.0144 <0.0001 
          
  
G/G 22 0.19 61 0.54 22 0.23 46 0.42    
G/A 62 0.54 40 0.36 52 0.55 41 0.37    
A/A 31 0.27 11 0.1 20 0.21 23 0.21 0.561 0.0401 <0.0001 
                        
P-values are for tests of difference in allele and genotype distribution between the case and control groups within each racial group;  
adjusting for age and gender; and between the two racial groups, adjusted for case-control status, age and gender.   
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Table 2.4a. P-values from tests of association between clinical variables and polymorphisms, both 
genotype and allelic, stratified by race, adjusted for age and gender. 
 
 
Black African Mixed Ancestry 
 
Thr6Lys Val81Ile Thr6Lys Val81Ile 
Clinical variable genotype allelic genotype allelic genotype allelic genotype allelic 
Weight (kg) 0.2944 0.1246 0.3871 0.1768 0.0668 0.0216 0.0172 0.0074 
Height (cm) 0.9729 0.8388 0.5729 0.4938 0.2508 0.1462 0.3128 0.2287 
BMI (kg/m2) 0.2664 0.1203 0.3861 0.2388 0.1270 0.0476 0.0160 0.0110 
FBG (mmol/L) 0.4337 0.7875 0.1725 0.7528 0.7216 0.4218 0.5231 0.2862 
TC (mmol/L) 0.2166 0.1404 0.0726 0.1218 0.0625 0.0315 0.0499 0.0307 
TG (mmol/L)* 0.0974 0.0404 0.4328 0.2065 0.2912 0.2183 0.1355 0.0910 
HDL-C (mmol/L) 0.3268 0.6687 0.1033 0.8736 0.6723 0.8861 0.9766 0.8283 
Midupperarm 
(cm) 0.5468 0.5133 0.4606 0.7714 0.0825 0.0268 0.0195 0.0119 
Waist (cm) 0.1386 0.2799 0.3112 0.6478 0.1867 0.0668 0.0451 0.0362 
Hip (cm) 0.3901 0.1738 0.4176 0.2155 0.0338 0.0099 0.0136 0.0071 
SBP (mm Hg) * 0.8249 0.5382 0.4505 0.7829 0.0311 0.0467 0.1468 0.5359 
DBP (mm Hg)* 0.9976 0.9599 0.4667 0.7060 0.0083 0.0213 0.2810 0.3798 
                  
*Triglycerides, Diastolic and Systolic blood pressure were log-transformed to symmetry for tests.  
 
 
Table 2.4b. Estimated effect and standard error of the A allele of each polymorphism, corresponding 
to allelic p-values in Table 2.4a, on clinical variables, adjusted for age and gender.  A negative effect 
indicates that individuals with the A allele have lower values for the trait than those with the wild type 
allele.   
 
 
Black African   Mixed Ancestry 
 
Thr6Lys Val81Ile 
 
Thr6Lys Val81Ile 
Clinical 
variable Effect SE Effect SE 
  
Effect SE Effect SE 
Weight (kg) 1.941 1.259 1.686 1.244  -3.225 1.394 -3.575 1.321 
Height (cm) 0.152 0.748 0.505 0.737  -1.171 0.803 -0.924 0.765 
BMI (kg/m2) 0.725 0.465 0.543 0.460  -0.959 0.481 -1.168 0.456 
FBG (mmol/L) -0.022 0.081 -0.025 0.079  0.060 0.074 0.075 0.070 
TC (mmol/L) -0.137 0.093 -0.142 0.091  -0.170 0.079 -0.162 0.075 
TG (mmol/L)* -0.107 0.052 -0.065 0.052  -0.050 0.040 -0.065 0.038 
HDL-C (mmol/L) -0.017 0.039 0.006 0.039  0.005 0.034 -0.007 0.032 
Midupperarm 
(cm) 0.245 0.374 0.108 0.370  -0.814 0.365 -0.878 0.347 
Waist (cm) 1.096 1.011 0.458 1.000  -1.971 1.070 -2.141 1.016 
Hip (cm) 1.490 1.092 1.339 1.078  -2.873 1.105 -2.852 1.050 
SBP (mm Hg)* 0.893 1.449 0.395 1.431  -2.498 1.249 -0.743 1.198 
DBP (mm Hg)* -0.061 1.210 -0.451 1.194  -2.087 0.899 -0.761 0.865 
                    
*Triglycerides, Diastolic and Systolic blood pressure were not log-transformed for estimation. 
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There was no statistically significant variation in the distribution of the Thr6Lys-Val81Ile haplotype 
between Black African obese/overweight and normal weight learners. However, the A-A haplotype 
was the most common in the former group, 52% vs 44%, p = 0.0749. In Mixed Ancestry learners, the 
haplotype distributions differed significantly between obese/overweight and normal weight learners 
(global P= 0.0185): C-G was more prevalent in obese/overweight learners (69% versus 55%, 
P=0.0063) whereas C-A was more frequent in normal weight learners (8% vs 2%, P=0.0142) (Table 
2.5). Table 2.6 shows the Thr6Lys-Val81Ile haplotype association tests with anthropometric and 
metabolic obesity traits and their corresponding estimated effect size.  No significant associations 
were observed between the Thr6Lys-Val81Ile haplotype and anthropometric and metabolic obesity 
traits in Black African learners. On the other hand, in Mixed Ancestry learners, the C-A haplotype was 
associated with a decrease of 2.4 kg in body weight compared to C-G carriers; while those carrying 
the A-A haplotype weighed 3.3 kg less. The systolic as well as diastolic blood pressures were 
decreased by 10 and 7.5 mmHg, respectively in A-G haplotype compared to the C-G haplotype 
carriers.  
 
Table 2.5. Inferred Thr6Lys-Val81Ile haplotype frequencies in normal and overweight-obese children, 
and joint individual p-values for test of association with overweight, stratified by race.  Global p-values 
are given in the heading. 
    Black Africans (p = 0.1089)   Mixed Ancestry (p = 0.0185) 
Haplotype 
Obese and 
overweight Normal P-value   
Obese and 
overweight Normal P-value 
C-A  0.02 0.05 0.0688  0.02 0.08 0.0142 
C-G  0.43 0.48 0.3541  0.69 0.55 0.0063 
A-G  0.03 0.03 0.7389  0.04 0.06 0.3496 
A-A  0.52 0.44 0.0749  0.25 0.32 0.1172 
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Table 2.6. P-values for Thr6Lys-Val81Ile haplotype (global) association with clinical traits, stratified by 
race and adjusted for age and gender.  For significant effects in mixed ancestry children: estimated 
effect [and standard error of estimate (SE)] of specific Thr6Lys-Val81Ile haplotype compared to C-G 
(wild types), adjusted for age and gender.  
 
P-value Mixed Ancestry 
 Clinical variable Black African Mixed ancestry Haplotype Effect SE 
Weight (kg) 0.4062 0.0338 A-A vs C-G -3.3 1.5 
Height (cm) 0.7946 0.5443    
BMI (kg/m2) 0.3542 0.0351 C-A vs C-G -2.4 1.1 
FBG (mmol/L) 0.9761 0.7336    
TC (mmol/L) 0.3791 0.1070    
TG (mmol/L)* 0.2409 0.2619    
HDL-C (mmol/L) 0.7290 0.7252    
Midupperarm (cm) 0.8572 0.0278 C-A vs C-G -1.7 0.8 
 
  A-A vs C-G -0.8 0.4 
Waist (cm) 0.3871 0.0993    
Hip (cm) 0.4666 0.077    
SBP (mm Hg) * 0.8694 0.0047 A-G vs C-G -10.0 2.8 
DBP (mm Hg)* 0.8363 0.0027 A-G vs C-G -7.5 2.0 
*Triglycerides, Diastolic and Systolic blood pressure were log-transformed to symmetry for tests. Effect sizes  
are not transformed.   
 
 
When physical activity was incorporated into the regression analyses, only total cholesterol showed a 
significant association with MC3R genotypes when adjusted for the frequency of each physical 
activity, age, gender and race. These effects are summarised in table 2.7. Total cholesterol was 
significantly decreased in learners who were homozygous for the Thr6Lys and Val81Ile minor alleles 
compared to the respective wild type homozygotes. Furthermore, the only activity by genotype 
interactions we detected on total cholesterol. They were between walking and both polymorphisms 
(Figure 2.5), and between doing house chores and Val181le (Figure 2.6). The walking-by-genotype 
interaction on total cholesterol did not follow a defined pattern and therefore could not be interpreted. 
The interaction between frequency of performing house chores and Val81le can be summarised as on 
total cholesterol was as follows: learners who did house chores often and carried AA or AG 
genotypes, had 0.355 mmol/L (95% CI: 0.148, 0.561) reduction in total cholesterol compared to GG 
homozygotes.    
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Table 2.7. P-values and effect sizes for the association between MC3R genotypes and clinical variables; adjusted for age, gender, race, 
and the frequency of each physical activity category. 
  Thr6Lys (N= 431) Val81Ile (N= 431) 
Clinical 
variable 
Activity P-value β coefficient (95% CI) P-value β coefficient (95% CI) 
 
 
 CA vs CC AA vs CC  GA vs GG AA vs GG 
Weight (kg)  
 
walking 0.5861 -1.52 (-4.44,1.40) -1.18 (-5.00,2.63) 0.3843 -1.35 (-4.29,1.59) -2.51 (-6.15,1.13) 
 
sport 0.4366 -1.90 (-4.85,1.05) -1.60 (-5.42,2.21) 0.3343 -1.74 (-4.71,1.23) -2.56 (-6.23,1.11) 
 TV viewing 0.6948 -1.20 (-4.11,1.71) -1.19 (-4.95,2.58) 0.4292 -1.20 (-4.12,1.72) -2.36 (-5.97,1.25) 
 
cycling 0.5339 -1.63 (-4.55,1.29) -1.42 (-5.21,2.38) 0.3886 -1.38 (-4.33,1.56) -2.48 (-6.13,1.16) 
 
House chores 0.5325 -1.62 (-4.55,1.31) -1.51 (-5.31,2.29) 0.3703 -1.47 (-4.42,1.48) -2.53 (-6.19,1.12) 
Height (cm)  
 
walking 0.4700 -1.03 (-2.72,0.66) -0.94 (-3.15,1.27) 0.7494 -0.62 (-2.33,1.08) -0.61 (-2.72,1.50) 
 
sport 0.3357 -1.26 (-2.97,0.46) -1.13 (-3.35,1.10) 0.6831 -0.73 (-2.46,1.01) -0.71 (-2.85,1.43) 
 TV viewing 0.5327 -0.93 (-2.63,0.77) -0.89 (-3.09,1.31) 0.8346 -0.48 (-2.19,1.23) -0.51 (-2.63,1.61) 
 
cycling 0.4156 -1.13 (-2.83,0.57) -0.94 (-3.15,1.27) 0.7670 -0.62 (-2.34,1.10) -0.53 (-2.66,1.60) 
 House chores 0.4074 -1.14 (-2.84,0.56) -0.98 (-3.19,1.23) 0.7531 -0.63 (-2.35,1.08) -0.57 (-2.69,1.56) 
BMI (kg/m2)  
 
walking 0.6783 -0.45 (-1.49,0.58) -0.17 (-1.53,1.18) 0.4616 -0.44 (-1.49,0.61) -0.80 (-2.09,0.50) 
 
sport 0.5859 -0.55 (-1.59,0.50) -0.28 (-1.63,1.07) 0.4230 -0.57 (-1.62,0.48) -0.78 (-2.08,0.51) 
 
TV viewing 0.7967 -0.35 (-1.39,0.68) -0.19 (-1.53,1.15) 0.4889 -0.41 (-1.45,0.63) -0.77 (-2.05,0.52) 
 
cycling 0.6703 -0.47 (-1.51,0.57) -0.26 (-1.60,1.09) 0.4525 -0.45 (-1.49,0.60) -0.81 (-2.10,0.49) 
 House chores 0.6826 -0.46 (-1.50,0.58) -0.29 (-1.64,1.06) 0.4381 -0.48 (-1.53,0.57) -0.82 (-2.11,0.48) 
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Table 2.7.  continues 
Clinical 
variable 
 Thr6Lys (N= 431) Val81Ile (N= 431) 
 Activity P-value β coefficient (95% CI) P-value β coefficient (95% CI) 
 
 
 CA vs CC AA vs CC  GA vs GG AA vs GG 
WC (cm)  
 
walking 0.0807 -2.39 (-4.60,-0.17) -0.52 (-3.41,2.36) 0.2349 -1.74 (-3.97,0.50) -1.98 (-4.74,0.79) 
 
sport 0.0627 -2.57 (-4.80,-0.35) -0.77 (-3.65,2.10) 0.1800 -2.00 (-4.25,0.25) -1.95 (-4.73,0.82) 
 TV viewing 0.1506 -2.10 (-4.31,0.11) -0.61 (-3.47,2.24) 0.2564 -1.64 (-3.86,0.58) -1.94 (-4.69,0.80) 
 
cycling 0.0872 -2.40 (-4.61,-0.19) -0.75 (-3.61,2.12) 0.2192 -1.78 (-4.01,0.45) -2.01 (-4.77,0.75) 
 
House chores 0.1033 -2.33 (-4.54,-0.12) -0.80 (-3.67,2.06) 0.2054 -1.80 (-4.03,0.43) -2.07 (-4.84,0.69) 
Hip (cm)  
 
walking 0.3464 -1.83 (-4.31,0.66) -0.87 (-4.12,2.38) 0.3815 -1.36 (-3.87,1.16) -2.07 (-5.18,1.05) 
 
sport 0.2600 -2.09 (-4.59,0.41) -1.26 (-4.49,1.97) 0.3044 -1.64 (-4.16,0.88) -2.20 (-5.31,0.91) 
 TV viewing 0.4550 -1.57 (-4.04,0.90) -0.79 (-3.99,2.41) 0.4378 -1.21 (-3.70,1.28) -1.92 (-5.00,1.17) 
 
cycling 0.3300 -1.88 (-4.37,0.60) -1.08 (-4.31,2.15) 0.3840 -1.37 (-3.88,1.15) -2.05 (-5.16,1.06) 
 House chores 0.3450 -1.85 (-4.33,0.64) -1.07 (-4.30,2.15) 0.3710 -1.39 (-3.90,1.11) -2.08 (-5.19,1.03) 
WHR (cm)  
 
walking 0.1289 -0.009 (-0.022,0.004) 0.006 (-0.011,0.023) 0.3110 -0.01 (-0.02,0.00) 0.00 (-0.02,0.01) 
 
sport 0.1693 -0.009 (-0.022,0.005) 0.005 (-0.012,0.022) 0.2898 -0.011 (-0.024,0.003) -0.004 (-0.021,0.012) 
 TV viewing 0.2069 -0.008 (-0.021,0.005) 0.005 (-0.012,0.022) 0.3105 -0.010 (-0.024,0.003) -0.005 (-0.021,0.011) 
 
cycling 0.1660 -0.009 (-0.022,0.004) 0.005 (-0.012,0.022) 0.3024 -0.010 (-0.024,0.003) -0.005 (-0.021,0.011) 
 House chores 0.1876 -0.009 (-0.022,0.004) 0.004 (-0.013,0.021) 0.2814 -0.011 (-0.024,0.003) -0.005 (-0.022,0.011) 
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Table 2.7.  continues 
Clinical 
variable 
 Thr6Lys (N= 431) Val81Ile (N= 431) 
 Activity P-value β coefficient (95% CI) P-value β coefficient (95% CI) 
 
 
 CA vs CC AA vs CC  GA vs GG AA vs GG 
SBP (mm Hg)  
 
walking 0.1525 -2.78 (-5.70,0.14) -0.84 (-4.66,2.97) 0.8690 -0.778 (-3.738,2.182) -0.271 (-3.935,3.392) 
 
sport 0.1044 -3.10 (-6.05,-0.15) -1.04 (-4.89,2.80) 0.7438 -1.13 (-4.12,1.86) -0.34 (-4.03,3.35) 
 TV viewing 0.1907 -2.68 (-5.63,0.27) -1.05 (-4.89,2.79) 0.8852 -0.74 (-3.72,2.23) -0.36 (-4.04,3.32) 
 
cycling 0.1715 -2.73 (-5.66,0.21) -0.95 (-4.78,2.88) 0.8796 -0.76 (-3.73,2.22) -0.31 (-3.99,3.36) 
 
House chores 0.1781 -2.71 (-5.65,0.22) -1.00 (-4.83,2.83) 0.8733 -0.78 (-3.76,2.19) -0.36 (-4.04,3.32) 
DBP (mm Hg)  
 
walking 0.1246 -2.40 (-4.71,-0.09) -1.55 (-4.57,1.47) 0.7365 -0.50 (-2.84,1.84) -1.15 (-4.04,1.75) 
 
sport 0.0789 -2.67 (-5.00,-0.34) -1.98 (-5.00,1.04) 0.6478 -0.85 (-3.20,1.51) -1.30 (-4.21,1.62) 
 TV viewing 0.1600 -2.23 (-4.55,0.09) -1.82 (-4.83,1.18) 0.7137 -0.49 (-2.83,1.84) -1.21 (-4.10,1.68) 
 
cycling 0.1214 -2.40 (-4.71,-0.09) -1.82 (-4.82,1.18) 0.7093 -0.61 (-2.95,1.73) -1.21 (-4.10,1.69) 
 House chores 0.1270 -2.37 (-4.69,-0.06) -1.85 (-4.86,1.15) 0.7033 -0.59 (-2.93,1.75) -1.23 (-4.13,1.67) 
FBG (mmol/L)  
 
walking 0.6556 -0.030 (-0.198,0.138) 0.065 (-0.155,0.284) 0.2821 -0.07 (-0.24,0.10) 0.09 (-0.12,0.30) 
 
sport 0.7437 0.002 (-0.167,0.171) 0.076 (-0.142,0.295) 0.3441 -0.042 (-0.211,0.128) 0.104 (-0.105,0.314) 
 TV viewing 0.7661 -0.023 (-0.192,0.147) 0.052 (-0.167,0.271) 0.3161 -0.066 (-0.236,0.103) 0.083 (-0.127,0.293) 
 
cycling 0.7163 -0.024 (-0.192,0.144) 0.060 (-0.159,0.278) 0.3058 -0.065 (-0.234,0.104) 0.087 (-0.123,0.296) 
 House chores 0.7491 -0.022 (-0.191,0.146) 0.056 (-0.163,0.274) 0.3118 -0.067 (-0.236,0.103) 0.084 (-0.126,0.293) 
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Table 2.7.  continues 
Clinical 
variable 
 Thr6Lys (N= 431) Val81Ile (N= 431) 
 Activity P-value β coefficient (95% CI) P-value β coefficient (95% CI) 
 
 
 CA vs CC AA vs CC  GA vs GG AA vs GG 
TC (mmol/L)  
 
walking 0.0292 -0.170 (-0.353,0.012) -0.312 (-0.550,-0.074) 0.0261 -0.133 (-0.317,0.051) -0.313 (-0.541,-0.086) 
 
sport 0.0207 -0.201 (-0.385,-0.017) -0.316 (-0.555,-0.078) 0.0264 -0.156 (-0.341,0.030) -0.312 (-0.541,-0.083) 
 TV viewing 0.0388 -0.175 (-0.358,0.007) -0.292 (-0.529,-0.055) 0.0354 -0.134 (-0.317,0.050) -0.299 (-0.526,-0.072) 
 
cycling 0.0325 -0.177 (-0.359,0.006) -0.302 (-0.538,-0.065) 0.0304 -0.136 (-0.319,0.048) -0.306 (-0.534,-0.079) 
 
House chores 0.0265 -0.179 (-0.360,0.002) -0.310 (-0.545,-0.074) 0.0245 -0.139 (-0.322,0.043) -0.314 (-0.540,-0.088) 
TG (mmol/L)  
 
walking 0.0586 -0.085 (-0.185,0.016) -0.155 (-0.287,-0.023) 0.1072 -0.065 (-0.167,0.037) -0.135 (-0.261,-0.009) 
 
sport 0.0705 -0.089 (-0.190,0.013) -0.147 (-0.278,-0.015) 0.1351 -0.066 (-0.169,0.036) -0.127 (-0.254,0.000) 
 TV viewing 0.0680 -0.085 (-0.186,0.016) -0.149 (-0.280,-0.018) 0.1161 -0.064 (-0.165,0.038) -0.132 (-0.259,-0.006) 
 
cycling 0.0581 -0.085 (-0.186,0.015) -0.153 (-0.284,-0.023) 0.1048 -0.067 (-0.169,0.034) -0.135 (-0.260,-0.009) 
 House chores 0.0601 -0.086 (-0.186,0.015) -0.151 (-0.282,-0.021) 0.1006 -0.066 (-0.167,0.036) -0.136 (-0.261,-0.011) 
HDL-C (mmol/L)  
 
walking 0.2593 0.047 (-0.033,0.127) -0.025 (-0.129,0.079) 0.2945 0.051 (-0.029,0.131) -0.012 (-0.111,0.088) 
 
sport 0.3181 0.042 (-0.038,0.122) -0.024 (-0.128,0.079) 0.3825 0.046 (-0.034,0.127) -0.008 (-0.108,0.091) 
 TV viewing 0.2716 0.046 (-0.034,0.125) -0.025 (-0.128,0.078) 0.3276 0.049 (-0.032,0.129) -0.011 (-0.110,0.088) 
 
cycling 0.2444 0.048 (-0.032,0.127) -0.025 (-0.128,0.078) 0.2971 0.050 (-0.030,0.130) -0.012 (-0.111,0.087) 
 House chores 0.2403 0.047 (-0.033,0.126) -0.027 (-0.130,0.076) 0.3051 0.049 (-0.031,0.129) -0.013 (-0.112,0.086) 
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Table 2.7.  continues 
 
Clinical 
variable 
 Thr6Lys (N= 431) Val81Ile (N= 431) 
 Activity P-value β coefficient (95% CI) P-value β coefficient (95% CI) 
 
 
 CA vs CC AA vs CC  GA vs GG AA vs GG 
LDL-C (mmol/L)  
 
walking 0.2525 -0.069 (-0.289,0.151) -0.249 (-0.544,0.046) 0.1177 -0.080 (-0.306,0.146) -0.288 (-0.563,-0.012) 
 
sport 0.2647 -0.088 (-0.308,0.133) -0.241 (-0.533,0.050) 0.1669 -0.097 (-0.323,0.129) -0.267 (-0.544,0.010) 
 
TV viewing 0.3127 -0.093 (-0.311,0.126) -0.224 (-0.515,0.067) 0.1759 -0.100 (-0.324,0.123) -0.261 (-0.535,0.014) 
 
cycling 0.2216 -0.083 (-0.302,0.136) -0.256 (-0.546,0.034) 0.1181 -0.110 (-0.334,0.114) -0.289 (-0.563,-0.015) 
 
House chores 0.2384 -0.091 (-0.310,0.128) -0.251 (-0.542,0.040) 0.1338 -0.103 (-0.328,0.123) -0.281 (-0.556,-0.006) 
Estimated effects and 95% CI of the A allele of each polymorphism.  A negative effect indicates that individuals with stated level have lower values for  
the trait than those with the reference level.  
Abbreviations: 95% CI: 95% confidence interval; BMI, body mass index ; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high  
density lipoprotein-cholesterol; HP, hip circumference; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides;  TV, television; WC, waist circumference; 
WHR, waist hip ratio. 
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Figure 2.5. A box plot of total cholesterol against the frequency of walking (categorized as never, occasional and often). The plot shows an 
interaction between the two variables in learners with different MC3R Val81Ile and Thr6Lys genotypes.  
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Figure 2.6. A box plot of total cholesterol against the frequency of doing house chores (categorized as never, occasional and often). The 
shows an interaction between the two variables in learners with different MC3R Val81Ile genotypes genotypes. 
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2.4. DISCUSSION 
In this study, MC4R and MC3R were analysed for sequence variants that may contribute to polygenic 
obesity in two South African racial groups, namely, Mixed Ancestry and Black Africans. Sequence 
analysis of MC3R in our study groups detected two common polymorphisms that showed variability in 
allele and corresponding genotype frequencies between the Mixed Ancestry and Black African 
learners. 
 
The minor A allele frequency of both polymorphisms were higher in Black African learners compared 
to Mixed Ancestry individuals, independent of their obesity status. Similarly, differences in the 
presence of the homozygous state of both Thr6Lys and Val81Ile polymorphisms have been observed 
in different populations elsewhere. In comparison to American Caucasians (Feng et al., 2005; Santoro 
et al., 2007), the homozygosity of these variants in Mixed Ancestry learners was not as low. Feng and 
co-workers (2005) reported a prevalence of 15.8% of the MCR3 homozygote variant allele in African-
Americans compared to 24% found in Black Africans in the present study. Interestingly, the two 
polymorphisms were associated with lower anthropometric and metabolic variables in Mixed Ancestry 
learners.  
 
The genotype and allele association was confirmed by haplotype analysis, demonstrating a negative 
association of Thr6Lys-Val81Ile haplotype (A-A and C-A compared to the C-G haplotype) with 
anthropometric variables, while the A-G (compared to the C-G haplotype) was negatively correlated 
with blood pressure in Mixed Ancestry learners. These results suggest a possible protection of minor-
allele carriers from obesity and hypertension. The effect posed by the C-A haplotype should, however, 
be analysed with caution and investigated further as there was a small number (2% in obese and 8% 
in normal) of learners harbouring this haplotype. Although the A allele was more prevalent in Black 
African learners, neither allele nor haplotype association tests demonstrated correlation with 
anthropometric and metabolic obesity traits in this ethnic group. Thr6Lys and Val81Ile are found, 
respectively, in the NH2-terminal extracellular part and the first transmembrane helix of MC3R protein. 
Mutations in either location are predicted to affect melanocortin receptor function, especially the first 
transmembrane region that is believed to be involved in the binding of melanocortin peptides. Co-
occurrence of MC3R Thr6Lys and Val81Ile was associated with impaired cAMP generation in vitro 
(Wong  et al., 2002; Tao and Segaloff, 2004) and with greater BMI, greater body fat mass, and higher 
plasma levels of insulin and leptin in African-American and Caucasian children (Hani et al., 2001; 
Wong et al., 2002; Schalin-Jantti et al., 2003; Li et al., 2004). Similar to our findings in Black African 
learners, Li and co-authors (2000) failed to demonstrate an association between these polymorphisms 
and body weight in African-Americans. Results observed in Mixed Ancestry learners are in contrast 
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with findings from other studies that demonstrated an association between double homozygosity of 
these variants and high body weight: minor allele carriers had greater body fat mass than those 
carrying the major alleles (Savastano et al., 2009; Feng et al., 2005).  It has also been demonstrated 
that MC3R-knockout mice have a characteristic reduced lean body mass and increased fat mass and 
are slightly hypophagic relative to wildtype controls (Butler et al., 2000; Chen et al., 2000; Savastano 
et al., 2009). Despite the increased adiposity seen in the MC3R-knockout mice, the animals did not 
exhibit increased food intake or weight gain, even on a high fat chow. The authors speculated that the 
obese phenotype of the MC3R-knockout mouse may be explained by defects in fatty acid oxidation 
and decreases in home-cage activity (Butler et al., 2000; Chen et al., 2000). The impaired MSH-
stimulated cAMP production may be due to the reduced total ligand binding capacity that is introduced 
by these two polymorphisms as suggested by Feng and coworkers (2005). This study also suggested 
that the mechanism of the lower activity of the double MC3R mutant may involve less receptor protein 
expression due to posttranslational events rather than reduced messenger RNA levels. Apart from 
brain areas, MC3R is expressed in peripheral tissues such as skeletal muscles, adipose tissue, 
kidney, stomach, and pancreas (Chhajlani, 1996).  It is possible that the negative association of the 
MC3R polymorphisms with BMI and other anthropometric variables, total cholesterol and blood 
pressure observed in the present study may be due to the interaction of this defective gene with other 
genes in a tissue-specific manner. This may also explain the different effects obtained in different 
studies. Our study did not specifically measure fat mass, rather reported values of generalized 
anthropometric measures. We cannot rule out the possibility that the association was related to lean 
mass instead of fat mass.  It is also theoretically possible that the observed association could have 
occurred by chance. 
 
The two MC3R polymorphisms were also associated with variable measures of total cholesterol. Total 
cholesterol was decreased in learners who carried Thr6Lys and Val81Ile minor A alleles after 
adjusting for each physical activity category. In the homozygous state, the Val81Ile minor A allele 
doubled the reduction of total cholesterol (0.299 mmol/L) compared to one A allele which reduced 
cholesterol by 0.134 mmol/L. Doing house chore further reduced total cholesterol in A allele carriers 
from 0.0.162 mmol/L to 0.355 mmol/L compared to wild type homozygotes. The type of house chores 
performed by adolescent learners in our study was not specified to explain the reduced levels of total 
cholesterol observed in the presence of MC3R genotypes. In general, several physical activity 
intervention studies done on school children and adolescents have reported statistically significant 
positive effects on mean blood total cholesterol (Alexandrov et al., 1988; Lionis et al., 1991; 
Vasconcelos et al., 2008), consistent with findings reported in adults (Scheers et al., 2008; Guo et al., 
2011). There is limited evidence for the direct effect of MC3R on lipid metabolism. However, Rutanen 
et al (2007) demonstrated that the MC3R Thr6 and Val81 alleles are associated with low lipid 
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oxidation, findings that were in line with those obtained from a MC3R-knockout mice study (Butler et 
al., 2000). Animal studies have also demonstrated the role of MC3R in energy expenditure, in which 
MC3R knockout mice exhibited diminished physical activity (Chen and Marsh, 2000; Butler et al., 
2000). Our findings, therefore, provides more evidence for the role of MC3R on energy expenditure 
and lipid metabolism. Surprisingly, HDL-C which provides soluble means of transporting cholesterol 
was not associated with MC3R polymorphisms and physical activity. The concentration of HDL-C is 
determined by a balance between the dietary fuel mix (with fat and alcohol increasing, and 
carbohydrates reducing HDL), the extent of caloric excess, the accompanying degree of obesity and 
lack of physical activity (Weggemans et al., 2001; Durrington, 2003), the effect of polymorphisms on 
response to dietary cholesterol and exercise, and clearance of HDL-C from plasma (Bernard et al., 
1998; Davignon et al., 1999). It has been suggested that which of these factors prevail may differ 
from one study to another, and thus balancing each other out so that no differences in HDL-C 
concentration are seen in individuals studied (Knuiman et al., 1987). Low density lipoprotein-
cholesterol measurements of learners were not available to determine the effect of MC3R 
polymorphisms and physical activity.  
 
The association of Thr6Lys with blood pressure is of interest as this further supports the role of MC3R 
in blood pressure regulation (Butler and Cone, 2002). Although both human and animal studies have 
supported the role of MC3R in the development of obesity, only animal models have demonstrated the 
contribution of this gene in blood pressure regulation. In a study by Ni et al (2003), mice lacking Mc3r 
had elevated levels of γ-MSH when on both low- and high-salt diet but developed hypertension when 
on a high-salt diet. This study suggests that the role of MC3R in blood pressure may only be apparent 
in the presence of high salt concentration. However, in the present study this association was not 
investigated.  
 
The MC4R has also been implicated in blood pressure regulation. Both animal and human studies 
have demonstrated that mutant MC4R confers a relative protective role on the expected increase of 
blood pressure in obese subjects (Ni et al., 2006; Greenfield et al., 2009). Intracerebroventricular 
injection of α-MSH elevated blood pressure and heart rate in wild-type mice but not in obese mice 
lacking Mc4r (Ni et al., 2006). Obesity is known to increase blood pressure, but in a study by 
Greenfield and co-workers (2009) humans with MC4R-deficiency had lower blood pressure than the 
control group. Blood pressure of control subjects was similar to that of overweight and obese subject 
with MC4R defects, suggesting that MC4R-deficient subjects were relatively protected from the 
expected relationship between overweight and raised blood pressure.  In the present study, no 
sequence variants were identified in the MC4R. The absence of MC4R variants in our study 
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population is not surprising due to rarity of polymorphisms implicated in mild obesity in this gene 
(Carroll et al., 2005). Similar to our findings some previous studies have also failed to detect sequence 
variants in MC4R (Ohshiro et al., 1999; Jacobson et al., 2002; Tao et al., 2004; Feng et al., 2005).  
According to Jacobson and co-workers, MC4R mutations are likely to occur in population groups 
exhibiting severe or early-onset obesity, and therefore, are not a common cause of obesity in the 
general population (Jacobson et al., 2002).  
 
Blood pressure, central obesity (measured by the waist circumference) and elevated lipid profile are 
metabolic components that are used to identify subjects with the metabolic syndrome (Reaven, 1988). 
Metabolic syndrome is a multiplex risk factor for cardiovascular diseases and type 2 diabetes. 
Individuals with lower waist circumference and blood pressure are known to be at a lower risk of 
developing cardiovascular diseases (Seidell et al., 2001). Although the MC3R polymorphism showed a 
negative effect on blood pressure, total cholesterol and weight gain (as measured by BMI and waist 
circumference) among Mixed Ancestry learners, the prevalence of metabolic syndrome between Black 
African and Mixed Ancestry learners was not significantly different in the cohort from which the sample 
for this study was obtained (Matsha et al., 2009). It is, therefore, unlikely that this association 
translates to the occurrence of metabolic syndrome in these two ethnic groups. Be it the case maybe, 
these findings are important as they suggest that carriers of the Thr6Lys and Val81I minor allele are at 
a lower risk of developing metabolic syndrome and type 2 diabetes. It is also important to note the 
significant association was detected in a South African ethnic group (Mixed Ancestry) that is 
understudied and with a unique genetic make-up. Mixed Ancestry are predominantly of Khoi and San 
(African) origin, with genetic contributions from European settlers (predominantly Dutch, German and 
French) and Asian (Indonesian and Madagascan) who migrated to the Western Cape Province of 
South Africa in the late 1600s (Nurse et al., 1985).    
 
Even when analysed individually, there was no significant variability in the prevalence of individual 
components of metabolic syndrome in these two ethnic groups, except the FBG. FBG was significantly 
higher in Mixed Ancestry learners, and this may be related to the prevalence of type 2 diabetes in this 
ethnic group. One of the early studies conducted on a sample of five ethnic groups (Cape Malay, 
Caucasians, Bantu-speaking Africans, and Mixed Ancestry) living in Cape Town, and (East) Indians in 
Durban reported higher blood glucose levels and diabetes among Indians and Mixed Ancestry 
individuals, and least among Caucasians and Bantu-speaking, each of the latter having a diabetes 
prevalence of approximately 3·5% over the age 15 years (Jackson, 1972). It is noted that the Mixed 
Ancestry ethnic group have more diabetes than any of the constituent groups from which they 
originated (Levitt et al., 1999). Several risk factors for the development of diabetes have been 
identified, and the most consistent significant independent risk factor is the blood glucose 
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concentration, both fasting and 2-hour post load plasma glucose; and less consistent BMI (Knowler et 
al., 1990; 1993). Longitudinal studies are required to determine the long-time effects of the higher 
fasting blood glucose level in the presence of obesity in Mixed Ancestry learners considering that this 
ethnic group has been previously reported to have a higher prevalence of type 2 diabetes. 
 
Obesity is known to increase blood pressure. However, multiple factors underlie blood pressure 
responses, and these include significant genetic and ethnic components, and environmental effects. In 
the present study, there were no ethnic differences observed in blood pressure, but higher values 
were found in obese-overweight learners. The increased blood pressure in adolescents in the 
presence of obesity may be a reason that 25.2% of South African adults were reported to be 
hypertensive in 1998 (Steyn et al., 2001). This is worrying considering that hypertension is the major 
risk factor for stroke (MacMahon et al., 1990). A positive association between obesity and blood 
pressure has been reported elsewhere. For example, in the Bogalusa Heart study overweight children 
were 4.5 times more likely to have elevated SBP (Freedman et al., 1999). A study conducted in rural 
Canadian children also reported a significant positive association between obesity and elevated blood 
pressure, independent of family history of hypertension and kidney disease (Salvadori et al., 2008). 
Because weight gain has been reported to be a key contributor to the development of increasing blood 
pressure, and ultimately, hypertension and a degree of metabolic risk factor clustering; further studies 
are required in this study population to determine the association between adiposity and blood 
pressure.   
 
A limitation of our study is its cross-sectional design. Cross sectional studies have been reported to be 
ineffective in demonstrating the relationship between physical activity and obesity or other metabolic 
parameters (Davison et al., 2006). Additionally, the use of questionnaires to measure physical activity 
may have introduced bias. Physical activity questionnaires and diaries are more applicable in large 
epidemiological studies, but they provide less accurate estimates of physical activity level compared to 
more objective measures (such as doubly-labeled water, indirect calorimetry, or heart rate calibration 
equations) as the tool relies on (parental or child/adolescent) self-reported information (Bull et al., 
2009). The type of house chores performed by adolescent learners was not specified in order to 
estimate the intensity of activity involved. Due to the mixed ancestry origin of the “Coloured” (Mixed 
Ancestry) ethnic group, associations identified in the present study may be due to population 
stratification, which was not adjusted for. Population stratification is one of the confounding factors that 
can lead to false positives, if the study group is heterogeneous as it is the case with the Mixed 
Ancestry ethnic group. Apart from ethnic differences in genetic background, it has been reported that 
puberty and sex hormones affect lipid profile, decreasing HDL-C, low density lipoprotein-cholesterol 
(LDL-C), and increasing TG levels (Codoñer-Franch et al., 2010). Serum lipid levels are also 
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influenced by sex hormones in children and adolescents, with lower HDL-C and LDL-C levels 
associated with increased testosterone in boys and increased estradiol in girls (Morrison et al., 2003). 
It has also been reported that growth hormone therapy causes a decline in LDL-C and HDL-C levels 
(Hilczer et al., 2008). These factors were also not adjusted for in the present study, and may have 
influenced the association obtained.  
 
In summary, there was a significant difference in frequency distribution of the MC3R Thr6Lys and 
Val81Ile between Black Africans and Mixed Ancestry ethnic groups. The two polymorphisms were 
associated with reduced anthropometric, blood pressure, and total cholesterol in Mixed Ancestry 
learners. The two MC3R polymorphisms have been extensively studied elsewhere and shown to be 
associated with different metabolic traits such as increased body fat, insulin resistance, high glucose 
oxidation and low lipid oxidation in different population groups. Further analysis is required to confirm 
the validity of the association observed in the present study, adjusting for population stratification, 
puberty and blood sex hormone levels.  
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3.1. BACKGROUND 
Leptin (LEP) and its receptor (LEPR), and the cocaine- and amphetamine-regulated transcript (CART) 
are among the peptides of the leptin-melanocortin pathway that are involved in energy homeostasis.  
The actions of LEP and ghrelin (GHRL) are reciprocal, resulting in opposite effects of energy 
regulation. Genetic disruption of molecules in the leptin-melanocortin system results in obesity in 
rodents and humans (Farooqi and O'Rahilly, 2005). 
 
Leptin and leptin receptor 
Leptin and its receptor were first discovered in obese (ob/ob) and diabetic (db/db) mice (Zhang et al., 
1994; Tartaglia et al., 1995). According to these animal models, ob/ob mice failed to produce a 
circulating factor from adipose tissue but their brains could respond to it when injected and would 
reduce food intake, while the db/db mice could not respond even when the peptide was produced by 
adipose tissue. It was later discovered that the rodent models had mutations in the ob (leptin) and ob-r 
(leptin receptor) genes (Vaisse et al., 1996).  
 
The LEP gene (LEP) exists as a single copy with three exons (Isse et al., 1995). The gene covers 20 
kb of chromosome 7q31.3. It is exclusively expressed in adipose tissue (Kline et al., 1997) and 
placenta (Gong et al., 1996) under hormonal and metabolic control. Studies in rodents and humans 
have demonstrated that hyperinsulinemia increases leptin levels (Cusin et al., 1995; Saladin et al., 
1995; Utriainen et al., 1996; Vidal et al., 1996) but there is no evidence that shows the role of insulin in 
regulation of leptin secretion (Slieker et al., 1996). In addition, LEP expression is regulated by cortisol, 
cAMP, and thiazolidinediones (De Vos et al., 1995; Slieker et al., 1996). LEP encodes a highly 
conserved 167-amino acid polypeptide, with the first 21 amino acids cleaved as a signal peptide (John 
and Bart, 1998). The remaining 146 residues form a protein of four antiparallel -helical and -sheet 
turns, with each helix 5-6 turns long (Fig 3.1). The helices are arranged in a left-handed helical bundle, 
and connected to each other by long crossover links: helix A connected to B, C to D; and B to C by a 
short loop (Fruhbeck, 2001). The helices lie between residues 3–26, 51–67, 71–94 and 121–143, 
while the four  turns lie between residues 39–42, 44–47, 104–107 and 106–119.  
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Figure 3.1. The helical loop of leptin. Letters A-E indicate helices joined by crossover links and a short 
loop. Adapted from Anubhuti and Arora, 2008. 
 
Several splice variants of LEPR exists, with the longest form consisting of 18 exons. Chung et al 
(1996) mapped the gene at chromosome 1p31. Unlike its ligand, the short forms of LEPR are 
ubiquitously expressed while the long splice variant is predominantly found in the hypothalamus 
(Mercer et al., 1996b; Schwartz et al., 1996c). The long splice variant encodes a 1165-amino acid 
membrane-spanning glycoprotein that consists of a signal sequence, two immunoglobulin domains, 
two cytokine receptor homology (CRH) domains each containing a Trp-Ser-X-Trp-Ser motif, 
fibronectin type III domains, a transmembrane region, and an intracellular domain (Fig 3.2) (White and 
Tartaglia,1996). 
 
LEP is secreted by the adipose tissue in response to increased fat storage (Masuzaki et al., 1995). 
Upon its release into the blood stream, LEP circulates and through its receptors, activates 
hypothalamic neurons expressing pro-opiomelanocortin (POMC) and CART located in the arcuate 
nucleus. It has been proposed that some of the LEPR short isoforms are involved in transportation of 
leptin in blood and its crossing of the blood-brain barrier (Devos et al., 1996) to sites of action. LEP’s 
physiological role is to suppress food intake and increasing energy expenditure. Due to the wide 
distribution of the LEPR in many tissues in its alternatively spliced forms, LEP has a variety of 
functions including regulation of angiogenesis and formation of new blood cells (Bouloumié et al., 
1998; Sierra-Honigmann et al., 1998), wound healing (Klingbeil et al., 1991; Frank et al., 2000), and 
the immune and inflammatory response (Loffreda et al., 1998; Maya-Monteiro et al., 2008).  
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Figure 3.2. Schematic representation of the human LEPR (Ob-R). Taken from Kamikubo et al., 2008. 
 
Ghrelin  
The ghrelin gene (GHRL) was mapped to chromosome 3p25–26, and was initially thought to contain 
four preproghrelin-coding exons (Kanamoto et al., 2004), but in 2007 Seim and Collet reported 
additional upstream exons. Human ghrelin is now reported to contain multiple first exons and is 
extensively spliced. Prepro-des-Gln14-ghrelin is a splice variant which is produced by employing an 
alternative splice site in exon 2, resulting in a 116 amino acid preproghrelin peptide (lacking one 
glutamine residue) that is likely to be processed and function in the same manner as the wild-type 
preproghrelin transcript (Hosoda et al., 2000; 2003). Another transcript with a deleted exon 3 exists 
that encodes a 91-amino acid preprohormone and lacks obestatin, and due to a change in reading 
frame, generates a novel 16 amino acid C-terminal sequence.  GHRL and obestatin are derived from 
a 117-amino acid precursor (proghrelin). Protease cleavage and acyl-modification at Ser-3 of the 
ghrelin precursor result in the production of a 28-amino-acid-long active acyl-modified ghrelin peptide. 
n-Octanoylation at Ser-3 is essential for GHRL activity (Fig. 3.3). Ghrelin exists in four different forms 
due to acylation at Ser-3: nonacylated, octanoylated (C8:0), decanoylated (C10:0), and decenoylated 
(C10:1). These forms are either 27- or 28-amino acid long with the former lacking Arg28 at the C-
terminus.  GHRL was discovered in the stomach where it is predominantly expressed as an 
endogenous ligand for the growth hormone secretagogue receptor (Kojima et al., 1999; Date et al., 
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2000; Ariyasu et al., 2001; Kojima M et al., 2001). GHRL-expressing cells were also detected in the 
duodenum, jejunum, ileum, and colon (Date et al., 2000). As in the stomach, the main molecular forms 
of intestinal ghrelin are n-octanoyl and des-acyl ghrelin. Pancreas also contains GHRL-producing 
cells, although it is not yet clear in which type of pancreatic cells (, , or  cells) GHRL is expressed 
(Wierup et al., 2002; Date et al., 2002; Wierup et al., 2004; Prado et al., 2004).  
 
Apart from regulating growth by stimulating secretion of growth hormone (Nakazato et al., 2001), 
GHRL has been shown to play a role in energy homeostasis as an orexigen. Ghrelin stimulates 
appetite through the melanocortin system, activating neuropeptide Y/agouti-related protein, and 
inhibiting POMC and CART neurons (Cowley et al., 2003; Korbonits et al., 2004). Several studies 
have supported the role of GHRL and its receptor in weight regulation, demonstrating that deficiency 
of one of these proteins results in resistance to diet-induced obesity (Asakawa et al., 2003; Wortley et 
al., 2005; Zigman et al., 2005; De Smet et al., 2006; Shearman et al., 2006; Vizcarra et al., 2007).  
 
 
 
 
 
 
Figure 3.3. Structure of human ghrelin. Ghrelin is a 28-amino acid peptide that is acylated at the third 
serine residue. Adapted from Kojima M et al., 2008. 
 
In addition to the mature ghrelin, a 23-amino acid peptide is derived from proghrelin. This peptide, 
which was named obestatin, is conserved in 11 mammalian species and is flanked by potential 
convertase cleavage sites (Zhang et al., 2005). The amidated obestatin was initially demonstrated in 
mice models to suppress food intake. However, a number of studies failed to reproduce obestatin's 
anorexigenic effect upon acute administration, and the reduction of body weight gain after chronic 
treatment (Gourcerol et al., 2007). According to Gourcerol and co-workers, this discrepancy between 
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the initial and subsequent studies was unlikely to be due to different experimental protocols, species 
or origin of the peptide used. For example, the function of obestatin was tested under conditions in 
which anorexigenic control substances such as cholecystokinin-8 (CCK-8), melanocortin-receptor 
agonist, MT-II, exendin, sibutramine or dexfenfluramine could produce the expected satiety effect or 
body weight reduction, or test control orexigenic peptide, such as ghrelin, increased food intake and 
body weight gain (Gourcerol et al., 2006; Holst et al., 2007; Nogueiras et al., 2007).  Furthermore, it is 
recognised that peptides that regulate meal initiation, meal-ending satiation, and inter-meal satiety 
modulate each other’s activities. Interaction of these peptides results in a more effective satiety 
response than when acting alone, or one peptide can counteract the effect of the other.  For example, 
studies have reported synergistic interactions between CCK and LEP at the level of capsaicin-
sensitive vagal afferents, which resulted in enhanced satiety response (Barrachina et al., 1997; Wang 
et al., 2000; Peters et al., 2006). Studies, however, have failed to demonstrate the interaction of 
ghrelin with obestatin as Zhang and co-workers (2005) initially reported. According to Zhang et al 
(2005), injections of obestatin prevented the body weight gain induced by peripheral injection of 
ghrelin in lean mice over a 1-week period.  Subsequent reports using central or peripheral injections of 
obestatin-ghrelin, however, failed to confirm such an interaction (Seoane et al., 2006; Nogueiras et al., 
2007). From these studies, it is clear that the role of obestatin in conveying a satiety signal and 
inhibiting upper gastrointestinal tract motility under basal- and ghrelin-stimulated conditions remains 
unconfirmed, instead a new central role has been proposed in regulation drinking behavior and sleep 
(Samson et al., 2007; Szentirmai and Krueger, 2006). 
 
Cocaine- and amphetamine-regulated transcript 
CART was first identified in rodents (rats) as a transcript regulated by cocaine and amphetamine 
(Douglass et al., 1996). Since the discovery of the rat transcript, CART genes (CARTPT) for human, 
mouse, bovine, and goldfish have been reported. The human CART covers approximately 2.0 
kilobases of chromosome 5q13-14 and consists of three exons (Douglass et al., 1996). CART is 
expressed in higher levels in the hypothalamus, frontal cortex, and midbrain. In addition to leptin, 
CART mRNA is regulated by lipopolysaccharides (Sergeyev et al., 2001; Volkoff et al., 2004), 
corticosterone (Hunter et al., 2005), and environmental toxins such as 2,3,7,8-tetrachlorodibenzo-p-
dioxin (anorexia inducer) (Fetissov et al., 2004). Unlike the rodent Cart, human CART is transcribed 
into proCART resulting in a 116-amino acid protein (Douglass et al., 1996). In humans the polypeptide 
is post-translationally processed at Lys 40-Arg 41 in a tissue-specific manner into an N-terminal 
peptide of 39 amino acids (CART1-39) and a C-terminal 48 residues (CART42-89) (Kuhar and Yoho, 
1999). A sequence variant that affects post-translational processing has been reported to have a 
possible role in obesity (Dominguez et al., 2004). CART as a protein consists mainly of turns and 
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loops spanned by a few stretches of antiparallel β-sheets (Fig 3. 4). The C-terminal part contains three 
disulfides bridges and is the biologically active part of the molecule (Ludvigsen et al., 2001).  
 
CART is a satiety factor that is closely associated with LEP and neuropeptide Y as demonstrated in 
animal studies (Kristensen et al., 1998). Animals deprived of food exhibited a significant decrease in 
the expression level of Cart messenger RNA in the arcuate nucleus. In obese animal models with 
disrupted Lep signaling, Cart mRNA was not detected. When recombinant Cart peptide was injected 
into animals, normal and starvation-induced feeding was inhibited, as well as feeding response 
induced by neuropeptide Y.  
 
 
Figure 3.4. Schematic representation of the human CART protein. Three turns could be identified: 
type I turn (residues 56-59), type II’ turn (residues 65-68), and type II turn (residues 76-79). Short 
antiparallel β-sheet is the most prominent secondary structural element, residues 62-64 and 69-71. 
Adapted from Wang Y et al., 2007 
 
Association with obesity and metabolic traits 
Polymorphisms in LEP and LEPR are known to confer susceptibility to polygenic obesity in both adults 
and children as demonstrated in several studies (Tables 3.1 and 3.2). However, replication of their 
association with obesity across different racial groups is still challenging. Three LEPR polymorphisms 
(Lys109Arg, Arg223Gln, Lys656Asn) have been extensively studied, but have not been replicated in 
their association with obesity and its related traits. Those studies showing a positive association reflect 
the distribution of LEPR in different tissues emphasizing the role of LEP in regulation of energy and 
the cardiovascular system. In LEP the most studied polymorphisms are located in the promoter region, 
and similar to LEPR, the association reported is related to energy homeostasis and the cardiovascular 
system. Polymorphisms in GHRL not only predispose to polygenic obesity (Ando et al., 2007; Zwirska-
Korczala et al., 2007), but have been associated with other components of metabolic syndrome 
(higher fasting glucose, lower high density lipoprotein, and higher triglyceride levels) and type 2 
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diabetes in both adults and children (Table 3.3). Only two GHRL polymorphisms have been 
extensively studied, and are located in the protein coding region. Unlike LEP, LEPR, and GHRL, few 
studies have investigated the role of CART in polygenic obesity. Only 6 polymorphisms have been 
studied in association with obesity and its related metabolic parameters (Table 3.4).  
 
It is evident from these association studies that polygenic obesity is due to a composite of 
polymorphisms in different genes, each polymorphism having variable physiological effects in various 
population groups depending on its interaction with background sequence variants. Variable 
physiological effects of polymorphisms may be a reflection of varying genotype and allele frequencies 
between populations from different ethnicities or geographical regions (Tiwari et al. 2008). It is 
therefore important to account for population stratification when association studies are conducted to 
eliminate its possible effect. Over- or -underestimation and a lack of association may also result from 
heterogeneity of the study group (Lewis 2002; Andersson et al. 2009). However, there are also 
confounding factors that may affect the outcome of association studies resulting in nonreplicable 
findings even among study groups of the same racial populations. One of the major contributing 
factors is the study design, for example cross-sectional and longitudinal studies may have different 
outcomes (Rey-Lopez et al., 2008). A good example is the study conducted by Davison et al. (2006), 
which did not observe any correlation between TV viewing and obesity when done cross-sectionally, 
but showed a positive association when it was done longitudinally. Other aspects of study design 
include sample size, power estimates, genome wide association vs. candidate/pathway approach, 
Hardy Weinberg Equilibrium, and genotyping success and errors (Andersson et al. 2009). 
 
Extensive investigation has been conducted on the contribution of environmental factors on obesity 
among South African ethnic population groups. However, there is limited data on genes and 
corresponding polymorphisms that predispose to obesity in both children and adults. The present 
chapter therefore, was aimed at analysing LEP, LEPR, GHRL, and CART for identifying 
polymorphisms and their possible association with obesity-related traits in two South African ethnic 
groups.  
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Table 3.1. Association studies for leptin gene (LEP) polymorphisms and metabolic parameters in different population groups, worldwide. 
 
Polymorphism Population group Phenotype Association Reference 
Gln25Gln  Japanese (n= 64) Obesity No Shigemoto et al., 1997 
-2549C>A, -1817C>T Caucasians (n=117) Leptin levels Yes Mammes et al., 1998 
-2548G/A Caucasian (n=423) Obesity, leptin levels Yes Mammes et al., 2000 
TTTC repeat in the promoter region American Samoan, adults 
(n= ?) 
BMI Yes McGarvey et al., 2002 
-2549C>A French, Caucasian, girls 
(n=233) 
Leptin level and body fat Yes Le Stunff et al., 2000 
Gln25Gln Japanese (n=185) Obesity Yes Ohshiro et al., 2000 
–2548 G>A European Caucasians, 
adults (n=308) 
Diet-related obesity risk Yes Nieters et al., 2002 
19A>G Brazilian, adults (n=336) BMI No Mattevi et al., 2002 
Tetranucleotide repeat in the 3’ UTR Japanese, adults (n=205) Hypertension Yes Shintani et al., 2002 
19A>G Italian, adults (n=205) Obesity-related traits No Lucantoni et al., 2000 
-2548G>A Chinese, adults (n=128) Obesity, Fat distribution Yes Zhang et al., 2003 
19A>G + Lys109Arg Caucasian and African 
Americans, adults (n=540) 
PA, insulin sensitivity Yes Lakka et al., 2004 
-2549C>A Chinese, adults (n= 269) Fasting leptin and type 2 diabetes Yes Ren et al., 2004 
Tetranucleotide repeat in the 3’ UTR Italian, adults (n= 218) Leptin levels No Porreca et al., 2005 
19A>G French, adults (n= 1195) MetS components No Meirhaeghe et al., 2005 
19A>G, -2548G>C French, adults (n=65) Weight loss, leptin levels Yes Poitou et al., 2005 
19A>G + Lys656Asn Caucasians respiratory quotient Yes Loos et al., 2005 
TTTC repeat in the promoter region Italian, adults (n= 325) Hypertension No Maestrini et al., 2006 
-2548G>A Spanish, adults (n = 909) Obesity No Portoles et al., 2006 
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Table 3.1. continues 
Polymorphism Population group Phenotype Association Reference 
3'HVR Brazilian, adults (n = 210) BMI and WC, leptin levels Yes Hinuy et al., 2006 
-2548G>A Taiwanese aborigines (n = 
448) 
Morbid obesity Yes Wang et al., 2006 
19A>G African- and Caucasian 
American 
(n= 13 405) 
BMI, body weight, leptin levels Yes Hart Sailors et al., 2007 
-2548G>A Chinese (n= 102) BMI Yes Zhang et al., 2007 
g.65875652A>G, g.65881417C>G, 
g.65868975G>A 
European Caucasian, 
adults (n = 17,357) 
Snacking behaviour Yes de Krom et al., 2007 
+4950G>A, +4998A>C Korean, adults (n= 1284) SBP and LDL-C Yes Han et al., 2008 
Tetranucleotide repeat in the 3’ UTR n=75 Obesity Yes Gardezi et al., 2008 
19A>G  Japanese (n= 3,653) Sweet preference Yes Mizuta et al., 2008 
c.-29+711G>C Indian (n=154) Drug-induced weight gain Yes Srivastava et al., 2008 
–2548G>A Finnish, adults (n=78) Overweight and obesity Yes Iciek et al., 2008 
–2548G>A Finnish, adults (n= 1284) Obesity Yes Drews et al., 2008 
19A>G +Arg223Gln European Caucasians, 
adults (n= 628) 
HDL-C Yes Souren et al., 2008 
17SNPs Caucasian American, (n= 
695) 
Hypertension Yes Ma et al., 2009 
–2548 G>A Tunisian (n=480) SBP Yes Ben Ali et al., 2008 
rs791601 Caucasian (n-=10260) BMI Yes Chung et al. 2009 
–2548 G>A European Caucasians, 
adults (n=200) 
Obesity No Gregoor et al., 2009 
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Table 3.1. continues 
 
Polymorphism Population group Phenotype Association Reference 
–2548 G>A Brazilian, adults (n= 140) Blood pressure, high insulin levels Yes Genelhu et al., 2009 
–2548 G>A Austronesian (n= 745) Weight, BMI No Furusawa et al., 2009 
Telomere Indian (n= 93) Hypertension Yes Das et al., 2009 
–2548 G>A European Caucasian (n= 
103) 
Hunger and satiety No den Hoed et al., 2009 
-2548G>A Not available TC/HDL-C ratio Yes Gregoor et al., 2010 
-2548G>A Finnish, adults (n= 48) Body fat, BMI, PA No Huuskonen et al., 2010 
19A>G Czech Caucasian (n= 140) BMI, percentage body fat, skinfold 
thickness, and eating pattern 
Yes Bienertova-Vasku et al., 
2010 
–2548 G>A Romanian (n=202) Leptin levels Yes Constantin et al., 2010 
Abbreviations: BMI, body mass index; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; MetS, metabolic syndrome; 
PA, physical activity; SBP, systolic blood pressure; TC/HDL-C ratio, total cholesterol/ high density lipoprotein cholesterol ratio 
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Table 3.2. Association studies for leptin receptor gene (LEPR) polymorphisms and metabolic parameters in different population groups, 
worldwide. 
Polymorphism Population group Phenotype Association Reference 
Lys109Arg Caucasian(n= 361) BMI  No Echwald et al., 1997 
Lys109Arg Asian (n= 115) BMI  No Matsuoka et al., 1997 
Lys109Arg Pima Indians (n= 20) percentage body fat  No Thompson et al., 1997 
Arg223Gln British Caucasians (n= 322) BMI No Gotoda et al., 1997 
Arg223Gln Pima Indians (n= 20) percentage body fat  No Thompson et al., 1997 
Arg223Gln Caucasian(n= 361) BMI  No Echwald et al., 1997 
Arg223Gln Asian (n= 115) BMI  No Matsuoka et al., 1997 
Lys656Asn British Caucasians (n= 322) BMI Yes Gotoda et al., 1997 
Lys656Asn Caucasian(n= 361) BMI  No Echwald et al., 1997 
Lys656Asn Asian (n= 115) BMI  No Matsuoka et al., 1997 
Lys109Arg British Caucasians (n= 322) BMI No Gotoda et al., 1997 
Arg223Gln Asian(n= 553) Obesity  No Endo et al. 2000 
Lys109Arg Swedish, adults(n= 284) BMI Yes Rosmond et al., 2000 
Arg223Gln Swedish, adults(n= 284) Blood pressure Yes Rosmond et al., 2000 
Lys109Arg Greek, adults  (n= 118) BMI, percentage fat mass No Yiannakouris et al., 2001 
Lys109Arg Caucasians, adults (n= 358) Insulin, glucose tolerance Yes Wauters et al., 2001 
Arg223Gln Greek, adults  (n= 118) BMI, percentage fat mass Yes Yiannakouris et al., 2001 
Lys656Asn Greek, adults  (n= 118) BMI, percentage fat mass No Yiannakouris et al., 2001 
Lys656Asn Caucasians, adults (n= 358) Insulin, glucose tolerance Yes Wauters et al., 2001 
Arg223Gln Brazilian (n= 335) BMI  Yes Mattevi et al., 2002 
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Table 3.2. continues 
 
Abbreviations: ADRB2, adrenergic beta-2-receptor gene; BMI, body mass index; LEPR, leptin receptor gene; RMR, resting metabolic rate; RQ, 
respiratory quotient; TC, total cholesterol 
WC, waist circumference  
 
 
 
 
 
 
 
Polymorphism Population group Phenotype Association Reference 
Lys656Asn Caucasians RQ Yes Loos et al., 2005 
Lys656Asn French, adults (n= 13000) Insulin resistance No Phillips et al., 2010 
Lys656Asn + 19A>G Caucasians RMR Yes Loos et al., 2005 
Arg223Gln Spanish, adults (n = 909) Obesity Yes Portoles et al., 2006 
Lys109Arg Korean (n= 1463) BMI Yes Park et al., 2006 
Lys109Arg Finnish (n= 487) PA, blood pressure Yes Kilpeläinen et al., 2008 
Arg223Gln+ 19G>A European Caucasians, adults (n= 628) Birth weight, HDL-C Yes Souren et al., 2008 
Arg223Gln Caucasians, adults (n= 7596) BMI change Yes Gallicchio et al., 2009 
Arg223Gln Tunisian (n= 692) Leptin level, BMI Yes Ben et al., 2009 
Arg223Gln Caucasians, adult (n= 372) Chronic heart failure Yes Bienertová-Vask et al., 2009 
Arg223Gln European Caucasians, adults (n= 200) Obesity Yes Gregoor et al., 2009 
Lys109Arg 167 African and 184 Caucasian Americans Fat  Yes Iuliano et al., 2009 
Lys109Arg Finnish, adults (n= 526) BMI, TC Yes Saukko et al., 2010 
Lys109Arg Austronesian (n= 745) BMI No Furusawa et al., 2010 
Lys109Arg European Caucasians, adults (n= 2379) Leptin levels Yes Sun et al., 2010 
Arg223Gln Finnish, adults (n= 526) SBP Yes Saukko et al., 2010 
Arg223Gln European Caucasians, adults (n= 2379) Leptin levels Yes Sun et al., 2010 
Arg223Gln Japanese, adults (n= 4,193)  LEPR+ADRB2, obesity Yes Pereira et al., 2011 
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Table 3.3. Association studies for ghrelin gene (GHRL) polymorphisms and metabolic parameters in different population groups, worldwide. 
 
Polymorphism Population group Phenotype Association Reference 
Arg51Gln, Leu72Met Swedish, adults (n= 219) BMI Yes Ukkola et al., 2001 
Arg51Gln, Leu72Met European Caucasian (n= 308) Obesity No  Hinney et al., 2002 
Leu72Met British Caucasian, children (n= 70) BMI, insulin sensitivity Yes Korbonits et al., 2002 
Arg51Gln Finnish (n=1045) Type 2 diabetes, hypertension Yes  Poykko et al., 2003 
Leu72Met Finnish (n=780) Type 2 diabetes No  Ukkola and Kesäniemi, 2003 
Leu72Met Italian (n= 249) Larger gestational weight, and 
lower BMI in controls 
Yes Vivenza et al., 2004 
Arg51Gln, Leu72Met Italian children and adolescents (n= 
600) 
Early age of obesity onset Yes Miraglia del Giudice et al., 
2004 
Leu72Met Caucasians (n= 2413) MetS  No Bing et al., 2005 
6 SNPs Caucasians (n= 1347) Type 2 diabetes, obesity No Larsen et al., 2005 
Arg51Gln, Leu72Met Amish (n= 856) MetS Yes Steinle et al., 2005 
Leu72Met Korean, children (n= 222) Obesity, Other metabolic 
parameters 
No Jo et al., 2005 
Arg51Gln, Leu72Met Caucasian, adults (n= 292) Anorexia nervosa, bulimia nervosa No Monteleone et al., 2006 
Leu72Met , 3056 T > C Caucasian, adults (n= 636) Eating disorders Yes Ando et al., 2006 
Leu72Met Korean, children (n= 132) Diabetic nephropathy, TC Yes Lee et al., 2006 
Leu72Met Japanese (n= 2238) BMI, WC, WHR Yes Kuzuya et al., 2006 
g.-1062G>C Korean (n= 1401) HDL-C Yes Choi et al., 2006 
Leu72Met French (n= 114) Anorexia nervosa Yes Dardennes et al., 2006 
Leu72Met Finnish (n= 1029) Type 2 diabetes Yes Mager et al., 2006 
-501A>C Finnish (n= 1045) BMI, WC Yes Vartiainen et al., 2006 
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Table 3.3. continues 
Polymorphism Population group Phenotype Association Reference 
5 SNPs Caucasian adults (n= 1377) Height No Gueorguiev et al., 2007 
3056 T>C Japanese (n= 264) BMI, fat mass, WC, skinfold 
thickness, HDL-C 
Yes Ando et al., 2007 
8 SNPs European Caucasian (n= 3380) MI, CAD  No Baessler et al., 2007 
Leu72Met Finnish (n= 487) PA, weight, WC Yes Kilpeläinen et al., 2008  
-501A/C Finnish (n= 487) PA, HDL-C Yes Kilpeläinen et al., 2008 
Arg51Gln Chinese (n= 225) HDL-C Yes Xuan Xie et al., 2008  
Leu72Met Chinese (n= 854) MetS Yes Xu et al., 2008  
g.10850C>T, g.11382T>G European Americans (n= 1,982)  BMI Yes Chung et al., 2009 
Leu72Met European and African American (n= 
351) 
Fat accumulation in the liver No Iuliano et al., 2009 
5 SNPs British Caucasian (n= 610) Type 2 diabetes No Garcia et al., 2009  
Leu72Met European Caucasian (n= 850) Type 2 diabetes Yes Berthold et al., 2009  
g.8113G>A, g.7267A>C European Caucasian (n= 2632) Hypertension Yes  Berthold et al., 2010  
Abbreviations: BMI, body mass index; CAD, coronary artery disease HDL-C, high density lipoprotein cholesterol; MetS, metabolic syndrome; MI, 
myocardial infarction; PA, physical activity; TC, total cholesterol; WC, waist circumference; WHR, waist-hip-ratio;  
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Table 3.4. Association studies for cocaine- and amphetamine-regulated transcript gene (CART) polymorphisms and metabolic parameters 
in different population groups, worldwide. 
Abbreviations: BMI, body mass index; LDL-C/HDL-C ratio, low density lipoprotein cholesterol/high density lipoprotein cholesterol; PA, physical activity 
 
 
 
 
 
 
 
 
 
Polymorphism Population group Phenotype Association Reference 
c.499delA, g.1475A>G Danish Caucasian (n= 191) Obesity No Challis et al., 2000 
c.499delA, g.1475A>G Italian, children and 
adolescents (n= 130) 
Obesity No del Giudice et al., 2001 
Leu34Phe Italian, children and 
adolescents (n= 130) 
Obesity Yes del Giudice et al., 2001 
c.499delA Chinese (n= 401) TC Yes Fu et al., 2002 
-156T>C Japanese (n= 528) BMI Yes Yamada et al., 2002 
-1475A>G + -2745C>T Caucasian (n= 669) BMI, PA Yes Loos et al., 2004 
-A1475A>G  PA Yes Loos et al., 2004 
-3608C>T French (n= 840) LDL-C, LDL/HDL ratio Yes Vasseur et al., 2006 
-3608T>C French (n= 660) Obesity Yes Guerardel et al., 2005 
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3.2. MATERIALS AND METHODS 
 
3.2.1. Study group 
The study group for this part of the study was selected as described in Chapter 2. Briefly, learners 
were classified according to their weight status as obese, overweight and normal using the 
International Obesity Task Force criteria as reported by Cole et al (2000). Due to the limited number of 
samples obtained for genetic analyses, 189 (89 obese-overweight, and 100 normal) individuals 
between 13-17 years of age were selected for this study. The case group (89 obese-overweight 
learners) was made up of 37 Black Africans and 52 Mixed Ancestry learners whilst the age-, gender-, 
and race-matched normal weight learners consisted of 42 Black Africans and 58 Mixed Ancestry 
learners. Due to the limited number of participants who chose to give venous blood for DNA analysis, 
the sample size for this part of the study decreased from the original number (431 learners) that was 
obtained and genotyped in chapter 2. For this analysis the sample size was calculated as follows: if a 
risk allele frequency of a specific polymorphism (e.g. c.517A>G) in a general population is 4%, then 
we had 80% power to detect, at a 5% significant level, a risk allele frequency of 16% in cases.  
 
3.2.2. Data collection 
Anthropometric measurements (body weight and height; waist and hip circumference; waist-hip ratio 
and skinfold thickness measurements etc), were performed on all learners as described in Chapter 2. 
Body Mass Index (BMI) was calculated as weight per square meter (kg/m2). Three readings were 
taken for blood pressure, waist and hip circumferences. Skinfold thickness was measured at three 
different body sites, namely subscapular, supra-ileac and upper arm.  Blood glucose, lipid levels and 
blood pressure have been previously described (please refer to chapter 2). 
 
3.2.3. Genetic analyses  
The coding regions (including splice junctions) of CART, GHRL, LEP, and three exons (exons 2, 4, 
and 12) of LEPR were amplified from genomic DNA extracted from either whole blood collected in 
vacutainer Ethylenediamine Tetra-acetic Acid (EDTA) tubes or capillary blood collected onto Whatman 
FTA® Cards (Merck Laboratories, United Kingdom) as described in chapter 2.  
3.2.3.1. Identification of sequence variants in leptin and leptin receptor genes (LEP and LEPR) 
Polymerase chain reaction (PCR): LEP consists of three exons that form a transcript of 3420 bp 
long, but with only 504 bp that is translated into a protein sequence. Oligonucleotide primers (Table 
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3.5) were designed for amplifying the protein coding region that spans exon 1, 2 and part of exon 3 
(including splice junctions) using Primer3Plus and Integrated DNA Technology (IDT) freely available 
software. The longest form of LEPR consists of 18 exons.  Due to the large number of polymorphisms 
identified across the entire LEPR gene, we selected three single nucleotide polymorphisms (SNP) 
(Arg109Lys, Arg223Gln, and Lys656Asn) that have been clinically associated with obesity and its 
related metabolic traits. Arg109Lys, Arg223Gln, and Lys656Asn are respectively located in exons 2, 4, 
and 12. The three LEPR exons were amplified using oligonucleotide primers  (Table 3.6) designed by 
the Primer3Plus and Integrated DNA Technology (IDT) freely available software (with the exception of 
LEPR exon 4 primers that were taken from Farooqi et al., 2007), and Bioline Taq DNA polymerase 
PCR kit. Designed primers were checked for occurrence of dimers and hairpin loops using the 
Integrated DNA Technology (IDT) freely available software. Furthermore, primers were submitted to 
the National Centre for Bioinformatics Institute (NCBI) primer Basic Alignment Search Tool (BLAST) 
for possible non-specific binding. Primer sequences were analysed for the presence or absence of 
polymorphisms that may inhibit amplification of corresponding gene regions. The PCR protocol was 
prepared as follows: a total volume of 50 
l reaction mixture contained 0.25 
g/
l DNA template, 0.24 

M of both forward and reverse primers, 1x buffer, 1.0 mM MgCl2, 0.3 mM dNTP, 0.4 units DNA 
polymerase, and distilled H2O added to a final volume. LEP and LEPR gene regions were amplified in 
a Perkin Elmer 2720 thermal cycler (Applied Biosystems) as follows: initial denaturation at 94°C for 3 
minutes, 35 cycles of denaturation at 94°C for 30 seconds, annealing at 50-53°C for 45 seconds, 
extension at 72°C for 45 seconds, and final extension at 72°C for 5 minutes. All amplicons were 
electrophoresed on a 2% agarose gel and visualised in a GelDoc system (BioRad). 
 
Table 3.5. Oligonucleotide primers and their characteristics for amplifying leptin gene (LEP) 
Primer Name Sequence (5’-3’) GC content (%) Tm 
(°C) 
 
Ta 
(°C) 
Product size 
(bp) 
LEP_1F CGGGAGCTGGCGCTAGAAAT 60.0 59.7 
53 206 LEP_1R CGGGATCCAGAGTTGTGTGGG 61.9 59.7 
LEP_2F GATGGGTGTATTCTGAGATACCG 47.8 59.7 
53 291 LEP_2R GCCACTAGGAGCCAGTGCT 63.2 60.6 
LEP_3F GATTCCTCCCACATGCTGA 52.6 59.6 
53 496 LEP_3R TGCAATGCTCTTCAATCCTG 45.0 59.9 
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Table 3.6. Oligonucleotide primers and their characteristics for amplifying the leptin receptor gene 
(LEPR) 
Primer Name Sequence (5’-3’ GC content Tm 
°C 
Ta 
°C 
Product size 
(bp) 
LEPR_SNP2F CATGCCACCAAATTCAACCT 45.5 60.8 52 346 
LEPR_SNP2R TCATAGCCATAAGACATCTATTTCA 32.0 57.1 
LEPR_4BF GTGTTCATGAATGTTGTGAAT 33.3 57.2 50 226 
LEPR_4BR AGCTAGCAAATATTTTTGTAAGCAAT 26.9 60.8 
LEPR_SNP12F AGGACCTGAATTTTGGAGAA 40.0 56.3 52 176 
LEPR_SNP12R ATTGTTGAGCTTTCCGAAGA 40.0 57.5 
 
Genotyping of case and control groups: Participating learners were genotyped for the LEPR-
Arg223Gln and LEP-19G>A by cutting the amplicons with Msp I (Hae III) and MspA1 I (Promega, 
USA), respectively (Gotoda et al., 1997). The LEPR-exon 4 fragment containing the Arg223Gln 
polymorphisms is 226-bp long. The A to G substitution created a Hae III recognition site, and digesting 
exon 4 fragment with Hae III produced two fragments of 125 and 101 bp long. The restriction enzyme 
digest was performed in a volume of 20 
l that contained 0.5 
l (10 U/
l) of Msp I, 2 
l of restriction 
enzyme 10x buffer, 1 
l of bovine serum albumin (1 
g/
l), 10 
l of amplicon, and nuclease-free water 
to a required total volume. The reaction mixture was incubated at 37°C for 4 hours. Similarly, the A to 
G substitution in LEP exon 1 created a recognition site for MspA1 I, producing two fragments of 114- 
and 92-bp long when the amplicon (206-bp long) was digested with the restriction enzyme. The 
restriction enzyme digest was performed in a volume of 20 
l as described above, and the reaction 
mixture incubated overnight at 37°C. Digested fragments were mixed with a bromophenol blue 
(appendix D) loading dye and GelRed™ staining solution (Inqaba Biotechnology), and separated 
electrophoretically in 3% agarose gels. Amplicons with each genotype were verified by sequencing.  
Amplicons of the remaining exons were sequenced as described in section 2.6.2.1. 
 
3.2.3.2. Identification of sequence variants in cocaine- and amphetamine-related transcript, and 
ghrelin genes (CART and GHRL) 
PCR: CART and GHRL exons (3 of each gene) were analysed by PCR, and subsequently underwent 
automated sequencing. The CART gene consists of three exons that form a transcript of 915 bp long, 
but with only 351 bp that is translated into a protein sequence. Oligonucleotide primers (Table 3.7) 
were designed for amplifying the protein coding region that spans exon 1, 2 and part of exon 3 using 
the Primer3Plus freely available software. The full-length preproghrelin gene contains four exons, with 
exon 2 spliced to generate a 117 amino acid preproghrelin peptide. Oligonucleotide primers were 
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designed for amplifying exon 2-4 (Table 3.8). Designed primers were checked for occurrence of 
hetero- and homodimers, and hairpin loops using the IDT software. Furthermore, primers were 
submitted to the NCBI-primer BLAST to check for non-specific binding. The two genes were amplified 
using GoTaq Flexi PCR kit (Promega, USA) as follows: a total volume of 50 
l reaction mixture 
contained 0.25 
g/
l DNA template, 0.24 
M of both forward and reverse primers, 1x buffer, 1.0 mM 
MgCl2, 0.3 mM dNTP, 1.25 units DNA polymerase, and dH2O added to a final volume. The two genes 
were amplified in a Perkin Elmer 2720 thermal cycler (Applied Biosystems) as follows: initial 
denaturation at 95°C for 3 minutes, 35 cycles of denaturation at 95°C for 30 seconds, annealing at 
54°C and 55°C (depending on the primer set) for 45 seconds, extension at 72°C for 45 seconds, and 
final extension at 72°C for 5 minutes. All amplicons were electrophoresed on a 2% agarose gel and 
visualised in a GelDoc system (BioRad).  
 
Genotyping of case and control groups: Participating individuals were genotyped for GHRL-
Leu72Met polymorphism by digesting amplicons with BseN I (Bsr I) restriction enzymes (Fermentas) 
according to the manufacturer’s instructions. The C to A substitution abolished a BseN I recognition 
site, and when the 598-bp amplicon with the wildtype allele was digested, two fragments of 501- and 
97-bp long were obtained while the minor allele was uncut. The protocol for digestion of amplicons 
was as follows: 16 
l of nuclease-free water was mixed with 2 
l of 10x restriction enzyme buffer, 0.17 
units of BseN I, and 10 
l of amplicon. After mixing, the reaction mixture was incubated at 65°C 
overnight. Digested fragments were mixed with a bromophenol blue (appendix) loading dye and 
GelRed™ staining solution (Inqaba Biotechnology), and separated electrophoretically in 3% agarose 
gels. Amplicons with each genotype were verified by sequencing. Amplicons of the remaining exons 
were sequenced as described in section 2.6.2.1. 
 
Table 3.7. Oligonucleotide primers and their characteristics for amplifying the cocaine- and 
amphetamine related transcript gene (CART). 
Primer Name Sequence (5’-3’ GC content Tm 
(°C) 
 
Ta 
(°C) 
Product size 
(bp) 
CART1F CTGTTCTCTGCGCTCTAGCC 60.0 60.4 55.0 494 
CART1R CCCTGACTCTGGGAATAGGA 55.0 59.1 
CART2F GTCCGGGGCTCCTTATAACT 55.0 59.4 54.0 242 
CART2R ACGATTCAAGGCGGTGTACT 50.0 59.6 
CART3F GAGACTTGCCTGTTGGGAAC 55.0 59.7 54.0 247 
CART3R AACTCCAGGGAGGAAGGTGT 55.0 60.0 
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Table 3.8. Oligonucleotide primers and their characteristics for amplifying the ghrelin gene (GHRL). 
Primer Name Sequence (5’-3’) GC content Tm 
(°C) 
Ta 
(°C) 
Product size 
(bp) 
GHRL_2F GAGCAAGCTCAGAGGCACAT 55.0 60.7 55 598 
GHRL_2R CTGTTCACTGCCACCTCTCC 60.0 60.9 
GHRL_3F CAGAGCCCCCTTTGAGATG 57.9 60.7 55 247 
GHRL_3R CCACAGAGTGAACTCCCATGT 52.4 60.0 
GHRL_4F CCACCATTACATCCCACCTC 55.0 60.0 55 380 
GHRL_4R TGGCCTTGCTACTTGTCCTT 50.0 59.9 
 
 
3.2.4. Statistical analyses 
All statistical analyses were executed by Prof Lize van der Merwe, a Biostatistician at the Medical 
Research Council of South Africa. Data was analysed using the freely available programming 
language R (R Foundation for Statistical Computing, Vienna, Australia. ISBN 3-900051-07-0; URL: 
www.r-project.org). In order to test association between relevant clinical variables and genetic markers 
(genotype and allelic), and to determine linkage disequilibrium (LD) and Hardy-Weinberg equilibrium 
(HWE), specific packages DGC-genetics was used as described in chapter 2.  
 
Statistical analyses of genetic data: Logistic regression was used to model obesity category.  The 
models were used to assess the obesity-genotype and -ethnic associations in joint models for each 
polymorphism; as well as to select factors included in an optimal model for obesity susceptibility. 
Logistic regression was also used to model the ethnic group and test its association with each 
polymorphism, while adjusting for obesity status.   
 
An optimal model for obesity susceptibility was selected using the following backwards selection 
procedure:  obesity susceptibility was modeled as a function of all the polymorphisms, age, gender 
and ethnicity. Predictors which contributed least to the model, judging by Akaiki’s Information Criterion, 
were removed and the model tested again.  Candidates were discarded one-by-one, until the model 
could not be improved.  Linear models were used to test association between quantitative traits and 
genotypes, alleles (additive) and inferred haplotypes. We inferred haplotypes from 2, 3 and 4 
polymorphisms adjacent to each other inside each gene for analysis.  Genotype-association (2 
degrees of freedom) was tested by coding genotype as a categorical factor as described by Cordell 
  111
and Clayton (2005) and additive allelic association (1 degree of freedom) with a numerical variable, 
counting the number of minor alleles. Haplotype analysis was done using methods described by 
Schaid and co-workers (2002). All models were adjusted for ethnicity, age and gender, where possible 
and replicated measurements were controlled for as random effects. All effect sizes and p-values are 
derived from the models described here.  
 
Multiple comparison consideration: P-values obtained from all analyses were not corrected for 
multiple testing because it has been suggested that correction is too conservative when several 
associations are tested in the same group of individuals (Nyholt, 2004), and might not be appropriate 
in a situation such as this, where there is prior evidence that such effects exist (Perneger, 1998). Our 
tests are not of independent null hypotheses as required by Benjamini, Yoav; Hochberg, Yosef (1995), 
as the polymorphisms are in tight LD with each other, and we explored different (genotype and 
additive allelic) models with individual variants, combinations of genotypes, and combination of alleles 
from the same polymorphisms. P-values below 5% are described as statistically significant.  The effect 
sizes and 95% confidence intervals reported in the results and tables were calculated from each 
specific model.  
 
3.3. RESULTS 
Clinical characteristics of participants according to race are summarized in Table 3.9. By selection, 
anthropometric obesity traits were significantly higher in obese-overweight learners. There were 
significant interactions between obesity susceptibly and ethnicity on weight, WC and MUAC. For WC 
and MUAC but not weight, the difference between obese and normal was larger in Mixed Ancestry 
than in Black African learners.  
 
Selected regions of LEP, LEPR, CART, and GHRL were successful amplified, and expected fragment 
size was obtained for each primer set (Figure 3.5-3.8). Sequence analysis of amplicons generated for 
selected regions detected the following polymorphisms: LEP (19A>G: rs2167270, Lys36Arg: 
rs111650508, Val94Met: rs17151919); GHRL (Leu72Met: rs696217); CART (c.160-33G>A: 
rs16871443, c.499delA: rs5868607, and c.517A>G: rs41271753) (Table 3.10). Different techniques 
such as ASREA (Figure 3.9) and sequencing (example of genotypes in Figures 3.10-3.12) were used 
to genotype the selected study groups. In addition to the above mentioned polymorphisms, the study 
groups were genotyped for the LEPR polymorphisms, namely, Arg109Lys, Arg223Gln, and 
Lys656Asn.  
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Table 3.9. Anthropometric characteristics and metabolic outcomes of obese-overweight and normal Black African and  
Mixed Ancestry South African learners. 
 
 Variables Obese-overweight Normal weight P-values 
  Black Africans Mixed ancestry Black Africans Mixed ancestry Obesity Race Interaction 
n 37 52 42 58    
Age 15.1 ± 1.5 15.3 ± 1.5 15.0 ± 1.7 14.7 ± 1.5 0.6530 0.4980 0.3890 
Gender, male 
(%) 5 (14) 9 (17) 8 (19) 14 (24) 0.5098 0.5450 0.9904 
Weight (m) 68.9 ± 8.5 72.3 ± 13.7 52.4 ± 6.7 49.2 ± 8.0 < 0.0001 0.1176 0.0253 
BMI (kg) 27.6 ± 3.1 28.4 ± 4.4 20.7 ± 1.9 19.9 ± 2.3 < 0.0001 0.1854 0.0789 
WC (cm) 82.8 ± 7.9 85.7 ± 10.3 70.1 ± 5.5 67.0 ± 5.6 < 0.0001 0.0308 0.0062 
Hip (cm) 103.2 ± 6.6 106.4 ± 8.7 89.6 ± 5.6 88.8 ± 7.6 < 0.0001 0.5880 0.0920 
Midupperarm 
(cm) 28.8 ± 2.5 29.1 ± 3.1 24.0 ± 2.1 23.0 ± 2.1 < 0.0001 0.0187 0.0474 
FBG(mmol/L) 3.91 ± 0.65 4.14 ± 0.75 3.85 ± 0.84 3.96 ± 0.74 0.6865 0.4491 0.6264 
TC (mmol/L) 3.68 ± 1.08 3.73 ± 0.81 3.55 ± 0.77 3.73 ± 0.84 0.5074 0.3106 0.6204 
TG (mmol/L)* 0.78 (0.57, 1.11) 0.65 (0.57, 1.00) 0.66 (0.57, 0.95) 0.62 (0.57, 0.81) 0.5413 0.0579 0.9504 
HDL-C (mmol/L) 1.01 ± 0.33 0.89 ± 0.25 1.14 ± 0.38 1.06 ± 0.35 0.0816 0.2016 0.7062 
SBP (mm Hg)* 114 (106, 123) 115 (106, 120) 106 (95, 118) 108 (94, 117) 0.0110 0.9540 0.8314 
DBP (mm Hg)* 68 (61, 76) 69 (64, 73) 64 (56, 74) 65 (59, 73) 0.0399 0.5182 0.6899 
Summary statistics are mean±SD unless indicated otherwise. P-values are for joint model, so each is adjusted for the other.  
*Triglycerides, Diastolic and Systolic blood pressure were summarised as median, (interquartile range) and were log-transformed to symmetry  
for tests. Abbreviations: BMI, body mass index; FBI, fasting blood glucose; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-cholesterol;  
SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; WC, waist circumference.  
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Figure 3.5. A representative 2% agarose gel of LEP exons 1-3. The product size for each exon was 
as follows: exon 1= 206 bp, exon 2= 291 bp, exon 3= 496 bp. A 100-bp DNA ladder (DL) was loaded 
alongside the amplicons to confirm their size. A negative control (NC) (PCR solution with water as a 
template) was included in every polymerase chain reaction.  
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Figure 3.6. Representative 2% and 3% (first and third pictures from left) agarose gels of LEPR exons 
2, 4, and 12. The gels show polymerase chain reaction products yielded from the sets of primers used 
to amplify selected regions of LEPR exons 2 (246 bp), 4 (226 bp), and 12 (176 bp). The lane marked 
DL contains a 100bp DNA ladder to confirm sizes of amplicons. A negative control (NC) (PCR solution 
with water as a template) was included in every polymerase chain reaction.  
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Figure 3.7. A representative 2% agarose of GHRL exons 2-4. The gel shows polymerase chain 
reaction products yielded from the sets of primers used to amplify selected regions of GHRL exons 2-
4. The product size for each exon was as follows: exon 2= 598 bp, exon 3= 247 bp, exon 4= 380 
bp.The lane marked DL contains a 100bp DNA ladder. A negative control (NC) (PCR solution with 
water as a template) was included in every polymerase chain reaction.  
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Figure 3.8. Representative 2% agarose gels of CART exons 1-3. The gel shows the polymerase chain 
reaction-based amplification of CART exons 1-3.  A 100-bp DNA ladder (DL) was used for confirming 
the PCR product size. The product size for each exon was as follows: exon 1= 494 bp, exon 2= 242 
bp, exon 3= 247 bp. A negative control (NC) (PCR solution with water as a template) was included in 
every PCR.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Representative 3% agarose gels showing the allele-specific restriction enzyme analysis of 
LEP 19A>G (A), LEPR Arg223Gln (B), and GHRL Leu72Met (C). LEP-exon 1, LEPR-exon 4, and 
GHRL exon 3 were amplified and subjected to restriction enzyme digest with BseN I, Msp I and 
MspA1 I, respectively. Three different genotypes were generated as indicated. 
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Table 3.10. Genes analysed in the present study and respective polymorphisms identified with their 
corresponding positions. 
Gene Sequence variants SNP identification number Gene region 
LEP c.19G>A 
Lys36Arg (c.164A>G) 
Val94Met (c.385G>A) 
rs2167270 
rs111650508 
rs17151919 
Exon 1 
Exon 2 
Exon 3 
GHRL Lue72Met (c. 214C>A) rs696217 Exon 3 
CART c.160-33G>A  
c.499delA 
c.517A>G 
rs16871443 
rs5868607 
rs41271753 
Intron 1 
Exon 2 
3’UTR  
Abbreviations: GHRL, Ghrelin; CART, cocaine- and amphetamine-regulated transcript; LEP, leptin. 
 
Exact HWE were performed on case (obese-overweight) and control (normal weight) individuals 
separately for each bi-allelic polymorphism, and were found to obey HWE in both case and control 
groups; except for Lys109Arg and Arg223Gln (Table 3.11[a]). LD analyses were performed, and table 
3.11(b) depicts the D’ values obtained. A high degree of LD was observed between the following 
polymorphisms: LEP 19A>G and Val94Met, Lys656Asn, CART c.517A>G; LEP Lys36Arg and LEPR 
Lys109Arg; LEP Val94Met and CART c.160-33G>A; LEPR Arg223Gln and CART c.160-33G>A. Very 
little pairwise LD was observed between LEP 19A>G and Lys36Arg although they are within a 
relatively short distance to each other. Table 3.11(c) shows the genotype and allelic distributions of the 
polymorphisms in overweight/obese and normal weight learners within each racial group, and between 
the two racial groups (adjusted for obesity status), adjusted for age and gender. The allele and/or 
genotype distributions differed between the racial groups, adjusted for obesity status, in Lys109Arg, 
Arg223Gln, c.160-33G>A, c.499delA, Leu72Met, and Val94Met polymorphisms. In the Mixed Ancestry 
learners, the distribution of alleles and genotypes differed between case (overweight/obese) and 
control (normal weight) groups in Lys109Arg, Lys656Asn, c.517A>G, and Lys36Arg polymorphisms. 
No differences in allele/genotype frequency were detected for any of the polymorphisms between 
Black African overweight/obese and normal weight learners. 
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Figure 3.10. Chromatograph depicting polymorphisms identified in LEP. A) A>G substitution at position 164 of the cDNA that resulted in 
Lys36Arg amino acid change. B) G>A substitution at position 337 of the cDNA that resulted in Val94Met amino acid change. The 
substituted nucleotides are indicated by arrows. 
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Figure 3.11. Chromatographs depicting polymorphisms identified in LEPR. A) A>G substitution at position 519 of the cDNA that resulted in 
Lys109Arg amino acid change. B) G>C substitution at position 2161 of the cDNA that resulted in Lys656Asn amino acid change. The 
substituted nucleotides are indicated by arrows. 
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Figure 3.12. Chromatographs depicting polymorphisms identified in CART. A) an A deletion identified at position 499 of the cDNA. B) an 
A>G substitution of the cDNA at position 519. C) G>A substitution detected at position 160-33 of the cDNA. Arrows indicate the substituted 
nucleotides. All genotypes that were identified for each polymorphism in the study group are presented. 
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Table 3.11(a). Exact Hardy-Weinberg equilibrium p-values for the obese-overweight and normal 
weight learners, and heterozygosity statistics for the bi-allelic candidate loci. 
Polymorphism Black Africans Mixed Ancestry 
 
Normal 
Obese/ 
Overweight Normal 
Obese/ 
Overweight 
LEP     
19G>A 1.0000 0.4897 0.2834 1.0000 
Lys36Arg  1.0000 1.0000 1.0000 1.0000 
Val94Met  0.5382 0.3156 1.0000 1.0000 
LERP 
    
Lys109Arg 1.0000 0.0839 0.1814 0.4062 
Arg223Gln 0.0289 1.0000 0.3955 0.5275 
Lys656Asn 0.5643 1.0000 1.0000 0.1814 
GHRL 
    
Lue72Met 1.0000 1.0000 1.0000 1.0000 
CART 
    
c.160-33G>A 0.1965 1.0000 0.3450 1.0000 
c.517A>G 1.0000 1.0000 0.0858 0.2246 
Abbreviations: GHRL, Ghrelin; CART, cocaine- and amphetamine-regulated transcript; LEP, leptin; 
 LEPR, leptin receptor. 
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Table 3.11(b). Pairwise LD (D') values for polymorphisms occurring within the same gene for the whole dataset in the present chapter. 
 
Polymorphism Lys36Arg Val94Met Lys109Arg Arg223Gln Lys656Asn Lue72Met  c.160-33G>A c.517A>G 
19G>A 0.8079740*   
 
0.2948910   0.0615479     0.0935268     0.3711410    0.0966840   0.1207813   0.0366715 
Lys36Arg   0.9830961   
 
0.0356369     0.1787810     0.3517405*   0.9713226    0.9898887   0.0871564 
Val94Met  - 
- 
0.9900789     
 
0.1553333     0.2066776   0.6852888    0.2090884*   0.9914644 
Lys109Arg - -  0.9981495*     0.9951822*   0.1174697    0.9959783*   0.1419448* 
 
Arg223Gln - - -  0.1438931   
 
0.2089118    0.1741305   0.6700476* 
Lys656Asn      0.0548696    
 
0.3852756   0.0989520 
Lue72Met         0.9857407   0.4827273 
 
c.160-33G>A        0.9947736 
*
 Nonsignificant LD test (P>0.05). Abbreviations: GHRL, Ghrelin; CART, cocaine- and amphetamine-regulated transcript; LEP, leptin; LEPR, leptin receptor. 
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Table 3.11(c). The frequency distribution of polymorphisms between obese-overweight and normal 
weight learners in the Black African and Mixed Ancestry groups.  
 
  
Obese-overweight  Normal  P-value 
 
   
 
Separate tests on 
obesity susceptibility 
 
  
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Race 
difference 
LEPR        
Lys109Arg        
Typed 36 48 41 52 
  
 
Allelic     0.3784 0.0955 0.0005 
A 68 (0.94) 86 (0.9) 80 (0.98) 85 (0.82) 
   
G 4 (0.06) 10 (0.1) 2 (0.02) 19 (0.18) 
   
Genotype         0.5392 0.0457 0.0001 
A/A 33 (0.92) 39 (0.81) 39 (0.95) 33 (0.63) 
   
A/G 2 (0.06) 8 (0.17) 2 (0.05) 19 (0.37) 
   
G/G 1 (0.02) 1 (0.02) 0 (0) 0 (0) 
   
Arg223Gln 
        
   
Typed 35 50 42 56 
   
Allelic         0.1489 0.5305 0.1308 
G 43 (0.61) 66 (0.66) 43 (0.51) 69 (0.62) 
   
A 27 (0.39) 34 (0.34) 41 (0.49) 43 (0.38) 
   
Genotype         0.1081 0.8180 0.0265 
G/G 13 (0.37) 23 (0.46) 7 (0.17) 23 (0.41) 
   
G/A 17 (0.49) 20 (0.4) 29 (0.69) 23 (0.41) 
   
A/A 5 (0.14) 7 (0.14) 6 (0.14) 10 (0.18) 
   
Lys656Asn 
        
   
Typed 36 52 40 56 
   
Allelic         0.5822 0.0278 0.2106 
G 58 (0.81) 85 (0.82) 67 (0.84) 102 (0.91) 
   
C 14 (0.19) 19 (0.18) 13 (0.16) 10 (0.09) 
   
Genotype         0.7405 0.0278 0.2736 
G/G 23 (0.64) 33 (0.63) 27 (0.68) 46 (0.82) 
   
G/C 12 (0.33) 19 (0.37) 13 (0.32) 10 (0.18) 
   
C/C 1 (0.03)  (0) 0 (0) 0 (0) 
   
 
 
 
 
 
  122
Table 3.11(c).continues 
  
Obese-overweight  Normal  P-value 
 
   
 
Separate tests on 
obesity susceptibility 
 
  
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Race 
difference 
 
CART 
   
   
c.160-33G>A 
      
   
Typed 30 52 39 58 
   
Allelic         0.4986 0.8047 0.0118 
G 48 (0.8) 96 (0.92) 66 (0.85) 106 (0.91) 
   
A 12 (0.2) 8 (0.08) 12 (0.15) 10 (0.09) 
   
Genotype         0.4762 0.5148 0.0417 
GG 19 (0.63) 44 (0.85) 29 (0.74) 49 (0.84) 
   
GA 10 (0.33) 8 (0.15) 8 (0.21) 8 (0.14) 
   
AA 1 (0.03) 0 (0) 2 (0.05) 1 (0.02) 
   
         
   
c.499delA 
        
   
Typed 29 50 36 58 
   
Allelic         1.0000 0.5613 0.0031 
A 58 (1) 95 (0.95) 72 (1) 112 (0.97) 
   
-A 0 (0) 5 (0.05) 0 (0) 4 (0.03) 
   
Genotype         1.0000 0.5613 0.0031 
A/A 29 (1) 45 (0.90) 36 (1) 54 (0.93) 
   
-A/A 0 (0) 5 (0.10) 0 (0) 4 (0.07) 
   
c.517A>G 
        
   
Typed 32 50 36 58 
   
Allelic         0.3112 0.0218 0.1254 
A 60 (0.94) 86 (0.86) 70 (0.97) 111 (0.96) 
   
G 4 (0.06) 14 (0.14) 2 (0.03) 5 (0.04) 
   
Genotype         1.0000 0.0115 0.2158 
A/A 28 (88) 38 (0.76) 34 (0.94) 54 (0.93) 
   
A/G 4 (12) 10 (0.20) 2 (0.06) 3 (0.05) 
   
G/G 0 (0) 2 (0.04) 0 (0) 1 (0.02) 
   
 
    
   
GHRL 
    
   
Leu72Met 
        
   
Typed 34 50 37 55 
   
Allelic         1.0000 0.8741 0.0010 
C 68 (1) 95 (0.95) 74 (1) 105 (0.95) 
   
A 0 (0) 5 (0.05) 0 (0) 5 (0.05) 
   
Genotype         1.0000 0.8741 0.0010 
C/C 34 (1) 45 (0.90) 37 (1) 50 (0.91) 
   
C/A 0 (0) 5 (0.10) 0 (0) 5 (0.09) 
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Table 3.11(c). continues 
  
Obese-overweight  Normal  P-value 
 
   
 
Separate tests on 
obesity susceptibility 
 
  
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Blacks Mixed 
Ancestry 
Race 
difference 
LEP           
19A>G 
        
  
Typed 34 51 37 58 
   
Allelic         0.9761 0.2114 0.5259 
G 32 (0.47) 49 (0.48) 35 (0.47) 66 (0.57) 
   
A 36 (0.53) 53 (0.52) 39 (0.53) 50 (0.43) 
   
Genotype         0.8154 0.3511 0.2524 
G/G 6 (0.18) 12 (0.24) 8 (0.22) 21 (0.36) 
   
G/A 20 (0.59) 25 (0.49) 19 (0.51) 24 (0.41) 
   
A/A 8 (0.24) 14 (0.27) 10 (0.27) 13 (0.22) 
   
Lys36Arg 
        
   
Typed 34 51 37 58 
   
Allelic         0.7786 0.0457 0.3103 
A 65 (0.96) 92 (0.90) 70 (0.95) 112 (0.97) 
   
G 3 (0.04) 10 (0.10) 4 (0.05) 4 (0.03) 
   
Genotype         0.7786 0.0457 0.5259 
A/A 31 (0.91) 41 (0.80) 33 (0.89) 54 (0.93) 
   
A/G 3 (0.09) 10 (0.20) 4 (0.11) 4 (0.07) 
   
Val94Met 
        
   
Typed 31 49 34 57 
   
Allelic         0.5842 0.1627 0.0011 
G 55 (0.89) 93 (0.95) 58 (0.85) 112 (0.98) 
   
A 7 (0.11) 5 (0.05) 10 (0.15) 2 (0.02) 
   
Genotype         0.7558 0.1627 0.0039 
G/G 25 (0.81) 44 (0.9) 25 (0.74) 55 (0.96) 
   
G/A 5 (0.16) 5 (0.10) 8 (0.24) 2 (0.04) 
   
A/A 1 (0.03) 0 (0) 1 (0.03) 0 (0) 
   
P-values are for tests of difference in allele and genotype distribution between the case and control groups within each racial 
group; adjusting for age and gender; and between the two racial groups, adjusted for case-control status, age and gender.  
Abbreviations: GHRL, Ghrelin; CART, cocaine- and amphetamine-regulated transcript; LEP, leptin; LEPR, leptin receptor. 
 
An optimal model for obesity susceptibility was selected from the following variables: age, gender, 
ethnicity, and all polymorphisms. Some genotypes (Lys109Arg, Lys656Asn, c.517A>G) were 
dichotomized (minor homozygotes combined with the heterozygotes) due to a small number or 
absence of the minor homozygotes. The optimal model (p=0.0018) contained the following predictors: 
gender and Lys109Arg, Lys656Asn, c.517A>G polymorphisms. Of the selected predictors, the 
c.517A>G polymorphism was independently significantly associated with obesity susceptibility, with 
the AG and GG carriers six times (OR= 5.98; 95%CI= 2.02, 21.27) likely to be obese than the AA 
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homozygotes, after adjusting for the other predictors. Even when not adjusted, the c.517A>G 
remained significantly associated with obesity (OR= 3.56; 95%CI= 1.38, 10.36). All subsequent 
analyses were adjusted for age, gender and ethnicity. From individual polymorphisms-phenotype 
association test, only Lys109Arg and c.517A>G polymorphisms were individually significantly 
associated with anthropometric obesity variables (Table 3.12). At least one 109Arg allele (AG and GG 
genotypes compared to AA) was associated with an average reduction of 2.36 kg/m2 in BMI, 5.66 cm 
in WC, and 1.61 cm in MUAC.  At least one c.517G allele (AG and GG genotypes compared to AA) 
increased the MUAC by 1.88 cm on average.  
 
Table 3.12. Summary of significant associations between LEPR, LEP and CART polymorphisms and 
anthropometric and metabolic obesity variables; adjusted for age, gender, and ethnicity.  
 
Variables SNP Specific 
genotype 
Reference 
genotype 
P- value Beta coefficient 
(95% CI) 
BMI (kg/m2) Lys109Arg  AG and GG AA 0.0148 -2.36 (-4.24, -0.47) 
MUAC (cm) Lys109Arg AG and GG AA 0.0238 -1.61 (-3.00, -0.22) 
WC (cm) Lys109Arg  AG and GG AA 0.0089 -5.66 (-9.89, -1.44) 
MUAC (cm) c.517A>G AG and GG AA 0.0192 1.88 (0.31, 3.44) 
A negative effect indicates that individuals with stated level have lower values for the trait than those with the reference level.  
Allelic effect is the estimated difference when adding another allele.  
Abbreviations: BMI, body mass index; WC, waist circumference 
 
No significant effects of individual LEP polymorphisms on anthropometric obesity and metabolic traits 
were detected, but the haplotype inferred from the three LEP polymorphisms, 19A>G, Lys36Arg and 
Val94Met, was significantly associated with the BMI, MUAC and hip circumference (Table 3.13).  The 
A-A-A haplotype increased BMI by 17.4 kg/m2, MUAC by 2.3 cm, and hip circumference by 8.0 cm, 
compared to the reference haplotype G-A-G. A significant interaction was observed between the three 
LEP polymorphisms and Lys109Arg (19A>G+Lys36Arg+Val94Met+Lys109Arg) for weight, BMI, 
MUAC and WC.  Carriers of the A-A-A-A haplotype-allele combination of 19A>G, Lys36Arg, Val94Met 
and Lys109Arg had significantly increased weight, BMI, MUAC and WC compared to G-A-G-A 
carriers.  Interestingly, individuals carrying the LEP haplotype G-A-G and the 109Arg allele had 
decreased anthropometric obesity phenotype indicators compared to those with the A allele (Table 
3.13).  The effect of the Arg223Gln-Lys656Asn haplotype (A-C compared to the G-G) was an increase 
of 2.6 cm in MUAC. Combinations of the Arg223Gln-Lys656Asn haplotype with other polymorphisms 
(Lys109Arg and Leu72Met) were also associated with an increase in MUAC.  
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Table 3.13.  Summaries of significant haplotype or allelic combination effects on anthropometric obesity variables (adjusted for age, 
gender, and ethnicity), and their frequency in the study group.  
 
Variables Haplotype or allelic combination p-value Specific 
haplotype 
Haplotype 
frequency 
Reference haplotype Beta coefficient 
Weight (cm) 19A>G + Lys36Arg + Val94Met + Lys109Arg 0.0168 AAAA 0.050 GAGA 11.5 
 19A>G + Lys36Arg + Val94Met + Lys109Arg  GAGG 0.058 GAGA -6.9 
BMI (kg/m2) 19A>G + Lys36Arg + Val94Met 0.0155 AAA 0.047 GAG 17.4 
 19A>G + Lys36Arg + Val94Met + Lys109Arg 0.0408 AAAA 0.051 GAGA 4.2 
 19A>G + Lys36Arg + Val94Met + Lys109Arg  GAGG 0.059 GAGA -2.8 
MUAC(cm) 19A>G + Lys36Arg + Val94Met 0.0146 AAA 0.047 GAG 2.3 
 19A>G + Lys36Arg + Val94Met + Lys109Arg 0.0411 AAAA 0.049 GAGA 2.5 
 19A>G + Lys36Arg + Val94Met + Lys109Arg  GAGG 0.059 GAGA -1.6 
 Arg223Gln + Lys656Asn 0.0377 AC 0.052 GG 2.6 
 Lys109Arg + Arg223Gln + Lys656Asn 0.0429 AAC 0.049 AGG 2.2 
 Arg223Gln + Lys656Asn + Leu72Met 0.0029 ACC 0.048 GGC 1.9 
WC (cm) 19A>G + Lys36Arg + Val94Met + Lys109Arg 0.0168 AAAA 0.049 GAGA 7.7 
 19A>G + Lys36Arg + Val94Met + Lys109Arg  GAGG 0.059 GAGA -7.3 
Hip (cm) 19A>G + Lys36Arg + Val94Met 0.0128 AAA 0.045 GAG  
A negative effect indicates that individuals with stated haplotype have lower values for the trait than those with the reference haplotype.  Only haplotypes  
with frequencies >0.05 are listed. Abbreviations: BMI, body mass index; MUAC, mid-upper-arm circumference; WC, waist circumference. 
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3.4. DISCUSSION 
Several polymorphisms were identified with significantly different distributions between the Mixed 
Ancestry and Black African population groups, as well as between cases and controls (obesity 
susceptibility) within the Mixed Ancestry ethnic group. The genotype frequency distributions of both 
Arg223Gln and Lys109Arg polymorphisms were different between the two ethnic groups. For the 
Arg223Gln polymorphisms, Black African learners had a higher heterozygote frequency, while the 
Mixed Ancestry group had higher frequencies of GG homozygotes; hence no significant difference in 
allelic frequencies. When compared to other population groups, the frequency of the G allele in Mixed 
Ancestry learners was higher than that reported in Caucasians (approximately 40%) but lower than 
that observed in Asians (85%) (Paracchini et al., 2005). A study by Ragin and co-workers (2009) 
reported a GG homozygous frequency of 24.73% in Africans, similar to that observed in the Black 
African ethnic group (26%). According to a meta-analysis done by Paracchini et al (2005), generally 
allelic frequency of the Arg223Gln polymorphisms is variable across different ethnic groups (in Pima 
Indians the G allele frequency was 32%). When comparing the genotype distribution of the Lys109Arg 
polymorphisms, the A allele was more prevalent in the Black African ethnic group (96% vs 86%). 
Similarly, Paracchini et al (2005) reported a higher frequency of the A allele in Caucasians while it was 
lower in Asians. The HapMap data also reported a higher frequency of the A allele in Sub-Saharan 
Africans and African Americans.  
 
Ethnic variation in the distribution of the Val94Met polymorphism was observed between Mixed 
Ancestry and Black African learners. Significant differences in the distribution of c.160-33G>A, 
c.499delA, Val94Met and Leu72Met between the two ethnic groups were also observed. Minor alleles 
of CART c.499delA and GHRL Leu72Met polymorphisms were only found in Mixed Ancestry learners 
but at low frequencies (up to 10%), similar to other population groups such as Finnish, Chinese, 
African-Americans and Caucasians (Ukkola and Kesäniemi, 2003; Bing et al., 2005 ; Xu et al., 2008; 
Friedlander et al., 2010). The A allele of the Val94Met polymorphisms was also found at a lower 
frequency in both ethnic groups (10% in Blacks and 3% in Mixed Ancestry). Similarly, African-
Americans had a lower frequency of the A allele (8.7%) while it was not found in Caucasians. The 
delA allele was found in Mixed Ancestry learners at a lower frequency (4.2%) compared to that 
observed by other authors (Challis et al., 2000; Guérardel et al., 2005) in Caucasians (7.3-10% and 
8.7%). 
 
The difference in genotype and/or allelic distribution of the polymorphisms observed between the two 
ethnic groups may be a reflection of a genetic admixture in Mixed Ancestry. The Mixed Ancestry 
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population (commonly known as Cape Coloured) has the highest levels of mixed ancestry in the world, 
representing a complex genetic background. The first generation of this racial group originated from 
an admixture of Hottentot and European racial groups (Desmore, 1937). Another racial mixture has 
occurred over the years between Europeans, Indians, Malays, various Bantu tribes, and other African 
groups along with indigenous Khoi and San, resulting in a heterogeneous genetic background (The 
Coloureds of Southern Africa, MixedFolks.com. Retrieved on 23/10/2009).  
 
The c.517A>G polymorphism was selected as the best predictors of obesity in an optimal model. 
Additionally, the c.517A>G G allele (GG and AG genotypes, compared to AA) was associated with 
increasing MUAC, when the regression analysis was adjusted for age, gender, and race. The 
importance of this finding is in line with the proposed role of the mid-upper-arm as another indicator of 
obesity (Chomtho et al., 2006), suggesting that the c.517A>G polymorphisms may be a predisposing 
factor for obesity. In their study consisting of healthy boys aged 4.4-13.9 years, Chomtho et al (2006) 
found a strong correlation between MUAC, triceps skinfold thickness, arm fat area and total fat mass. 
From their findings Mazıcıolu and coworkers (2010) suggested substitution of the WC and MUAC for 
one another as an additional evaluation tool next to BMI in detecting overweight and obese children 
and adolescents. There is currently no known clinical association of the c.517A>G polymorphism with 
obesity. c.517A is located in the 3 prime untranslated region of the CART gene, and the A>G 
substitution has no known effect on the function of CART or the expression level of its gene. It is likely 
that c.517A>G is in linkage disequilibrium with a functional casual polymorphism. There is currently 
very limited data on the role of CART polymorphisms (Leu34Phe, 1475A>G, -156T>C, and -3608T>C) 
in the development of obesity (Miraglia del Giudice et al., 2001; Yamada et al., 2002; Guérardel et al., 
2005; Yanik et al., 2006; Rigoli et al., 2010). 
 
The LEPR polymorphism (Lys109Arg) decreased BMI (as a measure of obesity), waist circumference 
and mid-upper-arm, as a single locus and in a haplotype with LEP variants. Interestingly, other 
haplotypes containing the A allele of the Lys109Arg polymorphism had an opposite effect, increasing 
obesity indices, suggesting that only the minor allele protected the carriers from obesity.  Similarly, 
Rosmond and co-workers (2000) found Arg109 homozygotes to have lower BMI in addition to lower 
abdominal sagittal diameter and blood pressure. In addition, the Lys109Arg variant was found to be 
marginally associated with BMI in a gene dose-dependent manner (Park et al., 2006). The C allele of 
the Lys656Asn variant was associated with increased obesity, consistent with the haplotype analysis 
that demonstrated an association between the A-A-C, A-C-C, A-C (haplotype containing the C allele of 
the Lys656Asn variant) and increasing obesity indices. Our findings are similar to those reported by 
Masuo and co-workers (2008), which showed Caucasian male subjects carrying the Arg223 
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homozygous or the Asn656 allele to have higher BMI, waist circumference, and waist-to-hip ratio in 
addition to increased levels of plasma leptin. Furthermore, other studies found weak associations 
between the Lys656Asn and either BMI or free fat mass in subgroups of lean British subjects (Gotoda 
et al., 1997) and/or overweight Caucasian females (Chagnon et al., 1999), respectively. 
 
Leptin polymorphisms as single loci were not associated with any variability in anthropometric and 
metabolic obesity-related traits. Instead haplotypes formed by these polymorphisms were associated 
with variation in BMI, MAUC, and hip circumference. The 19A>G-Lys36Arg-Val94Met haplotype (A-A-
A compared to the G-A-G) increased BMI, MUAC and hip circumference. The Lys109Arg + Arg223Gln 
+ Lys656Asn haplotypes (A-A-C and A-C compared to A-G-G and G-G, respectively), on the other 
hand, increased only the MUAC. When the Lys109Arg polymorphisms were analysed as a single 
locus, its minor allele was significantly associated with anthropometric obesity traits; decreasing BMI, 
MUAC and WC. Interestingly the A-A-C haplotype contains the Lys109Arg A allele, which on its own 
did not show any significant association with anthropometric obesity traits. The Arg223Gln-Lys656Asn 
haplotype of minor alleles had a greater effect on MUAC compared to the haplotype containing all 
three LEPR polymorphisms, suggesting that the A-C haplotype on its own is sufficient as an obesity 
risk factor compared to G-G. LEP-LEPR joint effects were also observed. When the Lys109 allele was 
combined with the LEP haplotypes (A-A-A-A versus G-A-G-A), the synergistic effect of the LEP 
polymorphisms was modulated, decreasing the effect on  BMI from 17.4 to 4.2 kg/m2 while the effect 
on MUAC was increased from 2.3 to 2.5 cm.  When the Lys109Arg G allele interacted with the LEP G-
A-G haplotype, (G-A-G-G versus G-A-G-A), this combination decreased the anthropometric obesity 
phenotype indicators (BMI, weight, MUAC, waist and hip circumferences), further strengthening 
evidence for the protective role of the Lys109Arg minor allele. Due to the small sample size of the 
present study and the heterogenous nature of the study population, the association observed should 
be analysed with caution and further studies conducted in a larger homogenous sample. Of note and a 
surprising finding is the effect of the A-A-A-A and A-A-A haplotypes, increasing weight and BMI, 
respectively. The small sample size of the present study could be the reason some polymorphisms as 
a single loci (for example, LEP polymorphisms) were not associated with obesity anthropometric 
variables. It is possible that individual polymorphisms have a small effect that may only be detected at 
a population level or in combination with other variants (as observed with haplotype analyses). The 
overestimated increase in weight and BMI could be due to population stratification as it is known that 
the Mixed Ancestry population has the highest levels of mixed ancestry, representing a complex 
genetic background.  According to Andersson and co-workers (2009), if population stratification is not 
accounted for, as it is the case in the present study, over or underestimation of associations can 
occur. 
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Although genes involved in regulation of food intake and energy expenditure have been extensively 
studied, replicating the association of polymorphisms with obesity across populations has been 
challenging. The LEPR polymorphisms (Lys109rg, Arg223Gln and Lysn656Asn) have been found to 
be either associated with (Quinton et al., 2001; Park et al., 2006; Han et al., 2008) or not have any 
effect (Heo et al., 2001) on obesity or its anthropometric traits. Most of the LEP and LEPR 
polymorphisms investigated in the present study produce amino acid changes and may thus have 
functional consequences, but there is no true evidence of their functionality. Two of the LEPR 
polymorphisms, Arg223Gln and Lys656Asn, result in nonconservative changes and are therefore the 
most likely to have functional consequences (Thompson et al., 1997; Chung et al., 1997). However, 
the exact functional consequence of these polymorphisms on the LEPR mRNA and protein is 
unknown. The Lys109Arg polymorphism is a conservative change and may not have functional 
implications.  
 
The 19A>G polymorphism located in the 5’ UTR of the LEP gene has also been associated with lower 
levels of leptin concentration (Hager et al., 1998; Karvonen et al., 1998; Li et al., 1999; Hart Sailors et 
al., 2007), while other studies failed to detect this association (Lucantoni et al., 2000; Jiang et al., 
2004; Meirhaeghe et al., 2005). The Lys36Arg polymorphism lies within the first short loop that 
connects helix A to B, while Val94Met is the last residue of the third helix. These two polymorphisms 
have not been associated with any metabolic phenotypes, but their location suggests that they may 
also impair LEP physiological activity. Leptin levels were not measured in the present study, it is 
therefore not known whether or not the LEP and LEPR polymorphisms have an effect on leptin 
concentration our study groups.  
 
It is evident from several studies that LEP and LEPR polymorphisms have different effect in various 
population groups. Linkage disequilibrium between the genotyped polymorphism and the causal one is 
reported to be one of the possible reasons for between-study heterogeneity. Another reason could be 
the modulating effect of interacting polymorphisms in the background of the investigated variant or 
marker, thereby neutralising or enhancing its association with the phenotype. The joint effect of 
polymorphisms is suggested to be the plausible model of inheritance for several obesity-related 
disorders. Although obtaining supporting evidence has been challenging, a few studies in human 
obesity have supported this hypothesis. For example, a significant interaction between LEP 19A>G 
and LEPR Lysn656Asn polymorphisms for respiratory quotient was observed in a study by Loos et al 
(2006). Souren et al (2008) observed a joint effect of the Lys109rg and Arg223Gln polymorphisms on 
birth weight, in which carriers of the Lys109Arg/Gln223Gln genotypes had significantly lower birth 
weight compared to carriers of other genotypes. The relevance of these findings stems from the 
association of low birth weight with an increased risk of obesity and type 2 diabetes. Another example 
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of the gene-gene interaction is found in a study by Lakka and coworkers (2004), which reported an 
association of the A19A/Arg109Arg and A19A/Lys109Arg genotypes with exercise-induced change in 
fasting insulin. LEPR polymorphisms also interact with other genes, as noted in a study by Angeli et al 
(2011), which reported a joint effect of Arg223Gln and 2-adrenergic receptor in the risk of 
overweight/obesity. A combined effect of different polymorphisms on BMI was also observed in a meta 
analysis by Willer et al (2009) in which six variants accounted for 0.4% of variance in BMI, and in 
conjunction with melanocortin-4-receptor and fat mass and obesity associated genes (MC4R and 
FTO), the association accounted for 0.84% of variability. Our findings, therefore, further supports the 
joint effect of LEP and LEPR on obesity and its related phenotypes, and provides a foundation for 
investigating interaction of polymorphisms in addition to single locus associations.  
  
Apart from genetic factors, ethnicity also contributes to the variability in anthropometric measurements 
as observed in the present study. Generally, anthropometric measurements were significantly higher 
in obese-overweight learners. When ethnicity was considered, anthropometric obesity indices were 
higher in obese Mixed Ancestry learners but only WC and MUAC were significantly different between 
the two ethnic groups. It is possible that the difference observed is due to variable pubertal stages of 
learners studied. Physiologically, there are differences in fat distribution and changes in total and 
percentage body weight between girls and boys (Ogle et al., 1995; Taylor et al., 1997). During 
adolescence, on average girls tend to have increased fat and fat-free mass, while boys gain more 
muscle mass (Deurenberg et al., 1990; Goodman-Gruen and Barrett-Connor, 1996). As a result, 
female adults have approximately 22% body fat while their male counterparts have an average of 
15%. Furthermore, fat in girls is usually deposited peripherally in breasts, hips, and buttocks while in 
boys it is centralised in the abdomen. There was a positive correlation between obesity and WC and 
MUAC based on ethnicity. However, the question that still remains in the South African context is 
whether or not other measurements such as WC and MUAC can be used as additional evaluation 
tools next to BMI in detecting overweight and obese children and adolescents. It has been 
recommended that WC and MUAC; which are the leading indirect methods of assessing fat mass, be 
used as an additional tool to screen children and adolescent for obesity as they show a good level of 
correlation with body mass (Jelliffe and Jelliffe, 1968; Cook et al., 2003; Mazıcıolu et al., 2010). 
However, systematic monitoring of WC and MUAC is not a commonly performed method in pediatric 
studies in many countries and internationally accepted cut−off values are also not yet established for 
different population groups. 
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4.1. Summary of findings 
To our knowledge, few obesity genetic studies have been conducted in South African populations. In 
March 2011 at the South African Society for Human genetics conference held in Cape Town, Dr Zane 
Lombard of the National Health Laboratory services reported a significant finding on leptin risk alleles, 
which increased the risk of obesity in adolescents residing in Soweto (Johannesburg). To add to this 
important finding, the present study investigated the contribution of six genes (LEP, LEPR, GHRL, 
CART, MC3R, and MC4R) of the leptin-melanocortin pathway in polygenic obesity in South African 
learners of Black African and Mixed Ancestry residing in Cape Town northern surbubs. The following 
polymorphisms were identified:  
Gene Polymorphism SNP identification number Gene region 
MC4R - - - 
MC3R Thr6Lys 
Val81Ile or Val44Ile 
rs3746619 
rs3827103 
Exon 1 
LEP c.19G>A 
Lys36Arg  
Val94Met 
rs2167270 
rs111650508 
rs17151919 
Exon 1 
Exon 2 
Exon 3 
GHRL Lue72Met rs696217 Exon 3 
CART c.160-33G>A  
c.499delA 
c.517A>G 
rs16871443 
rs5868607 
rs41271753 
Intron 1 
Exon 2 
3’UTR  
 
Association analysis of the polymorphisms with obesity-related quantitative traits identified the 
following: 
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Gene Polymorphism Association Clinical variable 
MC4R - - - 
MC3R Thr6Lys 
Val81Ile 
Yes 
Yes 
Lower BMI, weight, MAUC, hip, TC, BP in MA 
Lower BMI, weight, MAUC, hip, TC, BP in MA 
MC3R + House chores Val81Ile Yes TC 
LEP c.19G>A 
Lys36Arg 
Val94Met  
No  
GHRL Lue72Met+Gln223Arg + Lys656Asn No  
CART c.160-33G>A 
c.499delA 
c.517A>G 
No 
No 
Yes 
 
 
Higher MUAC, obesity risk 
LEPR Lys109Arg 
Gln223Arg 
Lys656Asn 
Yes 
No 
No 
Lower BMI, MUAC, WC 
LEP Haplotype:c.19G>A+Lys36Arg+ Val94Met (AAA)  Yes Higher BMI, MUAC, hip 
LEPR Haplotypes: AC and AAC Yes Higher MUAC 
GHRL+LEPR  Haplotype: Lue72Met+ Gln223Arg + Lys656Asn (CCA) Yes Higher MUAC 
LEP+LEPR Haplotype: 19G>A+Lys36Arg+ Val94Met+ Lys109Arg  
(AAAA) 
Yes Higher BMI, weight, WC, MUAC 
LEP+LEPR Haplotype:19G>A+Lys36Arg+ Val94Met+ Lys109Arg  
(GAGG) 
Yes Lower BMI, weight, WC, MUAC 
Abbreviations: BMI, body mass index; BP, blood pressure; MA, Mixed Ancestry; MUAC, mid-upper-arm circumference TC, total cholesterol; WC, waist circumference. 
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4.2. Conclusion 
The CART c.517A>G polymorphism was identified as a predisposing factor for obesity in adolescent 
learners: learners harbouring the minor allele were more likely to be obese and had higher MUAC 
compared to those carrying the A allele. However, it is not known whether or not this risk allele acts 
synergistically with other polymorphisms and/or in response to obesogenic environment. MC3R and 
LEPR polymorphisms were associated with lower values of anthropometric obesity traits (BMI, MUAC, 
hip and waist circumference), blood pressure and total cholesterol, suggesting a protective role 
against Metabolic Syndrome (MetS); which is defined as a cluster of metabolic disorders such as 
dyslipidemia, hypertension, insulin resistance, and visceral fat accumulation (referred to as central 
obesity). The effect of MC3R Val81IIe polymorphism on total cholesterol was enhanced in learners 
who reported to be physically active. The present study also demonstrated that more than one 
polymorphisms act together to elicit a specific phenotype. For example, genotype combination of LEP 
and LEPR polymorphisms displayed different effects on anthropometric obesity traits, depending on 
which alleles interacted. Individual LEP polymorphisms did not have an effect on obesity-related traits. 
Further studies are required to investigate whether or not findings of the present study translates to 
the lower prevalence of MetS previously identified in Mixed Ancestry learners (Matsha et al., 2009). 
Although the present study identified only polymorphisms with larger effects due to smaller sample 
size, it served as an example of the potential benefits of considering a combined effect of 
polymorphisms from one or more genes.  At this point the association of polymorphisms with obesity-
related traits that is reported in the present study has no clinical implications. Replication of these 
findings is critical and needs to be based on multiple independent samples of substantial sizes. Once 
replicated, clinical trials will be required to assess the effectiveness of genotype-based intervention 
programs against obesity and/or cardiovascular diseases. It will also be critically important to 
understand how the public (individuals at risk and those with protective allele) will perceive 
individualized genetic results. Predictive genetic testing may raise issues such as labeling a family at 
risk, inducing feelings of blame, or anxiety associated with knowledge of affected relatives. Moreover, 
some people may be falsely reassured if they are told that they have no genetic risk, and engage in 
unhealthy behaviour. On the other hand, results may have positive outcome, significantly improving 
patient outcomes and motivate people to engage in preventative behaviour to reduce their disease 
risk.  
The novel findings of the present study should thus be viewed as “hypotheses generating” for further 
studies.Once proven to be applicable in clinical practice, our findings may help to identify individuals 
at high risk for developing obesity, cardiovascular diseases or type 2 diabetes without the knowledge 
of family history. So far, most predictive genetic tests are used for identifying predispositions for 
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monogenic diseases with a strong genetic influence such as hereditary forms of cardiac diseases and 
cancers. Genotype-based management or prevention of obesity and related cardiovascular diseases 
such as hypercholesterolemia and hypertension can be subsequently developed for those individuals 
found to have risk alleles.  
Overall, our findings are based on international reference cut-off points (as developed by Cole and co-
workers) that were developed using data from other countries. Although these reference cut-off points 
are recommended for research settings, whether or not they are related to the development of 
cardiovascular diseases and MetS in South African ethnic groups remains to be proven through 
longitudinal studies. The use of these international reference cut-off points in South African population 
groups may have serious health-related implications if these findings are not investigated using a well-
defined study design.  
4.3. Limitations 
Single strand conformation polymorphisms (SSCP) and allele-specific restriction enzyme analysis 
(ASREA) are some of the molecular techniques that were used in the present study to detect possible 
sequence variants and genotype the selected study group, respectively; and this might have 
contributed to the detection rate of sequence variants. These techniques are subject to human error 
regarding interpretation of mobility shifts and genotypes, and hence other sequence variants could 
have been missed or genotyping error introduced. SSCP has been reported to detect up to 98% 
(addition of 15% urea in both 8% and 10% polyacrylamide gels increases the detection limit from 90 to 
98%) of nucleotide changes (IFCC Scientific Division, Committee on Molecular Biology Techniques). 
Genotyping errors can be suspected when frequencies are not in Hardy-Weinberg Equilibrium (HWE). 
However, deviations from HWE can also indicate that the sample consists of a heterogeneous 
population or in cases it can indicate a true genetic effect or strong association with the disease state. 
Therefore, the genotype frequencies of control or population-based samples (if selected from large 
populations where random mating is assumed) should be in HWE, whereas samples consisting of only 
cases may deviate from HWE (Lewis, 2002; Andersson et al. 2009). 
 
The use of questionnaires to measure physical activity may have introduced bias. Physical activity 
questionnaires and diaries are more applicable in large epidemiological studies, but they provide less 
accurate estimates of physical activity level compared to more objective measures as the tool relies on  
self-reported (parental or child/adolescent) information (Bull et al., 2009). The type of house chores 
performed by learners was not specified (i.e., heavy or light duties) in order to estimate the intensity of 
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activity involved and make assumptions about the observed association between house chores, total 
cholesterol, and MCR3 genotypes.  
 
The study population consisted of adolescents, who at the time of the study, might have been at 
different developmental stages. Puberty, a stage characterized by physiological changes in girls and 
boys, was not accounted for during the analyses due to the small sample size. Although the statistical 
analyses were adjusted for age and gender, puberty is another confounding factor that may introduce 
spurious positive or negative association. This developmental stage has been reported to affect lipid 
profile and body composition. With specific reference to lipid profile, puberty has been shown to 
decrease high and low density lipoprotein-cholesterol (HDL-C and LDL-C), and increase triglycerides 
(TG) levels (Codoñer-Franch et al., 2010). Serum lipid levels peak at age 9 to 10 years, followed by a 
decrease, and then begin to increase again in adolescence (Stozický et al., 1991; Labarthe et al., 
1997; Freedman et al., 2001). Changes in TC have also been observed, decreasing between the ages 
of 10 and 16 years in boys and 9 and 14 years in girls (Berenson et al., 1981). TC and HDL-C are 
associated with growth (age and height) in pubertal children (Kouda et al., 2003; Fujita et al., 2011). It 
has been reported that pubertal children who experience a large increase in height tended to show a 
decrease in serum lipids (TC and HDL-C), and children who experience a small increase in height 
tended to show an increase in serum lipids. Serum lipid profile is also affected by the levels of sex 
hormones in children and adolescents, with lower HDL-C and LDL-C levels associated with increased 
testosterone in boys and increased estradiol in girls (Morrison et al., 2003). Furthermore, growth 
hormone therapy has also been reported to cause a decline in LDL-C and HDL-C levels (Hilczer et al., 
2008).  
 
In addition to hormonal fluctuations, rapid growth in body size accompanied by marked changes in 
body composition is observed during pubertal stage. When considering gender and puberty, 
differences in fat distribution and changes in total and percentage body weight can be observed 
between girls and boys who are at this stage of development. During adolescence, on average girls 
tend to have increased fat and fat-free mass, while boys gain more muscle mass (Naumova et al., 
2001). Furthermore, fat in girls is usually deposited peripherally in breasts, hips, and buttocks while in 
boys it is centralised in the abdomen. It is therefore possible that the observed association between 
MC3R and LEPR polymorphisms anthropometric variables (BMI, MUAC, hip and waist circumference) 
is confounded by puberty. Different age of puberty onset may also contribute to the difference in lipid 
profile and body composition observed among children and adolescents of the same gender and age 
group, and thus affecting statistical analyses if not accounted for. Some individuals can experience 
precocious or delayed puberty (Herman-Giddens et al., 1997; Grumbach and Styne, 1998). 
Precocious puberty is defined as the development of secondary sexual characteristics before the age 
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of 8 years in girls and boys.Delayed puberty is the absence of breast development by 13 years of age 
in girls or testicular volume <4 mL by 14 years of age in boys.  
 
Due to the mixed ancestry origin of the “Coloured” (Mixed Ancestry) ethnic group, associations 
identified in the present study may be due to population stratification, which was not adjusted for. 
Potential population stratification in unrelated sample may cause spurious positive or negative 
associations in population-based association studies (Deng, 2001). Severalstatistical methods have 
been proposed to reduce the effect of population stratification on population-based association 
analyses, and the three major categories include structured association (SA) (Pritchard et al., 2000; 
2000), genomic control (GC) (Devlin et al., 1999), and principal components analysis (PCA) (Price et 
al., 2006). SA uses a set of ancestral informative markers (AIMs) to estimate population structure and 
individual ancestries (Pritchard et al., 2000; 2000). The model used in the analysis then accounts for 
the correlations between linked loci that arise in admixed populations. In the GC method, the effect of 
population stratification can be assessed using a set of disease-unlinked marker loci, providing a 
correction factor that can then be applied to adjust for statistical bias at candidate loci (Devlin and 
Roeder, 1999). For PCA method, classical principal components analysis is first applied to genotype 
data to model ancestral differences between cases and controls, which are then used to correct allele 
frequency variations at candidate loci across ancestral populations (Price et al., 2006). When Zhang 
and co-workers (2008) compared these methods, SA and PCA performed better than the GC only if 
120 or more AIMs were used. Using a small set of AIMs in the SA methods may result in high type 1 
error rate in populations with high stratification level.  
 
Structure analysis conducted in the South African Coloured population revealed that its origin is 
predominantly Khoesan (32-43%), Bantu-speaking African (20-36%), European (21-28%), and a small 
proportion Asian (9-11%) (de Wit et al., 2010). This analysis, however, was based on the Affymetrix 
500k SNP chip containing markers primarily designed for use in Europeans. According to de Wit and 
coworkers, the use of European markers in their study may have lead to ascertainment bias that might 
have influenced the quantitative details of the analyses. Additional markers of Malaysian, Indonesian, 
San (which are not publicly available), and appropriate tags of Bantu-speaking ethnic groups are 
needed to improve resolution of ancestral contribution in the Mixed Ancestry group. Appropriate 
markers that can be used to map disease genes or correct for population stratification in the Mixed 
Ancestry are not available as yet. Performing this analysis to correct for population stratification in the 
present study was beyond the ethical scope of the proposed study. We recommend that either SA 
(when appropriate markers are available) or PCA be conducted to correct for population stratification if 
further studies are to be conducted to confirm the association detected in the present study. 
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4.4. Recommendations for further studies 
Population-specific and standardised reference cut-off points are required for accurate classification of 
South African children and adolescents, and adults according to weight status or BMI. The response 
rate of the parent study was 65%, and thus affected the sample size of the present study. The 
response rate obtained is worrying as this may confound conducting further confirmatory studies. Be it 
the case may be, a larger sample size may be required to identify polymorphisms with small effects 
that might have been missed in the present study, and to replicate the observed associations with 
confidence taking into account confounding factors such as pubertal stage, diet, alcohol consumption, 
and physical activity. Larger sample size generally improves the power of detecting polymorphisms 
with smaller effect sizes (Andersson et al. 2009, De Krom et al. 2009). An improved study design is 
therefore recommended, which can also incorporate measurements of leptin that can be correlated 
with genotypes of the genes investigated in the present study. Further studies can be conducted in 
one properly selected South African racial group to eliminate the possible effect of population 
stratification. Genotype and allele frequencies may vary between populations from different ethnicities 
or geographical regions, resulting in over or underestimation of associations if the study group is not 
properly selected. Our study consisted of two racial groups, which although different, are primarily of 
African origin and have received little attention in population genetics of complex disorders, particularly 
obesity.  
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APPENDIX B: QUESTIONNAIRE 
  
UNIVERSITY OF STELLENBOSCH AND CAPE PENINSULA UNIVERSITY OF TECHNOLOGY 
  
    
    
  
 
   
     
                           
 
                           
                           
SECTION A    FAMILY HEALTH HISTORY AND LIFESTYLE SURVEY        
                           
      
Name and Reference Number 
                       
                           
PERSONAL & BIOGRAPHICAL DATA                   
                     
Age in 
Months     
1 What is your date of birth?                             1 
                                          
                            
2 What is your gender?  0 Male     1 Female           2 
                                          
                            
3 In which grade are you? 0    4    8            3 
                            
        1    5    9            
                            
        2    6    10            
                            
        3    7                
                                          
                            
4 How long have you been attending this school?               4 
                            
        a) < 6 Months b) < 1 Year              
        1    2                
                            
        c) 1-5 years  d) 6-10 years             
        3    4                
                                          
                            
5 How would you describe yourself? (select one response)             5 
                            
        a) Black  b) White  c) Coloured          
        1    2    3            
                            
        d) Asian  e) Other  If other, Please clarify       
        4    5    6            6 
                                          
                            
6a How would you describe your … ……..(Select one)               7 
 Mother?         Father?              
    a) Black  1    a) Black  1            8 
                            
    b) White  2    b) White  2            
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    c) Coloured  3    c) Coloured  3            
                            
    d) Asian  4    d) Asian  4            
                            
    e) Other  5    e) Other  5            
                                          
                            
6b Are any of your grandparents of a different description as you and your parents?       9 
 If yes, please state, who, of which description they are, & how they are related to you        
                            
    Mom's mother 1    Father's mother 3            
                            
    Mom's dad  2    Father's father 4            
                                          
                            
7 Are you related to someone also participating in this project? a) Yes    b) No       10 
 If yes, please state who and how you are related?               
                                                   
                                                   
                                          
                            
8 How many brothers and sisters do you have?                11 
                            
    a) Brothers       b) Sisters      Total         
                                            
                            
FAMILY HEALTH HISTORY                      
                            
9 Have you ever been told that you have diabetes (sugar levels)?           12 
                            
    a) Yes 1      b) No 2              
                                            
                            
10 Does your natural mother, father, brother or sister have diabetes?           13 
                            
    a) Yes 1      b) No 2              
                                            
                            
11 Has anyone in your extended family (Aunts, Uncles, Grandparents) ever suffer         14 
 from diabetes?                        
                            
    a) Yes 1      b) No 2              
                                            
                            
12 At which age did you have your first menstrual period?             15 
                            16 
                      
Tanner Stage 
        
                                            
 
 
                            
 
 
 
 
 
LIFESTYLE                          
                            
13a Do you smoke?                       17 
  219
                            
    a) Yes 1      b) No 2              
                                            
                            
13b If you answered yes, how many cigarettes do you smoke per day?             18 
                                            
                            
14 Do you consume any alcoholic beverages?                19 
                            
    a) Yes 1      b) No 2              
                                            
                            
SOCO-ECONOMIC DETAILS                     
                            
15 What type of house do you live in?                   20 
                            
    a) House 1   b) Flat  2   c) Back Room 3        
                            
    d) Hostels 4   e) Shack 5   f) Bungalow/ 6        
                  wendy house         
    g) Other 7                     
                                            
                            
16 What type of toilet facility do you have at your house?              21 
                            
    a) In-house Flush system 1   b) Out-door Flush system 2       
                            
    c) In-house Bucket system 3   d) Out-door Bucket system 4       
                                            
                            
17 How many people, including your Mom and Dad, live in your house?            22 
                                            
                            
18 Are your parents working? If so, what do they do for a living?            23 
                            
    Mother Yes / No     Father  Yes / No        
                                           24 
                                            
                            
19 Is anyone else (brother, sister, cousin, etc) in your house working? Who?         25 
                            
    a) Yes 1      b) No 2              
                            
    Who?                                 26 
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HABITUAL PHYSICAL AND LEISURE TIME ACTIVITY SURVEY 
                              
        
Name & Reference Number                   
      
                              
                              
1 How many days per week do you walk for at least 10 minutes (for recreation, pleasure    1 
 or exercise)?                         
                              
 a) 0 days 1  b) 1-2 days 2   c) 3-5 days 3   d) more 4       
                                              
                    
 
  
       
2 How many times per week do you participate in after-school sports activities  
    2 
 (extramural Activities)?            
 
  
       
                              
 a) 0 days 1  b) 1-2 days 2   c) 3-5 days 3   d) more 4       
                                              
                              
3 If you never participate in sports activities, please stat the reason for this  
     3 
 non-participation.                 
       
                                                    
                                                    
                                              
                              
4 In which sports do you participate? 
                 4 
                              
 a) Chess 1  
b) 
Tennis 2   c) Rugby 3   d)Swimming 4        
                              
 e) Netball 5  
f) 
Cricket 6   g) Soccer 7   h) Other  8        
                              
 If other, please specify                                   
                                              
          
                    
5 If you play after school in the afternoon, which games do you usually play? 
     5 
          
                    
 a) Dolls 1   b) Tennis 2   c) Rugby 3   d)Swimming 4       
 
                             
 e)Board games 5   f) Cricket 6   g) Soccer 7   
h) 
Other  8       
               
                               
          
                    
6 Where do you normally play? 
                   6 
                              
 a) Street 1  b) Backyard 2    c) In house 3   d)Other  4     
                                              
                              
7 Does your school offer physical education as a school subject?  
        7 
                              
 a) Yes 1     b) No 2                   
                                              
                           
   
8 If you answered yes at (7), how many days do you have physical education?  
   8 
                              
 a) 0 days 1  b) 1-2 days 2   c) 3-5 days 3   d) more 4       
                                              
                            
  
9 How many days per week do you spend watching TV or playing Computer games? 
  9 
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 a) 0 days 1  b) 1-2 days 2   c) 3-5 days 3   d) more 4       
                                              
                              
1
0 How often do you participate in the following activities?          
  
1
0 
                              
 
ACTIVITY Never 
Sometime
s Often 
Very 
often Always 
      
 Waching TV                                             
 Computer Games                                           
 Cycling, Dancing, Swimming                                       
 Household Chores                                           
 Other                                                 
                                              
                              
      
Thank you for participating in our survey 
           
                              
 
 
 
 
                             
   
UNIVERSITY OF STELLENBOSCH AND CAPE PENINSULA UNIVERSITY OF TECHNOLOGY 
   
      
      
   
BODY MEASUREMENTS DATA COLLECTION SHEET 
    
       
                             
                             
                             
                             
 Reference Number         Date of Interview           
                  
0           
         
              y y m m d d          
                             
                             
1 Did Subject eat this morning?                   1 
                            
 
 Age of Participant (years)                    2 
                            
 
2 Birth weight (kg)                       3 
 Body Weight (kg)                       4 
 Body Height (cm)                       5 
 Body Mass Index [BM] (m/kg2)    
  
              6 
 
             
              
 
 CIRCUMFERENCE MEASUREMENT 
    
             
 
3 Mid-upper arm Circumference 1 (cm)                    
 Mid-upper arm Circumference 2 (cm)                    
 Mid-upper arm Circumference 3 (cm)                    
 Mid-upper arm Circumference (cm)  
  
         
  
   
 
                            
 
4 Waist Circumference 1 (cm)                      
 Waist Circumference 2 (cm)                      
 Waist Circumference 3(cm)                      
 Waist Circumference (cm)     
 
         
  
   
 
                            
 
 Waist hip ratio 1                        
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 Waist hip ratio 2                        
 Waist hip ratio 3                        
 Waist Hip Ratio        
 
              
 
                            
 
 SKINFOLD MEASUREMENTS                    
 
5 Triceps skinfold 1 (cm)                       
 Triceps skinfold 2 (cm)                       
 Triceps skinfold 3 (cm)                       
 Triceps skinfold (cm)       
 
         
  
   
 
                            
 
 Biceps skinfold 1 (cm)                       
 Biceps skinfold 2 (cm)                       
 Biceps skinfold 3 (cm)                       
 Biceps Skinfold (cm)       
 
         
  
   
 
 
 
 
 
                           
 
 Sub-scapular skinfold 1 (cm)                     
 Sub-scapular skinfold 2 (cm)                     
 Sub-scapular skinfold 3 (cm)                     
 Sub-scapular skinfold (cm)     
 
         
  
   
 
                            
 
 Supra-iliac skinfold 1 (cm)                      
 Supra-iliac skinfold 2 (cm)                      
 Supra-iliac skinfold 3 (cm)                      
 Supra-iliac skinfold (cm)      
 
         
  
   
 
 SUM OF SKINFOLDS                  
  
   
 
                            
 
                            
 
 BLOOD PRESSURE MEASUREMENTS                 
 
 Systolic Pressure 1 (mmHg)                      
 Systolic Pressure 2 (mmHg)                      
 Systolic Pressure 3 (mmHg)                      
 Systolic Pressure        
 
              
 
                            
 
 Diastolic Pressure 1 ((mmHg)                     
 Diastolic Pressure 2 ((mmHg)                     
 Diastolic Pressure 3 ((mmHg)                     
 Diastolic Pressure        
 
              
 
                            
 
                            
 
 Pulse 1 (Beats per minute)                      
 Pulse 2 (Beats per minute)                      
 Pulse 3 (Beats per minute)                      
 Mean Pulse          
 
              
 
                            
 
                            
 
 Systolic Pressure (mmHg)                      
 Diastolic Pressure (mmHg)                      
                            
 
 BLOOD GLUCOMETER ANALYSES                  
 
 Glucose (mmol/L)                        
                            
 
 URINALYSIS                        
 
 Glucose mmol/L (N=Negative, P=Positive)   P  N             
  223
 Protein mmol/L (N=Negative, P=Positive)    P  N             
 Microalbumin µmol/l                       
                             
 
CARDIOCHEK ANALYSIS 
                     
 Cholesterol                          
 Triglycerides                         
 HDL                           
 LDL                           
                             
 
BLOOD ANALYSIS  
                     
 Microalbumin                         
 C-reactive Protein (CRP)                      
 
 
 
 
 
 
 
 
 
                            
                             
 
For Official Use Only 
                      
                             
 Were any measurements repeated     Y   N            
                             
 If yes, which one(s) and what was the repeated measurement?             
                             
 ________________________________                   
 ________________________________                   
 ________________________________                   
 ________________________________                   
                             
 Were all QC procedures perfomed to ensure accuracy and reliability? Y   N       
                             
 
 
 
                            
 Controlled and Signed by _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date: _ _ _ _ _ _ _ _ _ _     
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APPENDIX D: SOLUTIONS 
Phosphate Buffered Saline (PBS)- pH 7.4 
0.2 g KCl 
8.0 g NaCl 
0.2 g KH2PO4 
1.15 g NA2HPO4 
Add all components, one at a time to 900 ml of dH2O, then dissolve by adding dH2O to 1 L. 
 
6 M Sodium Chloride (NaCl) 
350.64 g of NaCl was dissolved in 800 ml of dH2O and then the volume was adjusted to 1 L with 
dH2O. 
 
Nuclear Lysis Buffer (500 ml)- pH 8.2 
11.5 g NaCl 
10 ml Tris (1M stock) 
10 ml EDTA (10mM stock). 
 
Lysis Buffer- pH 7.4 
31 ml from NH4Cl (1M stock) 
1 ml of KHCO3 (1M stock) 
100µl of EDTA (100mM stock) 
 
1X Tris EDTA (TE) Buffer 
10 mM Tris (10 ml 1 mM stock) 
1 mM EDTA (2 ml of 0.5M stock) 
Made up to 1 L with dH2O 
 
Ethidium Bromide (EtBr) Stain (10 mg/ml) 
 
1 g EtBr in 100 ml dH2O was added together and stored in a dark bottle 
 
10% (w/v) Sodium Dodecyl Sulphate (pH 7. 2) 
10 g of electrophoresis-grade SDS was dissolved in 100 ml dH2O. 
The solution was heated and stirred with a magnet stirrer to assist dissolution. 
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Loading Buffer (Bromophenol blue) 
0.2 g (2%) BPB powder 
1 ml (10 mM) of 1M Tris stock (pH 8.0) 
50 ml (50%) Glycerol 
49 ml dH2O 
 
 20X Sodium Borate (SB) Buffer 
Dissolve 38.137 g of SB powder in dH2O and add up to 1 L. 
 
SSCP Gel preparation 
Components 8% 10% 
Urea 24 g 24 g 
distilled H2O 91.8 ml 84 ml 
 
10XTBE 8ml 8ml 
Glycerol 8ml 8ml 
10% APS 1.6ml 1.6ml 
TEMED 160
l 160
l 
 
SSCP Loading dye  
• 95% formamide  
• 20 mM EDTA  
• 0.01% Bromophenol Blue 
• 0.05% of Xylene cyanol. 
 
Method: 
Glass plates and tanks were cleaned and prepared. A sheet of Gelbond® PAG film (Cambrex Bio 
science, Rockland, USA), was placed between the glass plates where it covalently bonded to the 
acrylamide gel during polymerization, thus providing support. Urea, sterile distilled H2O, 10X TBE and 
glycerol was added to a sterile beaker and mixed by stirring. 10% APS and TEMED were added last 
(Table A). The solution was then immediately poured into the cast that had previously been prepared. 
The gels were kept in the cast until set. Meanwhile, 0.5X TBE running buffer was poured into the 
tank. The samples were prepared by combining equal volumes of SSCP loading dye to the samples 
and denatured at 94.5ºC for 5 minutes. The samples were incubated on ice for 5 minutes or until just 
before loading. The gels were run at 23 Watts at 4ºC overnight. 
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Silver staining of SSCP gels 
Reagents: 
• 1% AgNO3 (Solution B) : 
• 1g AgNO3 was dissolved in distilled H2O to make up 1L. 
• Developing Solution (Solution C): 
• 15 g NaOH; 0.1g of NaBH4 and 4ml of Formaldehyde was dissolved in sterile 
• Distilled H2O to make up 1L. 
Method: 
500ml Solution B was added to a tray containing the SSCP gel .The gel was stained for 10 minutes on 
a shaker. Solution B was discarded and the gel was rinsed with distilled H2O. 500ml Solution C was 
then added to the tray containing the gel and placed on a shaker for a further 15 minutes or until the 
bands were clearly visible. The solution was discarded and the gel was once again rinsed with distilled 
H2O. The gels were then left to dry and sealed in plastic. 
 
